data_1l2y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1l2y _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -66.47 -30.9 71.34 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 mm -65.22 -45.94 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.767 1.227 . . . . 0.0 109.345 174.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.75 -30.35 71.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.46 0.704 . . . . 0.0 112.719 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.5 t90 -73.14 -43.42 61.63 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.965 0.802 . . . . 0.0 112.485 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.2 mt -64.88 -43.25 93.51 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.99 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -25.7 64.69 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.653 1.115 . . . . 0.0 113.921 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.99 -8.82 58.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.908 1.683 . . . . 0.0 113.646 174.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.78 8.08 24.77 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.373 1.463 . . . . 0.0 114.798 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.24 -124.37 32.77 Favored Glycine 0 CA--C 1.541 1.713 0 CA-C-N 118.825 1.312 . . . . 0.0 112.149 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.98 -28.77 84.35 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.794 2.33 . . . . 0.0 113.813 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.7 m -81.83 19.13 1.14 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.089 1.356 . . . . 0.0 113.737 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.06 13.4 9.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.843 1.257 . . . . 0.0 113.82 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.93 25.22 74.35 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.471 -0.768 . . . . 0.0 114.505 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -143.95 131.3 10.57 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.873 1.269 . . . . 0.0 111.893 -172.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.1 160.07 50.92 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.82 2.347 . . . . 0.0 111.692 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.48 145.67 59.48 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.472 2.115 . . . . 0.0 111.422 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 CA--C 1.539 0.759 0 C-N-CA 123.169 2.579 . . . . 0.0 110.894 176.285 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -54.78 -31.94 59.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.07 1.748 . . . . 0.0 113.742 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.6 mt -59.68 -49.11 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.45 1.1 . . . . 0.0 109.474 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -33.18 74.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.487 1.115 . . . . 0.0 111.799 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -66.8 -45.94 76.78 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.3 mt -61.18 -37.0 81.36 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.938 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -52.99 -33.48 51.65 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.025 0.93 . . . . 0.0 113.282 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.408 ' C ' ' HG ' ' A' ' 14' ' ' SER . 7.8 t0 -75.19 -11.09 60.0 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.336 1.454 . . . . 0.0 112.549 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.09 10.34 28.15 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.476 -1.39 . . . . 0.0 115.374 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.27 -125.2 38.76 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 118.672 1.236 . . . . 0.0 113.086 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.26 -23.17 61.05 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.446 2.098 . . . . 0.0 114.305 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.82 7.26 18.51 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.074 0.95 . . . . 0.0 113.263 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.408 ' HG ' ' C ' ' A' ' 9' ' ' ASP . 6.0 m -103.95 1.87 31.73 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.842 1.657 . . . . 0.0 114.422 -174.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.79 -37.52 1.25 Allowed Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.831 1.205 . . . . 0.0 115.019 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.2 ttp-105 -75.92 131.69 75.73 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.934 1.293 . . . . 0.0 111.36 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.09 162.4 32.96 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.328 2.685 . . . . 0.0 113.069 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.71 142.3 57.68 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.063 2.509 . . . . 0.0 112.376 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 CA--C 1.538 0.677 0 C-N-CA 123.409 2.739 . . . . 0.0 110.752 177.53 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -57.54 -36.5 71.7 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.839 0.856 . . . . 0.0 112.917 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.3 mt -62.92 -44.92 99.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.923 1.289 . . . . 0.0 110.533 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -46.52 89.17 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.437 1.095 . . . . 0.0 110.776 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -64.05 -43.56 95.16 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.1 mt -63.07 -36.06 82.32 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.26 -0.9 . . . . 0.0 112.454 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -56.13 -33.51 65.23 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.456 1.025 . . . . 0.0 113.079 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -71.95 -5.99 38.77 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 118.958 0.799 . . . . 0.0 113.056 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.33 -2.05 32.9 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.704 1.621 . . . . 0.0 114.183 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.77 -129.12 46.32 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 118.655 1.228 . . . . 0.0 111.277 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -54.77 -29.76 63.92 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.81 2.34 . . . . 0.0 114.253 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 p -67.21 -23.68 65.76 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.85 -6.43 56.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.05 -31.49 1.1 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.801 1.191 . . . . 0.0 115.159 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -64.15 135.28 96.26 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 118.82 1.31 . . . . 0.0 110.592 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.4 159.86 45.5 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.875 2.383 . . . . 0.0 112.847 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.99 162.81 41.41 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.383 2.722 . . . . 0.0 112.74 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.537 0.652 0 C-N-CA 123.616 2.877 . . . . 0.0 114.327 179.156 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.55 -30.97 68.99 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.126 0.97 . . . . 0.0 113.418 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.2 -51.19 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.074 0.949 . . . . 0.0 109.462 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -56.53 -48.06 78.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.452 1.101 . . . . 0.0 111.567 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -57.54 -46.99 83.22 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -65.07 -39.71 93.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.272 -0.87 . . . . 0.0 112.547 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -54.72 -40.0 68.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.236 1.015 . . . . 0.0 112.389 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -76.66 -11.85 59.91 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.014 1.326 . . . . 0.0 113.388 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.81 9.28 6.35 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.165 1.364 . . . . 0.0 115.714 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.06 -108.74 0.53 Allowed Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.383 1.468 . . . . 0.0 113.446 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.01 -27.66 65.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.537 2.158 . . . . 0.0 114.499 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.3 p -89.61 7.34 36.99 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -84.14 -5.23 59.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.006 1.322 . . . . 0.0 114.427 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.28 17.5 77.55 Favored Glycine 0 CA--C 1.538 1.494 0 O-C-N 120.561 -1.337 . . . . 0.0 115.171 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -143.27 143.64 25.21 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.502 1.521 . . . . 0.0 110.401 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.28 157.93 55.1 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.635 2.223 . . . . 0.0 112.767 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.89 140.7 39.01 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.205 2.603 . . . . 0.0 111.547 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 C-N-CA 123.205 2.603 . . . . 0.0 110.902 176.482 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -39.32 66.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.364 1.466 . . . . 0.0 113.701 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.5 mp -61.26 -50.03 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.016 0.927 . . . . 0.0 110.758 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -64.82 -37.82 88.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.389 0.676 . . . . 0.0 111.658 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -61.39 -46.32 90.65 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 172.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.5 mt -59.64 -37.11 77.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.96 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -57.06 -31.95 65.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.2 -19.84 63.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.267 1.027 . . . . 0.0 112.763 175.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.08 5.66 8.75 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 126.004 1.764 . . . . 0.0 114.549 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.94 -133.7 51.03 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 119.026 1.413 . . . . 0.0 112.198 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.21 -29.12 55.17 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.643 2.895 . . . . 0.0 114.464 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -81.44 21.32 0.79 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.803 1.641 . . . . 0.0 113.78 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.28 8.43 9.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.64 1.576 . . . . 0.0 113.317 -169.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.53 24.98 73.93 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.3 1.429 . . . . 0.0 114.784 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -148.93 134.08 9.37 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.974 1.31 . . . . 0.0 112.023 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.56 161.72 44.47 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.235 2.624 . . . . 0.0 112.029 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.79 146.25 65.6 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.01 2.473 . . . . 0.0 112.611 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo . . . . . 0 CA--C 1.538 0.699 0 C-N-CA 123.786 2.99 . . . . 0.0 111.086 178.117 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -54.35 -32.06 55.92 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.572 2.749 . . . . 0.0 113.588 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.46 -46.98 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.979 0.911 . . . . 0.0 110.718 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -44.25 96.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.252 0.621 . . . . 0.0 111.142 175.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -62.92 -39.33 94.24 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.75 -38.36 90.73 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.043 -1.035 . . . . 0.0 112.16 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -54.79 -33.78 61.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.302 1.041 . . . . 0.0 113.562 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -67.38 -20.35 65.54 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.429 1.013 . . . . 0.0 113.469 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.37 8.02 9.58 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.0 1.286 . . . . 0.0 114.889 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.49 -133.77 51.8 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-N 119.139 1.469 . . . . 0.0 112.183 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.75 -31.3 60.61 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.505 2.803 . . . . 0.0 114.726 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.2 m -77.09 10.13 2.57 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.614 1.166 . . . . 0.0 113.808 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -98.96 -1.81 38.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.467 1.507 . . . . 0.0 114.272 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -38.95 0.89 Allowed Glycine 0 CA--C 1.54 1.631 0 C-N-CA 125.043 1.306 . . . . 0.0 114.643 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -73.85 136.53 76.88 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.036 1.334 . . . . 0.0 112.283 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -70.64 161.3 46.55 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.334 2.689 . . . . 0.0 112.144 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.3 147.75 66.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.792 2.328 . . . . 0.0 111.723 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 CA--C 1.536 0.616 0 C-N-CA 123.075 2.516 . . . . 0.0 113.756 -179.122 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mt . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -54.24 -39.51 66.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.412 1.085 . . . . 0.0 113.406 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.25 -45.13 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.825 0.85 . . . . 0.0 110.627 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -34.93 77.34 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.339 1.455 . . . . 0.0 112.262 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -65.01 -47.19 78.36 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.661 0.784 . . . . 0.0 111.769 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.9 mt -60.75 -30.18 69.85 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 118.022 -0.989 . . . . 0.0 113.63 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -54.04 -34.85 61.11 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -74.09 -48.02 32.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.45 0.7 . . . . 0.0 111.079 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.9 26.91 0.02 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.373 0.987 . . . . 0.0 115.252 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.68 -133.38 43.72 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 118.869 1.335 . . . . 0.0 112.332 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -55.74 -28.77 68.33 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.026 2.484 . . . . 0.0 114.525 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.2 m -75.78 3.29 10.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.439 1.095 . . . . 0.0 113.679 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 m -81.75 -7.87 59.64 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.403 1.481 . . . . 0.0 114.169 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.05 12.29 84.78 Favored Glycine 0 CA--C 1.539 1.537 0 O-C-N 120.982 -1.074 . . . . 0.0 115.009 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -143.86 138.0 14.76 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.993 1.317 . . . . 0.0 111.167 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.87 161.01 41.22 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.948 2.432 . . . . 0.0 113.016 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.73 162.59 41.49 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.489 2.793 . . . . 0.0 112.708 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 CA--C 1.539 0.772 0 C-N-CA 123.592 2.861 . . . . 0.0 114.149 177.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -62.66 -33.79 75.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.1 mm -64.9 -45.53 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.069 0.948 . . . . 0.0 109.737 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.64 -38.89 92.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.158 0.583 . . . . 0.0 112.254 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -63.03 -45.13 93.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.021 0.828 . . . . 0.0 112.694 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.0 mt -58.65 -37.42 75.92 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.273 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -57.08 -27.65 61.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.738 1.215 . . . . 0.0 114.22 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.92 -20.14 60.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.776 0.831 . . . . 0.0 112.575 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.35 10.07 6.85 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.776 1.655 . . . . 0.0 114.751 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.24 -134.96 52.12 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-N 118.968 1.384 . . . . 0.0 111.823 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.89 -27.22 61.95 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.608 2.872 . . . . 0.0 114.893 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m -78.31 12.18 2.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.173 0.989 . . . . 0.0 113.62 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 m -107.19 -4.08 19.17 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.822 1.649 . . . . 0.0 113.905 -170.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.64 19.44 76.51 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 119.176 -0.791 . . . . 0.0 114.817 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -135.5 134.14 20.85 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 125.395 1.478 . . . . 0.0 111.839 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.98 160.05 51.47 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.768 2.312 . . . . 0.0 111.917 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.61 149.04 60.85 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.881 2.387 . . . . 0.0 112.012 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 CA--C 1.541 0.858 0 C-N-CA 124.074 3.182 . . . . 0.0 114.387 -179.062 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.39 -38.91 85.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.995 1.718 . . . . 0.0 113.032 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.1 mp -60.25 -47.28 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.791 0.836 . . . . 0.0 110.693 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -63.46 -38.1 89.86 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.372 0.669 . . . . 0.0 112.449 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -64.49 -45.32 87.81 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.868 0.758 . . . . 0.0 112.487 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.8 mt -60.58 -40.45 91.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.384 -0.817 . . . . 0.0 112.696 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -51.32 -34.12 32.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.136 1.374 . . . . 0.0 114.179 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -71.65 -39.97 69.99 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.572 0.749 . . . . 0.0 111.866 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.76 12.64 0.08 OUTLIER Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.45 -134.87 51.62 Favored Glycine 0 CA--C 1.543 1.836 0 CA-C-N 119.614 1.707 . . . . 0.0 112.416 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.8 -26.2 81.54 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.057 2.504 . . . . 0.0 115.565 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.1 p -82.14 8.5 10.73 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.649 1.113 . . . . 0.0 113.673 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -91.62 -4.27 55.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.807 2.043 . . . . 0.0 114.524 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.03 -38.33 1.76 Allowed Glycine 0 CA--C 1.539 1.59 0 O-C-N 120.583 -1.323 . . . . 0.0 114.886 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -74.44 135.49 75.6 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 118.847 1.324 . . . . 0.0 111.199 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -67.32 160.07 49.37 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.153 2.569 . . . . 0.0 113.192 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.03 139.53 39.53 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.099 2.533 . . . . 0.0 111.814 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo . . . . . 0 CA--C 1.538 0.723 0 C-N-CA 123.234 2.623 . . . . 0.0 110.913 175.72 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.42 -30.22 66.72 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.849 1.259 . . . . 0.0 113.952 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 mp -59.0 -48.13 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.719 0.808 . . . . 0.0 110.413 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -31.11 72.18 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.213 1.405 . . . . 0.0 112.456 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -76.39 -43.61 39.81 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.702 0.801 . . . . 0.0 112.804 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.6 mt -65.56 -43.98 88.18 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.939 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -19.41 56.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -15.86 58.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.241 1.417 . . . . 0.0 113.121 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.84 6.01 11.6 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.338 1.447 . . . . 0.0 114.671 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.93 -128.52 43.56 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 119.189 1.494 . . . . 0.0 112.04 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.62 -34.21 72.41 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.51 2.807 . . . . 0.0 114.545 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.4 m -74.98 7.04 3.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.717 1.207 . . . . 0.0 114.054 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -95.08 -11.28 28.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.7 27.89 66.29 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 118.8 0.727 . . . . 0.0 114.631 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.91 140.44 15.63 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.111 1.364 . . . . 0.0 111.684 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -70.67 160.32 49.83 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.067 2.512 . . . . 0.0 111.916 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.04 154.48 62.63 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.674 2.249 . . . . 0.0 112.141 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo . . . . . 0 CA--C 1.536 0.606 0 C-N-CA 123.62 2.88 . . . . 0.0 111.467 178.617 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -35.51 72.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.297 1.039 . . . . 0.0 112.345 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.25 -51.09 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.649 1.18 . . . . 0.0 109.621 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -55.68 -47.56 76.55 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.756 1.223 . . . . 0.0 111.836 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.0 t90 -61.59 -47.1 87.02 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.2 mt -63.42 -34.6 78.1 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.598 -0.689 . . . . 0.0 112.5 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -58.36 -36.6 73.72 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.75 1.22 . . . . 0.0 113.092 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.9 -21.1 63.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.025 0.93 . . . . 0.0 112.367 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.87 20.52 6.02 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.48 1.514 . . . . 0.0 113.708 -175.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.71 -124.69 30.29 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.061 1.43 . . . . 0.0 112.742 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -58.29 -23.88 64.92 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.488 2.125 . . . . 0.0 114.431 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.3 p -60.97 -31.22 70.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.209 0.913 . . . . 0.0 112.924 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -81.19 -5.08 57.32 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.917 1.287 . . . . 0.0 113.25 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.91 -27.63 1.95 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.616 1.579 . . . . 0.0 115.206 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -64.02 137.14 97.02 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 118.793 1.297 . . . . 0.0 111.14 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.22 161.23 46.7 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.119 2.546 . . . . 0.0 113.004 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.5 148.09 53.36 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.08 2.52 . . . . 0.0 112.105 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 123.128 2.552 . . . . 0.0 110.551 176.897 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -58.69 -39.79 81.76 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.95 1.7 . . . . 0.0 112.82 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.457 ' H ' HD11 ' A' ' 4' ' ' ILE . 3.6 mp -56.15 -45.07 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.384 1.074 . . . . 0.0 110.814 175.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -52.16 65.5 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.444 0.698 . . . . 0.0 111.062 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.7 t90 -61.22 -39.1 89.01 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.14 -37.1 85.88 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.343 -0.848 . . . . 0.0 111.876 171.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -58.81 -31.71 68.69 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -66.07 -24.0 66.64 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.938 0.79 . . . . 0.0 113.071 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.98 10.25 6.96 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 124.937 1.256 . . . . 0.0 115.286 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.39 -127.07 38.66 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 118.794 1.297 . . . . 0.0 113.554 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.46 -23.67 57.01 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.917 2.411 . . . . 0.0 114.714 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.7 m -83.39 2.54 35.92 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -93.44 -3.5 52.99 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.51 -39.72 0.75 Allowed Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.793 1.187 . . . . 0.0 114.757 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -68.6 137.51 90.73 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.789 1.235 . . . . 0.0 112.099 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.14 159.18 52.95 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.081 2.521 . . . . 0.0 112.359 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.18 156.2 46.8 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.062 2.508 . . . . 0.0 113.157 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo . . . . . 0 CA--C 1.542 0.917 0 C-N-CA 125.034 3.823 . . . . 0.0 114.168 178.131 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.04 -33.53 65.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.583 1.553 . . . . 0.0 113.513 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -63.57 -50.79 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.015 0.926 . . . . 0.0 110.767 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.89 -42.08 97.28 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.409 0.684 . . . . 0.0 111.667 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -62.03 -46.07 90.78 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.7 mt -60.87 -37.77 83.29 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.928 -1.107 . . . . 0.0 112.538 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -56.68 -28.26 60.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.95 0.796 . . . . 0.0 112.587 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.475 ' C ' ' HG ' ' A' ' 14' ' ' SER . 65.3 m-20 -75.92 -11.01 59.89 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.269 -0.894 . . . . 0.0 113.187 174.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.71 11.25 27.13 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-N 120.293 1.406 . . . . 0.0 115.714 -172.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.9 -127.79 44.99 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 124.727 1.156 . . . . 0.0 113.475 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.98 -20.68 46.14 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.693 2.262 . . . . 0.0 114.657 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.5 p -88.95 4.97 46.27 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.705 1.202 . . . . 0.0 114.177 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.475 ' HG ' ' C ' ' A' ' 9' ' ' ASP . 12.6 m -99.13 -1.17 40.1 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -172.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.79 -34.95 1.21 Allowed Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.733 1.159 . . . . 0.0 115.009 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -72.86 133.76 81.86 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.682 1.241 . . . . 0.0 110.967 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.38 157.74 58.73 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.816 2.344 . . . . 0.0 112.746 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.15 134.93 28.28 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.336 2.69 . . . . 0.0 111.313 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 CA--C 1.537 0.67 0 C-N-CA 122.564 2.176 . . . . 0.0 110.736 175.902 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.46 -33.62 74.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.845 1.258 . . . . 0.0 113.126 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.4 mt -58.56 -50.38 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.767 1.227 . . . . 0.0 109.955 176.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -41.89 96.27 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.845 1.258 . . . . 0.0 111.593 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -62.81 -43.57 98.44 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.22 -35.93 82.6 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.344 -0.836 . . . . 0.0 112.532 173.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -54.07 -37.95 64.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.469 1.108 . . . . 0.0 113.475 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -83.38 -8.42 59.41 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.582 1.953 . . . . 0.0 112.744 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.98 23.17 5.66 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.747 1.642 . . . . 0.0 115.067 177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 48.8 -108.99 0.47 Allowed Glycine 0 CA--C 1.54 1.595 0 C-N-CA 126.495 1.998 . . . . 0.0 113.708 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.12 -28.67 62.07 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.005 2.47 . . . . 0.0 114.3 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -82.69 -0.04 45.59 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.2 m -82.42 -3.67 56.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.459 1.504 . . . . 0.0 115.003 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.43 17.51 79.11 Favored Glycine 0 CA--C 1.539 1.573 0 O-C-N 121.178 -0.952 . . . . 0.0 115.26 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -153.85 144.82 16.18 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 125.472 1.509 . . . . 0.0 111.448 -172.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.52 164.74 34.19 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.532 2.821 . . . . 0.0 112.695 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.91 138.78 54.2 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.147 2.565 . . . . 0.0 112.651 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 CA--C 1.54 0.789 0 C-N-CA 123.633 2.889 . . . . 0.0 112.114 -179.4 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.99 -38.53 73.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.815 1.246 . . . . 0.0 112.649 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.49 -50.22 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 123.926 0.89 . . . . 0.0 110.552 176.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -62.07 -42.27 99.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.323 0.649 . . . . 0.0 111.979 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.8 t90 -60.72 -39.66 89.41 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.7 mt -66.42 -37.66 85.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 117.999 -1.001 . . . . 0.0 112.892 173.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -53.41 -39.77 64.59 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.736 1.153 . . . . 0.0 113.376 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.51 -11.96 61.26 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.22 14.42 9.88 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.326 0.965 . . . . 0.0 114.521 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.91 -120.21 8.79 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 117.998 -1.446 . . . . 0.0 112.219 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -54.7 -28.24 55.78 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.468 2.778 . . . . 0.0 114.466 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.9 p -79.6 2.97 20.4 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -88.96 -8.95 53.16 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.27 20.08 79.7 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 114.957 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.3 138.87 16.98 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 125.405 1.482 . . . . 0.0 110.681 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.58 159.36 48.43 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.882 2.388 . . . . 0.0 112.548 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.44 148.0 59.72 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.803 2.336 . . . . 0.0 111.711 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.538 0.7 0 C-N-CA 123.228 2.619 . . . . 0.0 111.418 175.883 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -62.1 -39.69 93.35 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mp -58.97 -51.5 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.771 1.229 . . . . 0.0 110.344 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -55.13 -46.54 75.63 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.175 0.99 . . . . 0.0 112.477 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -63.97 -47.29 80.98 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.69 -39.21 87.65 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.039 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -57.22 -34.45 68.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.89 1.276 . . . . 0.0 112.929 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -17.54 61.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.418 1.087 . . . . 0.0 112.722 176.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.75 5.86 8.89 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.762 1.648 . . . . 0.0 114.204 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.56 -124.07 32.27 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.026 -1.43 . . . . 0.0 111.509 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.27 -33.71 85.75 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.212 2.608 . . . . 0.0 114.299 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.4 m -60.75 -23.17 64.75 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.761 0.824 . . . . 0.0 112.932 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.67 -12.94 61.87 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.804 1.642 . . . . 0.0 113.199 175.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.89 12.09 74.57 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.051 0.834 . . . . 0.0 114.844 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -120.85 138.28 27.5 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.918 1.687 . . . . 0.0 110.09 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.38 158.67 43.78 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.844 2.363 . . . . 0.0 112.784 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.58 154.26 68.7 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.836 2.357 . . . . 0.0 112.372 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 123.635 2.89 . . . . 0.0 111.358 176.72 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.83 -35.52 73.02 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.695 0.798 . . . . 0.0 112.899 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 mm -64.69 -46.47 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.095 0.958 . . . . 0.0 109.971 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -59.45 -45.96 90.11 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.036 0.534 . . . . 0.0 111.744 175.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -60.07 -44.51 94.69 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.67 -38.65 88.57 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.456 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -56.84 -35.23 68.59 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.108 0.963 . . . . 0.0 113.573 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.36 -23.23 66.3 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.17 0.988 . . . . 0.0 112.447 175.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.54 11.18 5.65 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.721 1.629 . . . . 0.0 114.61 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.55 -134.83 52.32 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 118.857 -0.968 . . . . 0.0 111.648 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.5 -21.15 44.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.711 2.941 . . . . 0.0 114.414 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.0 p -86.47 21.1 2.22 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.952 1.301 . . . . 0.0 114.075 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.0 11.76 10.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.271 1.428 . . . . 0.0 112.969 -171.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.12 23.19 71.26 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.478 1.037 . . . . 0.0 114.143 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -144.51 130.56 9.81 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.032 1.333 . . . . 0.0 112.149 -175.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.95 166.67 28.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.285 2.656 . . . . 0.0 112.334 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.97 142.54 69.03 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.132 2.555 . . . . 0.0 112.172 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.458 -0.587 0 C-N-CA 123.494 2.796 . . . . 0.0 110.147 178.884 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.553 1.075 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -61.0 -35.77 77.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.022 1.729 . . . . 0.0 113.239 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.88 -41.82 94.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.132 0.973 . . . . 0.0 111.073 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -66.78 -39.72 87.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.854 0.862 . . . . 0.0 111.531 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -62.8 -46.14 89.38 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.8 mt -60.62 -37.68 82.23 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.689 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.07 -34.13 59.3 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.212 0.914 . . . . 0.0 113.0 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -80.74 -2.81 48.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.899 0.88 . . . . 0.0 113.298 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.61 9.23 31.29 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.896 -1.127 . . . . 0.0 115.555 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 52.14 -114.65 3.42 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.118 1.342 . . . . 0.0 113.218 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.12 -24.23 48.64 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.506 2.138 . . . . 0.0 114.416 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 4.03 41.48 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.165 0.986 . . . . 0.0 113.631 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 m -93.47 4.34 54.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.785 1.634 . . . . 0.0 114.711 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.47 13.01 67.53 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.019 -1.051 . . . . 0.0 114.823 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -144.96 137.63 13.6 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.497 1.519 . . . . 0.0 110.788 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.27 162.03 35.1 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.924 2.416 . . . . 0.0 112.657 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.34 146.64 69.69 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.852 2.368 . . . . 0.0 112.168 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.454 -0.817 0 C-N-CA 122.68 2.253 . . . . 0.0 110.133 173.055 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -59.23 -38.59 80.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.495 1.518 . . . . 0.0 113.632 -174.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 mp -59.82 -50.95 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 110.299 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -40.72 92.2 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.902 0.881 . . . . 0.0 112.703 176.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -60.69 -45.41 94.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.248 0.619 . . . . 0.0 112.563 173.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.8 mt -61.96 -44.1 97.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.432 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -54.45 -35.47 63.03 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.28 0.946 . . . . 0.0 113.238 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.04 -32.71 72.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.295 0.638 . . . . 0.0 112.444 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.56 4.3 2.5 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.989 1.281 . . . . 0.0 114.843 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.23 -125.97 40.67 Favored Glycine 0 CA--C 1.54 1.625 0 CA-C-N 118.794 1.297 . . . . 0.0 112.154 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.74 -25.32 75.38 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.648 2.232 . . . . 0.0 114.147 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.2 m -80.04 7.92 8.14 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 m -108.55 7.18 26.61 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.815 1.646 . . . . 0.0 114.522 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.49 19.86 74.94 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 114.07 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -137.62 128.17 15.76 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.607 1.563 . . . . 0.0 111.44 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.96 165.13 31.08 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.006 2.471 . . . . 0.0 111.863 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.13 135.63 51.86 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.729 2.286 . . . . 0.0 111.355 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 122.454 2.103 . . . . 0.0 110.777 176.443 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -57.04 -37.15 71.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.946 1.698 . . . . 0.0 113.646 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -56.94 -50.62 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.547 0.739 . . . . 0.0 109.897 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -44.43 96.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.694 1.198 . . . . 0.0 111.224 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.5 t90 -59.92 -47.1 87.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.79 0.836 . . . . 0.0 113.031 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.7 mt -61.86 -41.31 97.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.534 -0.746 . . . . 0.0 112.156 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -55.97 -36.22 67.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.658 1.183 . . . . 0.0 112.35 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.04 -22.64 63.06 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.066 0.946 . . . . 0.0 113.44 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.2 5.31 6.21 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.543 1.544 . . . . 0.0 114.906 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.61 -123.8 29.61 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 119.054 1.427 . . . . 0.0 112.34 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -58.11 -29.5 87.38 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.553 2.169 . . . . 0.0 113.863 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 t -64.51 -18.8 65.14 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.84 -4.64 58.83 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.461 1.904 . . . . 0.0 112.707 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.39 -35.73 0.97 Allowed Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.569 1.557 . . . . 0.0 114.68 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -62.42 133.4 94.56 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.951 1.3 . . . . 0.0 111.016 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.49 163.23 33.31 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.359 2.706 . . . . 0.0 113.128 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.79 159.34 51.83 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.0 2.467 . . . . 0.0 112.662 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 CA--C 1.538 0.689 0 C-N-CA 123.42 2.747 . . . . 0.0 114.606 179.513 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.04 -34.53 68.31 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.32 1.048 . . . . 0.0 113.16 177.397 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.9 mm -62.83 -47.6 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.522 0.729 . . . . 0.0 109.665 176.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -42.63 99.21 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.799 0.84 . . . . 0.0 111.133 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -61.42 -47.51 85.45 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.41 -36.11 81.33 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.718 -0.614 . . . . 0.0 112.085 174.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.5 tttp -58.89 -35.57 73.23 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.278 1.031 . . . . 0.0 113.376 178.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.5 -7.16 45.77 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.098 1.759 . . . . 0.0 113.502 173.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.81 10.1 29.18 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.071 1.32 . . . . 0.0 114.547 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.9 -129.62 49.81 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-N 119.319 1.559 . . . . 0.0 111.752 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -57.78 -27.29 77.39 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.652 2.234 . . . . 0.0 113.941 178.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.1 m -62.51 -33.47 74.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.887 0.875 . . . . 0.0 112.87 -177.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -15.06 62.7 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 176.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.05 35.79 23.28 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 118.593 0.633 . . . . 0.0 113.828 177.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 143.21 36.84 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.016 1.326 . . . . 0.0 111.761 -178.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.45 160.04 47.75 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.261 2.641 . . . . 0.0 112.064 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.75 152.67 58.84 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.669 2.246 . . . . 0.0 112.034 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.456 -0.7 0 C-N-CA 124.029 3.153 . . . . 0.0 110.328 179.009 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.8 mt . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -36.11 63.66 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.912 1.285 . . . . 0.0 112.625 178.001 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.8 mt -62.51 -49.59 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.577 0.751 . . . . 0.0 109.673 177.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -63.83 -40.23 96.1 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.394 0.678 . . . . 0.0 111.799 178.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -61.49 -47.22 86.63 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.895 0.878 . . . . 0.0 112.309 174.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.9 mt -64.63 -36.37 84.02 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.331 174.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -57.8 -39.25 77.11 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 178.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.01 -15.69 62.58 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.201 1.0 . . . . 0.0 113.162 176.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.52 8.36 9.22 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.524 1.059 . . . . 0.0 115.272 -177.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.14 -118.51 13.5 Favored Glycine 0 CA--C 1.542 1.74 0 CA-C-N 118.763 1.282 . . . . 0.0 112.608 177.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -58.65 -23.3 64.95 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.514 2.142 . . . . 0.0 114.127 176.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.2 m -92.54 27.89 2.16 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.632 1.173 . . . . 0.0 113.056 -178.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 m -118.07 3.16 12.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.607 1.163 . . . . 0.0 113.462 -176.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.66 28.26 73.55 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.757 0.694 . . . . 0.0 113.612 -178.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -153.71 141.52 13.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.57 1.148 . . . . 0.0 112.566 -176.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.33 165.35 32.78 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.359 2.706 . . . . 0.0 112.132 177.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.72 150.63 86.02 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.886 2.391 . . . . 0.0 111.911 177.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.537 0.672 0 C-N-CA 123.192 2.595 . . . . 0.0 113.623 -178.934 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -55.86 -37.04 68.26 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.76 1.224 . . . . 0.0 112.504 -178.178 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 mt -58.97 -50.03 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.92 1.288 . . . . 0.0 110.611 174.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -61.88 -40.41 95.28 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.806 0.843 . . . . 0.0 111.979 175.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -60.22 -45.55 92.82 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.429 0.559 . . . . 0.0 112.327 172.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.47 -39.25 93.97 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.785 173.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -55.05 -34.34 63.47 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.599 1.091 . . . . 0.0 112.976 176.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.53 -20.28 63.7 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 175.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.57 6.93 14.35 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.22 1.391 . . . . 0.0 113.929 -171.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.96 -127.45 42.99 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-N 118.614 1.207 . . . . 0.0 111.673 -178.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -59.29 -22.57 65.87 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.856 2.37 . . . . 0.0 114.26 177.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 t -61.11 -29.4 69.74 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.089 0.859 . . . . 0.0 113.168 -176.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.4 m -89.37 6.33 41.07 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.685 1.194 . . . . 0.0 113.141 175.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.58 -28.21 0.73 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.518 1.532 . . . . 0.0 115.368 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 ptm85 -56.55 127.59 72.96 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.35 1.46 . . . . 0.0 111.726 175.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -70.17 162.42 42.37 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.737 2.292 . . . . 0.0 111.856 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.08 159.74 52.68 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.786 2.324 . . . . 0.0 112.25 178.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 CA--C 1.541 0.826 0 C-N-CA 123.438 2.759 . . . . 0.0 113.912 178.73 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -56.33 -33.94 66.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.346 1.459 . . . . 0.0 113.436 -176.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.56 -43.9 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.11 0.964 . . . . 0.0 110.996 176.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -48.12 80.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.025 0.93 . . . . 0.0 110.861 175.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -60.63 -38.19 83.97 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.26 -37.61 87.93 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.713 -1.137 . . . . 0.0 112.459 171.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -57.68 -32.38 67.27 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.29 1.405 . . . . 0.0 113.244 173.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -67.01 -13.45 61.92 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 174.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.91 11.6 24.13 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.27 1.414 . . . . 0.0 114.045 -174.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.33 -135.17 48.13 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 118.661 1.23 . . . . 0.0 112.037 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.16 -32.01 68.23 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.094 2.529 . . . . 0.0 113.928 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.3 p -63.52 -23.24 67.31 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.76 -3.9 57.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.832 1.253 . . . . 0.0 113.415 176.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.98 -33.99 0.75 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.603 1.573 . . . . 0.0 115.513 177.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -60.68 138.58 93.14 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.986 1.393 . . . . 0.0 111.758 175.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.91 159.3 50.79 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.047 2.498 . . . . 0.0 112.155 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.37 149.96 63.81 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.834 2.356 . . . . 0.0 112.186 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 N--CA 1.459 -0.534 0 C-N-CA 124.005 3.137 . . . . 0.0 110.275 178.697 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.9 -36.76 65.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.77 1.228 . . . . 0.0 113.215 176.167 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.04 -52.6 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.741 0.817 . . . . 0.0 109.308 177.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -46.15 89.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.79 1.236 . . . . 0.0 110.75 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -55.5 -50.77 69.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.818 1.247 . . . . 0.0 112.478 174.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.72 -41.11 99.0 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.614 174.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -55.57 -41.82 73.86 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.3 1.04 . . . . 0.0 111.277 176.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -6.97 26.16 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.06 10.8 31.34 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.888 1.232 . . . . 0.0 114.09 -178.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.08 -119.18 14.51 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.683 1.611 . . . . 0.0 111.922 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.04 -27.37 45.29 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.956 2.437 . . . . 0.0 113.634 176.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 m -59.54 -28.93 67.53 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.94 1.296 . . . . 0.0 113.026 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 t -77.95 -7.21 56.49 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 176.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.03 -9.85 44.05 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.077 1.323 . . . . 0.0 115.07 178.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 -88.42 139.56 30.05 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.751 1.276 . . . . 0.0 110.692 176.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.71 163.32 28.07 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.055 2.503 . . . . 0.0 113.213 174.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.45 136.16 42.1 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.419 2.746 . . . . 0.0 112.262 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 CA--C 1.541 0.834 0 C-N-CA 124.048 3.166 . . . . 0.0 112.43 -178.986 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 tp . . . . . 0 CA--C 1.552 1.03 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -57.32 -37.34 72.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.868 1.267 . . . . 0.0 113.107 -176.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.51 -41.33 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.724 0.809 . . . . 0.0 111.656 177.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -63.55 -41.47 98.43 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.861 0.864 . . . . 0.0 111.852 176.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -64.34 -42.37 96.3 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 173.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.48 -37.68 84.53 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.489 173.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -37.56 59.98 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.329 1.052 . . . . 0.0 113.08 176.222 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.67 -25.95 63.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.279 0.632 . . . . 0.0 112.57 178.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.34 2.24 5.97 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.873 1.225 . . . . 0.0 114.614 -172.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.21 -125.42 38.98 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 119.033 1.417 . . . . 0.0 112.246 177.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.83 -28.71 68.86 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.51 2.14 . . . . 0.0 114.09 178.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 m -74.75 -3.76 33.52 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.7 m -93.38 -4.87 50.7 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.42 -36.02 0.97 Allowed Glycine 0 CA--C 1.539 1.581 0 O-C-N 120.764 -1.21 . . . . 0.0 114.792 -176.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -72.42 134.37 82.36 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 118.914 1.357 . . . . 0.0 111.227 174.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.26 163.98 34.14 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.259 2.64 . . . . 0.0 112.951 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.03 154.22 66.9 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.078 2.519 . . . . 0.0 112.79 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 C--N 1.35 0.636 0 C-N-CA 123.869 3.046 . . . . 0.0 114.176 -177.625 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -53.3 -36.19 60.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.842 1.257 . . . . 0.0 113.08 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mt -63.15 -38.09 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.838 0.855 . . . . 0.0 112.092 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -67.96 -46.73 70.59 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.449 1.1 . . . . 0.0 110.67 175.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -60.63 -41.98 96.0 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 175.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.99 -37.48 79.78 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.274 -0.891 . . . . 0.0 111.894 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -34.56 68.85 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.192 0.997 . . . . 0.0 113.06 175.093 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -67.16 -16.75 64.51 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.07 8.71 21.55 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.322 1.439 . . . . 0.0 114.327 -172.648 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.71 -132.94 52.23 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-N 119.149 1.474 . . . . 0.0 112.298 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -56.44 -29.19 76.75 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.885 2.39 . . . . 0.0 113.785 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 m -73.83 3.41 6.65 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.806 1.242 . . . . 0.0 113.965 -177.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.8 13.09 17.15 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.137 1.375 . . . . 0.0 113.813 -176.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.07 24.48 74.58 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.597 1.094 . . . . 0.0 115.067 172.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -141.15 135.32 15.09 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.319 1.448 . . . . 0.0 111.564 -170.576 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.92 160.25 46.38 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.781 2.32 . . . . 0.0 111.711 178.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.29 157.11 60.38 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.942 2.428 . . . . 0.0 112.754 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 CA--C 1.538 0.695 0 C-N-CA 124.194 3.263 . . . . 0.0 113.733 -179.544 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -39.1 77.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.479 1.511 . . . . 0.0 113.549 -172.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.61 -42.4 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.781 0.832 . . . . 0.0 110.632 175.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.6 -42.43 86.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.974 0.91 . . . . 0.0 111.895 177.467 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.0 t90 -61.05 -42.99 99.53 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 172.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.12 -37.12 86.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.26 -0.876 . . . . 0.0 113.361 176.262 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -55.25 -38.33 68.38 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.773 1.169 . . . . 0.0 113.023 176.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.434 ' C ' ' HG ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -77.11 3.37 12.72 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.954 1.302 . . . . 0.0 113.828 174.536 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.7 11.44 43.93 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.273 -1.517 . . . . 0.0 115.603 178.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.68 -110.41 0.93 Allowed Glycine 0 CA--C 1.542 1.778 0 C-N-CA 125.83 1.681 . . . . 0.0 113.665 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -55.72 -26.8 58.16 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.392 2.062 . . . . 0.0 114.15 177.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.8 m -86.59 4.4 40.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.301 1.04 . . . . 0.0 113.505 -178.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.434 ' HG ' ' C ' ' A' ' 9' ' ' ASP . 14.4 m -91.4 -4.8 55.32 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.469 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.09 -10.0 10.94 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -179.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -112.49 139.76 23.02 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.866 1.667 . . . . 0.0 110.269 177.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.38 159.94 41.59 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.911 2.407 . . . . 0.0 112.954 176.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.73 140.81 43.7 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.068 2.512 . . . . 0.0 111.852 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 N--CA 1.458 -0.616 0 C-N-CA 122.909 2.406 . . . . 0.0 110.312 172.986 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.79 -36.96 62.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.132 1.773 . . . . 0.0 113.116 179.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mp -60.18 -48.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.148 0.979 . . . . 0.0 110.748 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -38.69 91.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.261 1.024 . . . . 0.0 111.235 178.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.0 t90 -62.67 -49.35 75.47 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.042 0.537 . . . . 0.0 112.318 172.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.6 mt -59.81 -34.35 72.94 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.403 -0.808 . . . . 0.0 112.842 175.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -53.47 -36.71 61.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.986 1.314 . . . . 0.0 113.502 177.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.63 -49.64 45.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.034 0.934 . . . . 0.0 111.49 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.61 25.97 0.02 OUTLIER Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.278 0.942 . . . . 0.0 115.25 179.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.6 -133.85 34.82 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-N 118.574 1.187 . . . . 0.0 112.413 -175.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.97 -25.57 54.16 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.082 2.521 . . . . 0.0 114.703 178.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.6 t -78.28 6.7 7.68 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -90.25 -7.62 53.02 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.494 1.918 . . . . 0.0 113.941 -176.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.6 -18.79 3.5 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 120.685 -1.26 . . . . 0.0 115.739 -176.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.6 ttt-85 -100.95 138.22 19.96 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.323 1.449 . . . . 0.0 110.963 176.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.0 159.8 47.46 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.797 2.332 . . . . 0.0 112.842 175.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.37 147.29 71.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.175 2.583 . . . . 0.0 111.432 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo . . . . . 0 CA--C 1.539 0.741 0 C-N-CA 122.652 2.235 . . . . 0.0 111.037 175.333 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -60.85 -34.43 74.57 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.762 1.225 . . . . 0.0 112.961 -177.181 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.9 mp -58.01 -52.7 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.315 0.646 . . . . 0.0 109.947 175.518 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -40.13 87.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.88 0.872 . . . . 0.0 112.184 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -62.82 -45.93 90.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.205 0.602 . . . . 0.0 112.468 173.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.13 -37.24 84.39 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.157 -0.925 . . . . 0.0 113.127 175.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -54.34 -31.78 55.19 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.524 1.056 . . . . 0.0 113.591 175.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.66 -13.23 60.6 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 176.545 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.89 2.64 20.46 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.867 1.698 . . . . 0.0 115.29 -177.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.17 -128.69 34.03 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 118.701 1.25 . . . . 0.0 112.877 175.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.24 -24.38 67.01 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.585 2.19 . . . . 0.0 114.106 179.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.6 m -87.64 20.24 3.05 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.463 1.105 . . . . 0.0 113.467 -176.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -120.36 6.5 10.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.921 1.288 . . . . 0.0 113.698 -171.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.61 27.11 73.02 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.013 0.816 . . . . 0.0 114.136 178.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.26 132.6 10.93 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.985 1.314 . . . . 0.0 111.796 -174.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.62 157.91 57.35 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.736 2.291 . . . . 0.0 111.854 178.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.66 154.81 59.47 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.079 2.519 . . . . 0.0 112.007 178.108 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 CA--C 1.538 0.705 0 C-N-CA 122.876 2.384 . . . . 0.0 111.124 175.936 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.94 -29.93 69.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.577 1.551 . . . . 0.0 113.094 -176.343 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.51 -52.09 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.909 0.884 . . . . 0.0 110.195 177.291 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -57.03 -49.67 75.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.836 0.855 . . . . 0.0 111.49 174.096 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -57.52 -43.01 83.94 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 178.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.0 mt -67.01 -39.21 87.01 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.225 -0.922 . . . . 0.0 112.576 172.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.94 -35.9 62.23 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.133 1.373 . . . . 0.0 113.373 176.742 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -72.3 -19.4 61.67 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 174.721 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.91 8.74 7.88 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.731 1.157 . . . . 0.0 115.118 -175.487 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.96 -124.25 31.9 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 119.09 1.445 . . . . 0.0 113.192 175.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.04 -28.48 60.27 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.721 2.281 . . . . 0.0 113.951 179.661 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -76.44 -3.76 38.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.094 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.1 m -91.44 -3.83 56.22 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.345 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.51 -33.68 1.37 Allowed Glycine 0 CA--C 1.539 1.538 0 O-C-N 120.93 -1.106 . . . . 0.0 115.163 -179.063 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -74.18 135.5 76.44 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 118.883 1.341 . . . . 0.0 110.673 176.037 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.02 161.01 47.6 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.928 2.419 . . . . 0.0 112.842 -178.234 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.09 138.79 44.73 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.31 2.673 . . . . 0.0 111.75 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 0 CA--C 1.538 0.701 0 C-N-CA 122.824 2.35 . . . . 0.0 111.222 177.505 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 tp . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.16 -36.25 40.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.434 1.494 . . . . 0.0 112.975 176.747 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.18 -44.72 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.009 0.924 . . . . 0.0 110.589 176.487 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.57 -44.8 85.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.202 0.601 . . . . 0.0 110.945 174.088 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.8 t90 -60.11 -38.13 82.1 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 176.226 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.32 -33.5 75.66 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.995 -1.065 . . . . 0.0 112.245 171.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -58.11 -35.87 72.09 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.482 1.113 . . . . 0.0 112.622 175.896 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.05 -20.72 66.63 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 173.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.64 7.75 10.5 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.344 1.449 . . . . 0.0 114.755 -171.796 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.95 -132.95 51.13 Favored Glycine 0 CA--C 1.542 1.769 0 CA-C-N 119.203 1.501 . . . . 0.0 112.446 -176.014 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -55.35 -30.81 74.41 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.512 2.808 . . . . 0.0 114.603 -178.202 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 64.5 m -79.59 14.62 1.58 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.059 1.344 . . . . 0.0 113.94 -175.553 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.82 3.5 16.45 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -168.799 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.63 21.45 78.8 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.738 1.161 . . . . 0.0 114.921 178.642 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -144.55 135.44 12.32 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.058 1.343 . . . . 0.0 111.557 -174.589 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.98 158.92 56.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.021 2.481 . . . . 0.0 111.851 -179.093 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.89 151.49 68.34 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.582 2.188 . . . . 0.0 111.556 177.523 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 N--CA 1.457 -0.676 0 C-N-CA 123.437 2.758 . . . . 0.0 112.105 175.791 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -64.82 -35.72 82.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.053 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.8 mt -62.63 -43.41 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.886 0.874 . . . . 0.0 110.173 176.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -41.69 92.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.252 1.021 . . . . 0.0 112.088 174.917 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -65.25 -43.46 91.26 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 173.522 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.4 mt -60.34 -39.49 87.28 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.506 174.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -50.69 -37.53 41.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.33 1.052 . . . . 0.0 113.028 178.019 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.5 -16.63 60.84 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.016 0.926 . . . . 0.0 113.27 -179.591 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.34 11.06 6.32 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.166 1.365 . . . . 0.0 115.095 -175.477 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.48 -119.54 7.44 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.055 1.312 . . . . 0.0 113.295 -178.418 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.9 -26.6 75.12 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.607 2.205 . . . . 0.0 114.188 177.167 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t -82.47 -0.87 48.33 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.201 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.9 m -84.5 -9.52 58.28 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.455 1.902 . . . . 0.0 114.668 -175.48 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.01 13.05 84.08 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 115.006 -174.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -137.89 136.3 19.7 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 118.875 1.338 . . . . 0.0 110.971 -178.083 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.26 160.41 42.41 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.053 2.502 . . . . 0.0 112.9 178.732 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.2 149.37 70.38 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.042 2.495 . . . . 0.0 112.022 179.049 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 CA--C 1.541 0.863 0 C-N-CA 123.76 2.973 . . . . 0.0 114.191 -179.237 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -58.25 -35.69 72.12 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.067 0.947 . . . . 0.0 112.92 -175.397 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mp -61.42 -50.38 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.324 1.05 . . . . 0.0 110.448 176.266 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -59.37 -44.58 92.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.577 1.151 . . . . 0.0 112.067 174.859 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -60.47 -46.36 90.38 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 175.924 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.14 -42.04 94.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.86 171.593 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -25.7 63.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.141 0.976 . . . . 0.0 113.557 177.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.1 -12.34 59.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 173.852 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.24 4.03 14.43 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.051 1.31 . . . . 0.0 115.248 -177.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.55 -130.58 48.58 Favored Glycine 0 CA--C 1.545 1.963 0 CA-C-N 119.567 1.684 . . . . 0.0 112.766 177.548 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -66.86 11.15 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.806 3.004 . . . . 0.0 115.935 -177.481 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.0 m -115.96 12.18 15.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.836 1.654 . . . . 0.0 113.501 -175.247 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -120.26 8.77 10.91 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.635 1.174 . . . . 0.0 113.575 -167.383 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.62 20.55 74.05 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.301 0.953 . . . . 0.0 114.963 178.881 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -136.45 133.92 19.51 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.261 1.424 . . . . 0.0 112.007 -174.085 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -70.44 159.32 53.32 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.678 2.252 . . . . 0.0 111.894 177.695 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.37 146.56 45.27 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.886 2.39 . . . . 0.0 111.987 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 CA--C 1.54 0.803 0 C-N-CA 123.634 2.89 . . . . 0.0 111.63 178.116 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.551 0.987 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -54.66 -34.86 62.84 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.864 1.666 . . . . 0.0 113.019 -178.279 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.2 mt -60.48 -47.85 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.593 1.157 . . . . 0.0 110.378 175.514 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.42 -39.36 81.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.04 1.336 . . . . 0.0 111.471 178.432 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -62.41 -44.31 96.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.021 0.929 . . . . 0.0 112.827 173.083 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.15 -42.29 98.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.008 172.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -53.14 -32.84 49.64 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 176.493 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -76.06 -18.93 59.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.931 0.892 . . . . 0.0 113.346 177.242 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.15 9.3 5.66 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.856 1.217 . . . . 0.0 115.231 -175.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.66 -118.97 7.68 Favored Glycine 0 CA--C 1.544 1.876 0 CA-C-N 118.941 1.371 . . . . 0.0 113.379 -178.991 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.3 -26.92 72.86 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.644 2.23 . . . . 0.0 114.452 178.342 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -81.26 1.29 33.01 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -179.447 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -89.28 -1.95 58.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.89 1.676 . . . . 0.0 114.582 -176.8 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.88 -36.73 1.25 Allowed Glycine 0 CA--C 1.539 1.54 0 O-C-N 120.442 -1.411 . . . . 0.0 114.709 -177.433 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -83.23 136.79 43.05 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.706 1.253 . . . . 0.0 111.425 175.081 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.56 164.68 25.41 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.439 2.76 . . . . 0.0 113.087 174.533 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 156.18 64.62 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.713 2.275 . . . . 0.0 112.519 -179.92 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 CA--C 1.539 0.758 0 C-N-CA 123.595 2.864 . . . . 0.0 114.285 -178.685 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.28 -29.1 68.59 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.881 0.872 . . . . 0.0 113.263 177.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.6 mm -66.54 -51.12 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.577 1.151 . . . . 0.0 109.454 176.648 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -54.48 -51.85 63.77 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.19 0.996 . . . . 0.0 110.839 173.024 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.7 t90 -57.7 -44.46 85.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.829 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.2 mt -61.65 -37.06 82.64 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.225 -0.922 . . . . 0.0 111.963 172.377 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.24 -16.31 61.8 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.286 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.63 -9.74 51.09 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.488 1.515 . . . . 0.0 113.252 169.235 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.32 5.39 19.31 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.077 1.323 . . . . 0.0 114.625 -178.515 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.64 -130.25 48.04 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 119.165 1.482 . . . . 0.0 111.693 -178.498 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.97 -32.8 69.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.891 2.394 . . . . 0.0 113.814 179.638 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 m -63.67 -22.37 66.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.837 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -3.89 56.67 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 174.774 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.13 -30.5 0.95 Allowed Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.18 1.371 . . . . 0.0 115.345 177.851 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 ttt85 -65.92 133.8 94.95 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 118.886 1.343 . . . . 0.0 110.513 175.183 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.57 160.27 43.95 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.702 2.268 . . . . 0.0 112.463 178.833 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.34 153.83 70.27 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.796 2.331 . . . . 0.0 112.121 179.253 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 N--CA 1.456 -0.693 0 C-N-CA 123.477 2.784 . . . . 0.0 110.666 176.032 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.84 -39.86 72.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.347 1.459 . . . . 0.0 112.782 -173.881 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.14 -45.21 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.727 0.811 . . . . 0.0 110.526 177.106 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -35.23 77.96 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 176.964 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -64.93 -45.25 86.64 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.484 0.584 . . . . 0.0 112.249 171.99 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.6 mt -65.48 -32.44 74.05 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.753 -1.118 . . . . 0.0 113.514 176.315 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -52.96 -37.25 60.93 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.544 1.065 . . . . 0.0 113.617 176.791 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.17 -52.57 18.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.637 0.775 . . . . 0.0 111.341 179.329 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.43 29.35 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 N-CA-C 115.307 0.883 . . . . 0.0 115.307 177.772 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.45 -133.24 34.6 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.431 1.116 . . . . 0.0 112.236 -177.022 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.49 -24.57 62.1 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.184 2.589 . . . . 0.0 114.461 178.393 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 m -75.03 -11.24 60.06 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.994 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -69.64 -10.38 57.99 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.716 1.606 . . . . 0.0 113.46 177.779 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.94 -35.73 2.12 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.051 1.31 . . . . 0.0 114.292 -177.528 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -79.47 138.12 55.33 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 118.551 1.175 . . . . 0.0 111.328 174.665 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.01 160.68 36.61 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.615 2.877 . . . . 0.0 113.339 175.199 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.48 155.51 55.07 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.012 2.475 . . . . 0.0 112.507 179.597 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 CA--C 1.537 0.658 0 C-N-CA 123.61 2.873 . . . . 0.0 114.177 179.142 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 CA--C 1.545 0.768 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -59.32 -31.97 69.65 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.928 1.291 . . . . 0.0 113.053 -177.631 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mp -57.73 -49.78 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.448 0.699 . . . . 0.0 110.188 174.97 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.58 -45.16 94.99 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.917 0.887 . . . . 0.0 111.284 -179.121 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -59.65 -47.93 83.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.687 0.795 . . . . 0.0 112.283 175.461 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.56 -40.37 96.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.377 173.749 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.418 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -57.79 -38.83 76.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.521 1.128 . . . . 0.0 112.701 -179.4 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -20.05 63.64 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.918 1.287 . . . . 0.0 113.009 176.049 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.31 8.88 5.77 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.1 1.333 . . . . 0.0 114.806 -176.701 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.24 -124.95 37.54 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 119.022 1.411 . . . . 0.0 111.632 -177.205 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -56.31 -30.42 80.7 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.165 2.577 . . . . 0.0 114.178 178.379 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 m -75.34 12.05 1.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.907 1.283 . . . . 0.0 114.007 -178.11 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.99 3.32 20.33 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.916 1.686 . . . . 0.0 113.288 -172.726 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.51 20.41 75.47 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.363 -0.835 . . . . 0.0 114.222 -175.417 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.11 129.59 19.01 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.765 1.226 . . . . 0.0 110.92 -170.202 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.26 159.95 49.85 Favored 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.104 2.536 . . . . 0.0 113.221 -178.998 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.65 122.35 9.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.571 2.847 . . . . 0.0 111.461 -179.351 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 C--N 1.349 0.6 0 C-N-CA 122.49 2.127 . . . . 0.0 110.517 178.137 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 117.846 -1.074 . . . . 0.0 113.507 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 pp -43.98 -51.31 7.82 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -66.47 -30.9 71.34 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 mm -65.22 -45.94 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.767 1.227 . . . . 0.0 109.345 174.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.75 -30.35 71.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.46 0.704 . . . . 0.0 112.719 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.5 t90 -73.14 -43.42 61.63 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.965 0.802 . . . . 0.0 112.485 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.2 mt -64.88 -43.25 93.51 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.99 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -25.7 64.69 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.653 1.115 . . . . 0.0 113.921 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.99 -8.82 58.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.908 1.683 . . . . 0.0 113.646 174.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.78 8.08 24.77 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.373 1.463 . . . . 0.0 114.798 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.24 -124.37 32.77 Favored Glycine 0 CA--C 1.541 1.713 0 CA-C-N 118.825 1.312 . . . . 0.0 112.149 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.98 -28.77 84.35 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.794 2.33 . . . . 0.0 113.813 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.7 m -81.83 19.13 1.14 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.089 1.356 . . . . 0.0 113.737 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.06 13.4 9.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.843 1.257 . . . . 0.0 113.82 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.93 25.22 74.35 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.471 -0.768 . . . . 0.0 114.505 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -143.95 131.3 10.57 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.873 1.269 . . . . 0.0 111.893 -172.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.1 160.07 50.92 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.82 2.347 . . . . 0.0 111.692 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.48 145.67 59.48 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.472 2.115 . . . . 0.0 111.422 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.26 124.22 7.07 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.169 2.579 . . . . 0.0 110.894 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.25 1.119 0 C-N-CA 125.739 1.616 . . . . 0.0 111.968 171.654 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 m120 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 118.229 -0.891 . . . . 0.0 113.058 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 mp -62.0 -10.74 10.64 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -54.78 -31.94 59.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.07 1.748 . . . . 0.0 113.742 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.6 mt -59.68 -49.11 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.45 1.1 . . . . 0.0 109.474 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -33.18 74.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.487 1.115 . . . . 0.0 111.799 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -66.8 -45.94 76.78 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.3 mt -61.18 -37.0 81.36 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.938 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -52.99 -33.48 51.65 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.025 0.93 . . . . 0.0 113.282 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.408 ' C ' ' HG ' ' A' ' 14' ' ' SER . 7.8 t0 -75.19 -11.09 60.0 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.336 1.454 . . . . 0.0 112.549 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.09 10.34 28.15 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.476 -1.39 . . . . 0.0 115.374 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.27 -125.2 38.76 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 118.672 1.236 . . . . 0.0 113.086 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.26 -23.17 61.05 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.446 2.098 . . . . 0.0 114.305 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.82 7.26 18.51 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.074 0.95 . . . . 0.0 113.263 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.408 ' HG ' ' C ' ' A' ' 9' ' ' ASP . 6.0 m -103.95 1.87 31.73 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.842 1.657 . . . . 0.0 114.422 -174.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.79 -37.52 1.25 Allowed Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.831 1.205 . . . . 0.0 115.019 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.2 ttp-105 -75.92 131.69 75.73 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.934 1.293 . . . . 0.0 111.36 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.09 162.4 32.96 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.328 2.685 . . . . 0.0 113.069 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.71 142.3 57.68 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.063 2.509 . . . . 0.0 112.376 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.66 117.65 4.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.409 2.739 . . . . 0.0 110.752 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.251 1.14 0 CA-C-O 115.622 -2.132 . . . . 0.0 112.502 172.685 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.03 -0.3 57.47 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.205 1.366 . . . . 0.0 114.352 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -57.54 -36.5 71.7 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.839 0.856 . . . . 0.0 112.917 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.3 mt -62.92 -44.92 99.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.923 1.289 . . . . 0.0 110.533 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -46.52 89.17 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.437 1.095 . . . . 0.0 110.776 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -64.05 -43.56 95.16 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.1 mt -63.07 -36.06 82.32 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.26 -0.9 . . . . 0.0 112.454 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -56.13 -33.51 65.23 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.456 1.025 . . . . 0.0 113.079 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -71.95 -5.99 38.77 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 118.958 0.799 . . . . 0.0 113.056 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.33 -2.05 32.9 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.704 1.621 . . . . 0.0 114.183 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.77 -129.12 46.32 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 118.655 1.228 . . . . 0.0 111.277 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -54.77 -29.76 63.92 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.81 2.34 . . . . 0.0 114.253 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 p -67.21 -23.68 65.76 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.85 -6.43 56.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.05 -31.49 1.1 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.801 1.191 . . . . 0.0 115.159 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -64.15 135.28 96.26 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 118.82 1.31 . . . . 0.0 110.592 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.4 159.86 45.5 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.875 2.383 . . . . 0.0 112.847 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.99 162.81 41.41 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.383 2.722 . . . . 0.0 112.74 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.84 -21.75 12.28 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.616 2.877 . . . . 0.0 114.327 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 C--O 1.248 1.011 0 C-N-CA 126.468 1.907 . . . . 0.0 110.883 174.877 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.2 m120 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 117.195 -1.383 . . . . 0.0 113.94 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -49.42 -38.98 31.18 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.596 1.544 . . . . 0.0 114.302 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.55 -30.97 68.99 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.126 0.97 . . . . 0.0 113.418 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.2 -51.19 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.074 0.949 . . . . 0.0 109.462 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -56.53 -48.06 78.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.452 1.101 . . . . 0.0 111.567 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -57.54 -46.99 83.22 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -65.07 -39.71 93.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.272 -0.87 . . . . 0.0 112.547 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -54.72 -40.0 68.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.236 1.015 . . . . 0.0 112.389 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -76.66 -11.85 59.91 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.014 1.326 . . . . 0.0 113.388 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.81 9.28 6.35 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.165 1.364 . . . . 0.0 115.714 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.06 -108.74 0.53 Allowed Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.383 1.468 . . . . 0.0 113.446 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.01 -27.66 65.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.537 2.158 . . . . 0.0 114.499 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.3 p -89.61 7.34 36.99 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -84.14 -5.23 59.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.006 1.322 . . . . 0.0 114.427 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.28 17.5 77.55 Favored Glycine 0 CA--C 1.538 1.494 0 O-C-N 120.561 -1.337 . . . . 0.0 115.171 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -143.27 143.64 25.21 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.502 1.521 . . . . 0.0 110.401 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.28 157.93 55.1 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.635 2.223 . . . . 0.0 112.767 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.89 140.7 39.01 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.205 2.603 . . . . 0.0 111.547 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.97 133.46 12.44 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.205 2.603 . . . . 0.0 110.902 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.245 0.817 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 173.689 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 116.716 -1.612 . . . . 0.0 115.14 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt 72.95 -34.83 0.31 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.312 1.845 . . . . 0.0 113.125 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -39.32 66.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.364 1.466 . . . . 0.0 113.701 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.5 mp -61.26 -50.03 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.016 0.927 . . . . 0.0 110.758 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -64.82 -37.82 88.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.389 0.676 . . . . 0.0 111.658 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -61.39 -46.32 90.65 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 172.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.5 mt -59.64 -37.11 77.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.96 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -57.06 -31.95 65.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.2 -19.84 63.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.267 1.027 . . . . 0.0 112.763 175.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.08 5.66 8.75 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 126.004 1.764 . . . . 0.0 114.549 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.94 -133.7 51.03 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 119.026 1.413 . . . . 0.0 112.198 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.21 -29.12 55.17 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.643 2.895 . . . . 0.0 114.464 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -81.44 21.32 0.79 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.803 1.641 . . . . 0.0 113.78 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.28 8.43 9.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.64 1.576 . . . . 0.0 113.317 -169.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.53 24.98 73.93 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.3 1.429 . . . . 0.0 114.784 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -148.93 134.08 9.37 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.974 1.31 . . . . 0.0 112.023 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.56 161.72 44.47 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.235 2.624 . . . . 0.0 112.029 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.79 146.25 65.6 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.01 2.473 . . . . 0.0 112.611 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -82.74 97.09 0.85 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.786 2.99 . . . . 0.0 111.086 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 115.677 -2.106 . . . . 0.0 114.0 -179.368 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tp 63.45 -33.93 0.13 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -54.35 -32.06 55.92 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.572 2.749 . . . . 0.0 113.588 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.46 -46.98 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.979 0.911 . . . . 0.0 110.718 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -44.25 96.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.252 0.621 . . . . 0.0 111.142 175.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -62.92 -39.33 94.24 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.75 -38.36 90.73 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.043 -1.035 . . . . 0.0 112.16 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -54.79 -33.78 61.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.302 1.041 . . . . 0.0 113.562 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -67.38 -20.35 65.54 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.429 1.013 . . . . 0.0 113.469 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.37 8.02 9.58 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.0 1.286 . . . . 0.0 114.889 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.49 -133.77 51.8 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-N 119.139 1.469 . . . . 0.0 112.183 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.75 -31.3 60.61 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.505 2.803 . . . . 0.0 114.726 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.2 m -77.09 10.13 2.57 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.614 1.166 . . . . 0.0 113.808 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -98.96 -1.81 38.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.467 1.507 . . . . 0.0 114.272 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -38.95 0.89 Allowed Glycine 0 CA--C 1.54 1.631 0 C-N-CA 125.043 1.306 . . . . 0.0 114.643 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -73.85 136.53 76.88 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.036 1.334 . . . . 0.0 112.283 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -70.64 161.3 46.55 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.334 2.689 . . . . 0.0 112.144 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.3 147.75 66.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.792 2.328 . . . . 0.0 111.723 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.62 -18.53 10.58 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.075 2.516 . . . . 0.0 113.756 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.258 1.517 0 CA-C-O 116.0 -1.952 . . . . 0.0 112.868 -171.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mt -71.45 -13.36 61.8 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.383 0.992 . . . . 0.0 113.632 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -54.24 -39.51 66.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.412 1.085 . . . . 0.0 113.406 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.25 -45.13 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.825 0.85 . . . . 0.0 110.627 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -34.93 77.34 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.339 1.455 . . . . 0.0 112.262 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -65.01 -47.19 78.36 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.661 0.784 . . . . 0.0 111.769 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.9 mt -60.75 -30.18 69.85 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 118.022 -0.989 . . . . 0.0 113.63 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -54.04 -34.85 61.11 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -74.09 -48.02 32.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.45 0.7 . . . . 0.0 111.079 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.9 26.91 0.02 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.373 0.987 . . . . 0.0 115.252 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.68 -133.38 43.72 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 118.869 1.335 . . . . 0.0 112.332 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -55.74 -28.77 68.33 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.026 2.484 . . . . 0.0 114.525 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.2 m -75.78 3.29 10.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.439 1.095 . . . . 0.0 113.679 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 m -81.75 -7.87 59.64 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.403 1.481 . . . . 0.0 114.169 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.05 12.29 84.78 Favored Glycine 0 CA--C 1.539 1.537 0 O-C-N 120.982 -1.074 . . . . 0.0 115.009 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -143.86 138.0 14.76 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.993 1.317 . . . . 0.0 111.167 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.87 161.01 41.22 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.948 2.432 . . . . 0.0 113.016 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.73 162.59 41.49 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.489 2.793 . . . . 0.0 112.708 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.18 -19.7 7.82 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.592 2.861 . . . . 0.0 114.149 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.248 1.019 0 C-N-CA 126.245 1.818 . . . . 0.0 110.4 170.413 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.94 -46.94 8.4 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 120.229 1.377 . . . . 0.0 114.088 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -62.66 -33.79 75.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.1 mm -64.9 -45.53 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.069 0.948 . . . . 0.0 109.737 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.64 -38.89 92.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.158 0.583 . . . . 0.0 112.254 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -63.03 -45.13 93.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.021 0.828 . . . . 0.0 112.694 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.0 mt -58.65 -37.42 75.92 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.273 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -57.08 -27.65 61.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.738 1.215 . . . . 0.0 114.22 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.92 -20.14 60.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.776 0.831 . . . . 0.0 112.575 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.35 10.07 6.85 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.776 1.655 . . . . 0.0 114.751 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.24 -134.96 52.12 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-N 118.968 1.384 . . . . 0.0 111.823 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.89 -27.22 61.95 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.608 2.872 . . . . 0.0 114.893 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m -78.31 12.18 2.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.173 0.989 . . . . 0.0 113.62 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 m -107.19 -4.08 19.17 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.822 1.649 . . . . 0.0 113.905 -170.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.64 19.44 76.51 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 119.176 -0.791 . . . . 0.0 114.817 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -135.5 134.14 20.85 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 125.395 1.478 . . . . 0.0 111.839 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.98 160.05 51.47 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.768 2.312 . . . . 0.0 111.917 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.61 149.04 60.85 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.881 2.387 . . . . 0.0 112.012 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -85.46 -8.17 8.58 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.074 3.182 . . . . 0.0 114.387 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.254 1.298 0 CA-C-O 116.12 -1.895 . . . . 0.0 109.33 177.437 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 117.179 -1.391 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 57.13 -18.34 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 128.729 2.812 . . . . 0.0 117.039 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.39 -38.91 85.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.995 1.718 . . . . 0.0 113.032 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.1 mp -60.25 -47.28 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.791 0.836 . . . . 0.0 110.693 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -63.46 -38.1 89.86 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.372 0.669 . . . . 0.0 112.449 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -64.49 -45.32 87.81 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.868 0.758 . . . . 0.0 112.487 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.8 mt -60.58 -40.45 91.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.384 -0.817 . . . . 0.0 112.696 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -51.32 -34.12 32.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.136 1.374 . . . . 0.0 114.179 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -71.65 -39.97 69.99 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.572 0.749 . . . . 0.0 111.866 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.76 12.64 0.08 OUTLIER Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.45 -134.87 51.62 Favored Glycine 0 CA--C 1.543 1.836 0 CA-C-N 119.614 1.707 . . . . 0.0 112.416 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.8 -26.2 81.54 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.057 2.504 . . . . 0.0 115.565 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.1 p -82.14 8.5 10.73 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.649 1.113 . . . . 0.0 113.673 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -91.62 -4.27 55.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.807 2.043 . . . . 0.0 114.524 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.03 -38.33 1.76 Allowed Glycine 0 CA--C 1.539 1.59 0 O-C-N 120.583 -1.323 . . . . 0.0 114.886 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -74.44 135.49 75.6 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 118.847 1.324 . . . . 0.0 111.199 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -67.32 160.07 49.37 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.153 2.569 . . . . 0.0 113.192 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.03 139.53 39.53 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.099 2.533 . . . . 0.0 111.814 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.82 138.73 15.09 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.234 2.623 . . . . 0.0 110.913 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.252 1.219 0 CA-C-O 116.271 -1.823 . . . . 0.0 109.342 176.581 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 117.449 -1.262 . . . . 0.0 113.747 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.31 -4.25 41.1 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 121.175 1.807 . . . . 0.0 114.332 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.42 -30.22 66.72 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.849 1.259 . . . . 0.0 113.952 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 mp -59.0 -48.13 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.719 0.808 . . . . 0.0 110.413 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -31.11 72.18 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.213 1.405 . . . . 0.0 112.456 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -76.39 -43.61 39.81 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.702 0.801 . . . . 0.0 112.804 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.6 mt -65.56 -43.98 88.18 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.939 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -19.41 56.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -15.86 58.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.241 1.417 . . . . 0.0 113.121 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.84 6.01 11.6 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.338 1.447 . . . . 0.0 114.671 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.93 -128.52 43.56 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 119.189 1.494 . . . . 0.0 112.04 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.62 -34.21 72.41 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.51 2.807 . . . . 0.0 114.545 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.4 m -74.98 7.04 3.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.717 1.207 . . . . 0.0 114.054 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -95.08 -11.28 28.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.7 27.89 66.29 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 118.8 0.727 . . . . 0.0 114.631 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.91 140.44 15.63 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.111 1.364 . . . . 0.0 111.684 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -70.67 160.32 49.83 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.067 2.512 . . . . 0.0 111.916 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.04 154.48 62.63 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.674 2.249 . . . . 0.0 112.141 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.24 110.89 3.09 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.62 2.88 . . . . 0.0 111.467 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 C--O 1.258 1.506 0 CA-C-O 114.774 -2.536 . . . . 0.0 110.659 177.504 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.2 t30 . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mt -79.8 -4.32 51.56 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.923 1.238 . . . . 0.0 114.058 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -35.51 72.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.297 1.039 . . . . 0.0 112.345 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.25 -51.09 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.649 1.18 . . . . 0.0 109.621 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -55.68 -47.56 76.55 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.756 1.223 . . . . 0.0 111.836 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.0 t90 -61.59 -47.1 87.02 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.2 mt -63.42 -34.6 78.1 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.598 -0.689 . . . . 0.0 112.5 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -58.36 -36.6 73.72 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.75 1.22 . . . . 0.0 113.092 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.9 -21.1 63.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.025 0.93 . . . . 0.0 112.367 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.87 20.52 6.02 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.48 1.514 . . . . 0.0 113.708 -175.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.71 -124.69 30.29 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.061 1.43 . . . . 0.0 112.742 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -58.29 -23.88 64.92 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.488 2.125 . . . . 0.0 114.431 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.3 p -60.97 -31.22 70.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.209 0.913 . . . . 0.0 112.924 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -81.19 -5.08 57.32 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.917 1.287 . . . . 0.0 113.25 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.91 -27.63 1.95 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.616 1.579 . . . . 0.0 115.206 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -64.02 137.14 97.02 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 118.793 1.297 . . . . 0.0 111.14 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.22 161.23 46.7 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.119 2.546 . . . . 0.0 113.004 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.5 148.09 53.36 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.08 2.52 . . . . 0.0 112.105 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.28 142.18 23.84 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.128 2.552 . . . . 0.0 110.551 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.088 1.755 . . . . 0.0 109.564 176.654 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.68 0.82 0.7 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.998 1.719 . . . . 0.0 115.241 175.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -58.69 -39.79 81.76 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.95 1.7 . . . . 0.0 112.82 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.457 ' H ' HD11 ' A' ' 4' ' ' ILE . 3.6 mp -56.15 -45.07 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.384 1.074 . . . . 0.0 110.814 175.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -52.16 65.5 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.444 0.698 . . . . 0.0 111.062 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.7 t90 -61.22 -39.1 89.01 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.14 -37.1 85.88 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.343 -0.848 . . . . 0.0 111.876 171.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -58.81 -31.71 68.69 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -66.07 -24.0 66.64 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.938 0.79 . . . . 0.0 113.071 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.98 10.25 6.96 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 124.937 1.256 . . . . 0.0 115.286 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.39 -127.07 38.66 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 118.794 1.297 . . . . 0.0 113.554 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.46 -23.67 57.01 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.917 2.411 . . . . 0.0 114.714 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.7 m -83.39 2.54 35.92 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -93.44 -3.5 52.99 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.51 -39.72 0.75 Allowed Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.793 1.187 . . . . 0.0 114.757 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -68.6 137.51 90.73 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.789 1.235 . . . . 0.0 112.099 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.14 159.18 52.95 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.081 2.521 . . . . 0.0 112.359 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.18 156.2 46.8 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.062 2.508 . . . . 0.0 113.157 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -84.77 -5.67 9.8 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 125.034 3.823 . . . . 0.0 114.168 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.4 m . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.367 1.867 . . . . 0.0 108.747 179.366 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 116.349 -1.786 . . . . 0.0 115.326 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mt 66.32 -33.72 0.19 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.449 1.9 . . . . 0.0 114.841 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.04 -33.53 65.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.583 1.553 . . . . 0.0 113.513 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -63.57 -50.79 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.015 0.926 . . . . 0.0 110.767 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.89 -42.08 97.28 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.409 0.684 . . . . 0.0 111.667 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -62.03 -46.07 90.78 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.7 mt -60.87 -37.77 83.29 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.928 -1.107 . . . . 0.0 112.538 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -56.68 -28.26 60.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.95 0.796 . . . . 0.0 112.587 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.475 ' C ' ' HG ' ' A' ' 14' ' ' SER . 65.3 m-20 -75.92 -11.01 59.89 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.269 -0.894 . . . . 0.0 113.187 174.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.71 11.25 27.13 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-N 120.293 1.406 . . . . 0.0 115.714 -172.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.9 -127.79 44.99 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 124.727 1.156 . . . . 0.0 113.475 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.98 -20.68 46.14 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.693 2.262 . . . . 0.0 114.657 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.5 p -88.95 4.97 46.27 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.705 1.202 . . . . 0.0 114.177 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.475 ' HG ' ' C ' ' A' ' 9' ' ' ASP . 12.6 m -99.13 -1.17 40.1 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -172.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.79 -34.95 1.21 Allowed Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.733 1.159 . . . . 0.0 115.009 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -72.86 133.76 81.86 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.682 1.241 . . . . 0.0 110.967 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.38 157.74 58.73 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.816 2.344 . . . . 0.0 112.746 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.15 134.93 28.28 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.336 2.69 . . . . 0.0 111.313 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.11 142.08 21.42 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.564 2.176 . . . . 0.0 110.736 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.253 1.271 0 CA-C-O 116.201 -1.857 . . . . 0.0 110.475 176.009 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -110.11 -3.64 16.28 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.003 -1.061 . . . . 0.0 113.65 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.46 -33.62 74.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.845 1.258 . . . . 0.0 113.126 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.4 mt -58.56 -50.38 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.767 1.227 . . . . 0.0 109.955 176.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -41.89 96.27 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.845 1.258 . . . . 0.0 111.593 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -62.81 -43.57 98.44 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.22 -35.93 82.6 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.344 -0.836 . . . . 0.0 112.532 173.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -54.07 -37.95 64.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.469 1.108 . . . . 0.0 113.475 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -83.38 -8.42 59.41 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.582 1.953 . . . . 0.0 112.744 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.98 23.17 5.66 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.747 1.642 . . . . 0.0 115.067 177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 48.8 -108.99 0.47 Allowed Glycine 0 CA--C 1.54 1.595 0 C-N-CA 126.495 1.998 . . . . 0.0 113.708 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.12 -28.67 62.07 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.005 2.47 . . . . 0.0 114.3 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -82.69 -0.04 45.59 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.2 m -82.42 -3.67 56.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.459 1.504 . . . . 0.0 115.003 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.43 17.51 79.11 Favored Glycine 0 CA--C 1.539 1.573 0 O-C-N 121.178 -0.952 . . . . 0.0 115.26 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -153.85 144.82 16.18 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 125.472 1.509 . . . . 0.0 111.448 -172.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.52 164.74 34.19 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.532 2.821 . . . . 0.0 112.695 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.91 138.78 54.2 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.147 2.565 . . . . 0.0 112.651 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.77 106.84 1.3 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.633 2.889 . . . . 0.0 112.114 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 t . . . . . 0 C--O 1.25 1.121 0 C-N-CA 127.884 2.473 . . . . 0.0 114.927 175.779 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.5 t30 . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.5 mt -105.58 1.9 27.82 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.631 -1.293 . . . . 0.0 113.143 -175.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.99 -38.53 73.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.815 1.246 . . . . 0.0 112.649 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.49 -50.22 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 123.926 0.89 . . . . 0.0 110.552 176.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -62.07 -42.27 99.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.323 0.649 . . . . 0.0 111.979 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.8 t90 -60.72 -39.66 89.41 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.7 mt -66.42 -37.66 85.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 117.999 -1.001 . . . . 0.0 112.892 173.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -53.41 -39.77 64.59 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.736 1.153 . . . . 0.0 113.376 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.51 -11.96 61.26 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.22 14.42 9.88 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.326 0.965 . . . . 0.0 114.521 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.91 -120.21 8.79 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 117.998 -1.446 . . . . 0.0 112.219 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -54.7 -28.24 55.78 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.468 2.778 . . . . 0.0 114.466 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.9 p -79.6 2.97 20.4 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -88.96 -8.95 53.16 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.27 20.08 79.7 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 114.957 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.3 138.87 16.98 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 125.405 1.482 . . . . 0.0 110.681 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.58 159.36 48.43 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.882 2.388 . . . . 0.0 112.548 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.44 148.0 59.72 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.803 2.336 . . . . 0.0 111.711 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.79 145.57 18.07 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.228 2.619 . . . . 0.0 111.418 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.6 p . . . . . 0 C--O 1.258 1.509 0 CA-C-O 114.601 -2.618 . . . . 0.0 109.565 176.435 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 117.391 -1.29 . . . . 0.0 113.124 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -41.27 -60.78 1.16 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -62.1 -39.69 93.35 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mp -58.97 -51.5 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.771 1.229 . . . . 0.0 110.344 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -55.13 -46.54 75.63 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.175 0.99 . . . . 0.0 112.477 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -63.97 -47.29 80.98 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.69 -39.21 87.65 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.039 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -57.22 -34.45 68.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.89 1.276 . . . . 0.0 112.929 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -17.54 61.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.418 1.087 . . . . 0.0 112.722 176.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.75 5.86 8.89 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.762 1.648 . . . . 0.0 114.204 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.56 -124.07 32.27 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.026 -1.43 . . . . 0.0 111.509 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.27 -33.71 85.75 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.212 2.608 . . . . 0.0 114.299 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.4 m -60.75 -23.17 64.75 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.761 0.824 . . . . 0.0 112.932 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.67 -12.94 61.87 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.804 1.642 . . . . 0.0 113.199 175.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.89 12.09 74.57 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.051 0.834 . . . . 0.0 114.844 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -120.85 138.28 27.5 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.918 1.687 . . . . 0.0 110.09 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.38 158.67 43.78 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.844 2.363 . . . . 0.0 112.784 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.58 154.26 68.7 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.836 2.357 . . . . 0.0 112.372 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.06 114.03 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.635 2.89 . . . . 0.0 111.358 176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 C--O 1.257 1.498 0 CA-C-O 114.156 -2.83 . . . . 0.0 115.318 176.29 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 117.864 -1.065 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.1 mt -52.37 -37.27 55.84 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.084 1.311 . . . . 0.0 114.141 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.83 -35.52 73.02 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.695 0.798 . . . . 0.0 112.899 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 mm -64.69 -46.47 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.095 0.958 . . . . 0.0 109.971 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -59.45 -45.96 90.11 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.036 0.534 . . . . 0.0 111.744 175.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -60.07 -44.51 94.69 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.67 -38.65 88.57 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.456 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -56.84 -35.23 68.59 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.108 0.963 . . . . 0.0 113.573 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.36 -23.23 66.3 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.17 0.988 . . . . 0.0 112.447 175.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.54 11.18 5.65 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.721 1.629 . . . . 0.0 114.61 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.55 -134.83 52.32 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 118.857 -0.968 . . . . 0.0 111.648 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.5 -21.15 44.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.711 2.941 . . . . 0.0 114.414 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.0 p -86.47 21.1 2.22 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.952 1.301 . . . . 0.0 114.075 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.0 11.76 10.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.271 1.428 . . . . 0.0 112.969 -171.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.12 23.19 71.26 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.478 1.037 . . . . 0.0 114.143 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -144.51 130.56 9.81 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.032 1.333 . . . . 0.0 112.149 -175.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.95 166.67 28.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.285 2.656 . . . . 0.0 112.334 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.97 142.54 69.03 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.132 2.555 . . . . 0.0 112.172 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.59 106.69 2.32 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.494 2.796 . . . . 0.0 110.147 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.0 m . . . . . 0 C--O 1.252 1.226 0 CA-C-O 116.764 -1.589 . . . . 0.0 111.062 174.195 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.5 -3.11 0.15 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.653 2.381 . . . . 0.0 115.959 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -61.0 -35.77 77.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.022 1.729 . . . . 0.0 113.239 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.88 -41.82 94.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.132 0.973 . . . . 0.0 111.073 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -66.78 -39.72 87.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.854 0.862 . . . . 0.0 111.531 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -62.8 -46.14 89.38 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.8 mt -60.62 -37.68 82.23 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.689 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.07 -34.13 59.3 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.212 0.914 . . . . 0.0 113.0 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -80.74 -2.81 48.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.899 0.88 . . . . 0.0 113.298 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.61 9.23 31.29 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.896 -1.127 . . . . 0.0 115.555 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 52.14 -114.65 3.42 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.118 1.342 . . . . 0.0 113.218 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.12 -24.23 48.64 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.506 2.138 . . . . 0.0 114.416 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 4.03 41.48 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.165 0.986 . . . . 0.0 113.631 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 m -93.47 4.34 54.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.785 1.634 . . . . 0.0 114.711 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.47 13.01 67.53 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.019 -1.051 . . . . 0.0 114.823 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -144.96 137.63 13.6 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.497 1.519 . . . . 0.0 110.788 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.27 162.03 35.1 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.924 2.416 . . . . 0.0 112.657 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.34 146.64 69.69 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.852 2.368 . . . . 0.0 112.168 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.65 137.68 22.91 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.68 2.253 . . . . 0.0 110.133 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 116.813 -1.565 . . . . 0.0 109.883 174.899 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.1 t30 . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 58.98 -1.16 0.12 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 178.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -59.23 -38.59 80.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.495 1.518 . . . . 0.0 113.632 -174.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 mp -59.82 -50.95 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 110.299 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -40.72 92.2 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.902 0.881 . . . . 0.0 112.703 176.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -60.69 -45.41 94.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.248 0.619 . . . . 0.0 112.563 173.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.8 mt -61.96 -44.1 97.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.432 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -54.45 -35.47 63.03 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.28 0.946 . . . . 0.0 113.238 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.04 -32.71 72.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.295 0.638 . . . . 0.0 112.444 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.56 4.3 2.5 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.989 1.281 . . . . 0.0 114.843 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.23 -125.97 40.67 Favored Glycine 0 CA--C 1.54 1.625 0 CA-C-N 118.794 1.297 . . . . 0.0 112.154 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.74 -25.32 75.38 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.648 2.232 . . . . 0.0 114.147 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.2 m -80.04 7.92 8.14 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 m -108.55 7.18 26.61 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.815 1.646 . . . . 0.0 114.522 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.49 19.86 74.94 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 114.07 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -137.62 128.17 15.76 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.607 1.563 . . . . 0.0 111.44 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.96 165.13 31.08 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.006 2.471 . . . . 0.0 111.863 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.13 135.63 51.86 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.729 2.286 . . . . 0.0 111.355 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -81.12 145.7 15.52 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.454 2.103 . . . . 0.0 110.777 176.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.068 0 C-N-CA 127.182 2.193 . . . . 0.0 116.104 167.126 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 68.39 -32.96 0.22 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.936 1.695 . . . . 0.0 114.931 -178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -57.04 -37.15 71.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.946 1.698 . . . . 0.0 113.646 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -56.94 -50.62 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.547 0.739 . . . . 0.0 109.897 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -44.43 96.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.694 1.198 . . . . 0.0 111.224 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.5 t90 -59.92 -47.1 87.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.79 0.836 . . . . 0.0 113.031 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.7 mt -61.86 -41.31 97.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.534 -0.746 . . . . 0.0 112.156 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -55.97 -36.22 67.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.658 1.183 . . . . 0.0 112.35 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.04 -22.64 63.06 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.066 0.946 . . . . 0.0 113.44 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.2 5.31 6.21 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.543 1.544 . . . . 0.0 114.906 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.61 -123.8 29.61 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 119.054 1.427 . . . . 0.0 112.34 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -58.11 -29.5 87.38 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.553 2.169 . . . . 0.0 113.863 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 t -64.51 -18.8 65.14 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.84 -4.64 58.83 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.461 1.904 . . . . 0.0 112.707 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.39 -35.73 0.97 Allowed Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.569 1.557 . . . . 0.0 114.68 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -62.42 133.4 94.56 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.951 1.3 . . . . 0.0 111.016 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.49 163.23 33.31 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.359 2.706 . . . . 0.0 113.128 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.79 159.34 51.83 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.0 2.467 . . . . 0.0 112.662 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.94 -20.91 8.57 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.42 2.747 . . . . 0.0 114.606 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--O 1.254 1.325 0 C-N-CA 126.645 1.978 . . . . 0.0 111.099 175.957 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 118.495 -0.764 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.16 -36.06 60.45 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.381 1.073 . . . . 0.0 113.656 -178.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.04 -34.53 68.31 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.32 1.048 . . . . 0.0 113.16 177.397 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.9 mm -62.83 -47.6 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.522 0.729 . . . . 0.0 109.665 176.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -42.63 99.21 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.799 0.84 . . . . 0.0 111.133 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -61.42 -47.51 85.45 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.41 -36.11 81.33 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.718 -0.614 . . . . 0.0 112.085 174.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.5 tttp -58.89 -35.57 73.23 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.278 1.031 . . . . 0.0 113.376 178.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.5 -7.16 45.77 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.098 1.759 . . . . 0.0 113.502 173.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.81 10.1 29.18 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.071 1.32 . . . . 0.0 114.547 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.9 -129.62 49.81 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-N 119.319 1.559 . . . . 0.0 111.752 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -57.78 -27.29 77.39 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.652 2.234 . . . . 0.0 113.941 178.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.1 m -62.51 -33.47 74.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.887 0.875 . . . . 0.0 112.87 -177.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -15.06 62.7 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 176.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.05 35.79 23.28 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 118.593 0.633 . . . . 0.0 113.828 177.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 143.21 36.84 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.016 1.326 . . . . 0.0 111.761 -178.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.45 160.04 47.75 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.261 2.641 . . . . 0.0 112.064 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.75 152.67 58.84 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.669 2.246 . . . . 0.0 112.034 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.33 105.37 2.03 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.029 3.153 . . . . 0.0 110.328 179.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.697 -1.621 . . . . 0.0 111.016 175.188 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 118.946 -0.55 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.8 mt -58.81 -24.43 61.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.104 1.362 . . . . 0.0 113.632 -178.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -36.11 63.66 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.912 1.285 . . . . 0.0 112.625 178.001 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.8 mt -62.51 -49.59 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.577 0.751 . . . . 0.0 109.673 177.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -63.83 -40.23 96.1 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.394 0.678 . . . . 0.0 111.799 178.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -61.49 -47.22 86.63 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.895 0.878 . . . . 0.0 112.309 174.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.9 mt -64.63 -36.37 84.02 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.331 174.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -57.8 -39.25 77.11 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 178.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.01 -15.69 62.58 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.201 1.0 . . . . 0.0 113.162 176.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.52 8.36 9.22 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.524 1.059 . . . . 0.0 115.272 -177.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.14 -118.51 13.5 Favored Glycine 0 CA--C 1.542 1.74 0 CA-C-N 118.763 1.282 . . . . 0.0 112.608 177.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -58.65 -23.3 64.95 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.514 2.142 . . . . 0.0 114.127 176.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.2 m -92.54 27.89 2.16 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.632 1.173 . . . . 0.0 113.056 -178.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 m -118.07 3.16 12.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.607 1.163 . . . . 0.0 113.462 -176.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.66 28.26 73.55 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.757 0.694 . . . . 0.0 113.612 -178.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -153.71 141.52 13.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.57 1.148 . . . . 0.0 112.566 -176.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.33 165.35 32.78 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.359 2.706 . . . . 0.0 112.132 177.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.72 150.63 86.02 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.886 2.391 . . . . 0.0 111.911 177.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.59 -35.99 0.7 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.192 2.595 . . . . 0.0 113.623 -178.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.733 175.839 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp 63.92 -47.12 0.27 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.648 2.379 . . . . 0.0 115.475 -177.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -55.86 -37.04 68.26 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.76 1.224 . . . . 0.0 112.504 -178.178 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 mt -58.97 -50.03 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.92 1.288 . . . . 0.0 110.611 174.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -61.88 -40.41 95.28 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.806 0.843 . . . . 0.0 111.979 175.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -60.22 -45.55 92.82 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.429 0.559 . . . . 0.0 112.327 172.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.47 -39.25 93.97 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.785 173.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -55.05 -34.34 63.47 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.599 1.091 . . . . 0.0 112.976 176.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.53 -20.28 63.7 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 175.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.57 6.93 14.35 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.22 1.391 . . . . 0.0 113.929 -171.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.96 -127.45 42.99 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-N 118.614 1.207 . . . . 0.0 111.673 -178.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -59.29 -22.57 65.87 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.856 2.37 . . . . 0.0 114.26 177.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 t -61.11 -29.4 69.74 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.089 0.859 . . . . 0.0 113.168 -176.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.4 m -89.37 6.33 41.07 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.685 1.194 . . . . 0.0 113.141 175.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.58 -28.21 0.73 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.518 1.532 . . . . 0.0 115.368 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 ptm85 -56.55 127.59 72.96 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.35 1.46 . . . . 0.0 111.726 175.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -70.17 162.42 42.37 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.737 2.292 . . . . 0.0 111.856 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.08 159.74 52.68 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.786 2.324 . . . . 0.0 112.25 178.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.28 -18.85 12.3 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.438 2.759 . . . . 0.0 113.912 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 C--O 1.26 1.628 0 CA-C-O 114.251 -2.785 . . . . 0.0 111.116 174.073 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.2 0.54 48.35 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.426 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -56.33 -33.94 66.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.346 1.459 . . . . 0.0 113.436 -176.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.56 -43.9 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.11 0.964 . . . . 0.0 110.996 176.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -48.12 80.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.025 0.93 . . . . 0.0 110.861 175.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -60.63 -38.19 83.97 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.26 -37.61 87.93 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.713 -1.137 . . . . 0.0 112.459 171.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -57.68 -32.38 67.27 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.29 1.405 . . . . 0.0 113.244 173.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -67.01 -13.45 61.92 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 174.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.91 11.6 24.13 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.27 1.414 . . . . 0.0 114.045 -174.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.33 -135.17 48.13 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 118.661 1.23 . . . . 0.0 112.037 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.16 -32.01 68.23 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.094 2.529 . . . . 0.0 113.928 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.3 p -63.52 -23.24 67.31 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.76 -3.9 57.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.832 1.253 . . . . 0.0 113.415 176.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.98 -33.99 0.75 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.603 1.573 . . . . 0.0 115.513 177.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -60.68 138.58 93.14 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.986 1.393 . . . . 0.0 111.758 175.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.91 159.3 50.79 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.047 2.498 . . . . 0.0 112.155 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.37 149.96 63.81 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.834 2.356 . . . . 0.0 112.186 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.02 127.37 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.005 3.137 . . . . 0.0 110.275 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 C--O 1.249 1.061 0 C-N-CA 124.323 1.049 . . . . 0.0 113.127 175.962 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 118.712 -0.661 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.19 -34.58 68.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.462 1.505 . . . . 0.0 111.739 -176.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.9 -36.76 65.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.77 1.228 . . . . 0.0 113.215 176.167 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.04 -52.6 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.741 0.817 . . . . 0.0 109.308 177.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -46.15 89.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.79 1.236 . . . . 0.0 110.75 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -55.5 -50.77 69.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.818 1.247 . . . . 0.0 112.478 174.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.72 -41.11 99.0 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.614 174.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -55.57 -41.82 73.86 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.3 1.04 . . . . 0.0 111.277 176.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -6.97 26.16 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.06 10.8 31.34 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.888 1.232 . . . . 0.0 114.09 -178.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.08 -119.18 14.51 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.683 1.611 . . . . 0.0 111.922 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.04 -27.37 45.29 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.956 2.437 . . . . 0.0 113.634 176.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 m -59.54 -28.93 67.53 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.94 1.296 . . . . 0.0 113.026 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 t -77.95 -7.21 56.49 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 176.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.03 -9.85 44.05 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.077 1.323 . . . . 0.0 115.07 178.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 -88.42 139.56 30.05 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.751 1.276 . . . . 0.0 110.692 176.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.71 163.32 28.07 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.055 2.503 . . . . 0.0 113.213 174.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.45 136.16 42.1 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.419 2.746 . . . . 0.0 112.262 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -88.66 108.99 0.51 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.048 3.166 . . . . 0.0 112.43 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 116.719 -1.61 . . . . 0.0 113.44 -172.902 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 22.7 t30 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 tp -72.37 4.88 3.31 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -57.32 -37.34 72.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.868 1.267 . . . . 0.0 113.107 -176.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.51 -41.33 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.724 0.809 . . . . 0.0 111.656 177.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -63.55 -41.47 98.43 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.861 0.864 . . . . 0.0 111.852 176.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -64.34 -42.37 96.3 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 173.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.48 -37.68 84.53 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.489 173.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -37.56 59.98 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.329 1.052 . . . . 0.0 113.08 176.222 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.67 -25.95 63.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.279 0.632 . . . . 0.0 112.57 178.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.34 2.24 5.97 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.873 1.225 . . . . 0.0 114.614 -172.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.21 -125.42 38.98 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 119.033 1.417 . . . . 0.0 112.246 177.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.83 -28.71 68.86 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.51 2.14 . . . . 0.0 114.09 178.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 m -74.75 -3.76 33.52 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.7 m -93.38 -4.87 50.7 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.42 -36.02 0.97 Allowed Glycine 0 CA--C 1.539 1.581 0 O-C-N 120.764 -1.21 . . . . 0.0 114.792 -176.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -72.42 134.37 82.36 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 118.914 1.357 . . . . 0.0 111.227 174.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.26 163.98 34.14 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.259 2.64 . . . . 0.0 112.951 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.03 154.22 66.9 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.078 2.519 . . . . 0.0 112.79 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.85 -25.41 3.56 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.869 3.046 . . . . 0.0 114.176 -177.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.345 1.858 . . . . 0.0 111.092 -178.418 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.913 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -10.13 2.88 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 179.326 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -53.3 -36.19 60.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.842 1.257 . . . . 0.0 113.08 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mt -63.15 -38.09 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.838 0.855 . . . . 0.0 112.092 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -67.96 -46.73 70.59 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.449 1.1 . . . . 0.0 110.67 175.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -60.63 -41.98 96.0 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 175.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.99 -37.48 79.78 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.274 -0.891 . . . . 0.0 111.894 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -34.56 68.85 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.192 0.997 . . . . 0.0 113.06 175.093 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -67.16 -16.75 64.51 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.07 8.71 21.55 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.322 1.439 . . . . 0.0 114.327 -172.648 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.71 -132.94 52.23 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-N 119.149 1.474 . . . . 0.0 112.298 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -56.44 -29.19 76.75 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.885 2.39 . . . . 0.0 113.785 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 m -73.83 3.41 6.65 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.806 1.242 . . . . 0.0 113.965 -177.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.8 13.09 17.15 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.137 1.375 . . . . 0.0 113.813 -176.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.07 24.48 74.58 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.597 1.094 . . . . 0.0 115.067 172.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -141.15 135.32 15.09 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.319 1.448 . . . . 0.0 111.564 -170.576 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.92 160.25 46.38 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.781 2.32 . . . . 0.0 111.711 178.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.29 157.11 60.38 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.942 2.428 . . . . 0.0 112.754 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.51 -16.98 10.31 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.194 3.263 . . . . 0.0 113.733 -179.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p . . . . . 0 C--O 1.245 0.852 0 C-N-CA 127.686 2.394 . . . . 0.0 109.019 -178.427 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 51.0 t30 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mp 61.26 -2.46 0.22 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.968 2.507 . . . . 0.0 115.917 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -39.1 77.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.479 1.511 . . . . 0.0 113.549 -172.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.61 -42.4 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.781 0.832 . . . . 0.0 110.632 175.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.6 -42.43 86.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.974 0.91 . . . . 0.0 111.895 177.467 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.0 t90 -61.05 -42.99 99.53 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 172.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.12 -37.12 86.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.26 -0.876 . . . . 0.0 113.361 176.262 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -55.25 -38.33 68.38 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.773 1.169 . . . . 0.0 113.023 176.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.434 ' C ' ' HG ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -77.11 3.37 12.72 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.954 1.302 . . . . 0.0 113.828 174.536 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.7 11.44 43.93 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.273 -1.517 . . . . 0.0 115.603 178.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.68 -110.41 0.93 Allowed Glycine 0 CA--C 1.542 1.778 0 C-N-CA 125.83 1.681 . . . . 0.0 113.665 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -55.72 -26.8 58.16 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.392 2.062 . . . . 0.0 114.15 177.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.8 m -86.59 4.4 40.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.301 1.04 . . . . 0.0 113.505 -178.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.434 ' HG ' ' C ' ' A' ' 9' ' ' ASP . 14.4 m -91.4 -4.8 55.32 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.469 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.09 -10.0 10.94 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -179.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -112.49 139.76 23.02 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.866 1.667 . . . . 0.0 110.269 177.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.38 159.94 41.59 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.911 2.407 . . . . 0.0 112.954 176.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.73 140.81 43.7 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.068 2.512 . . . . 0.0 111.852 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.39 141.07 22.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.909 2.406 . . . . 0.0 110.312 172.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 C--O 1.252 1.199 0 CA-C-O 116.041 -1.933 . . . . 0.0 110.082 177.171 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 66.43 -42.02 0.39 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.237 1.815 . . . . 0.0 114.737 179.676 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.79 -36.96 62.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.132 1.773 . . . . 0.0 113.116 179.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mp -60.18 -48.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.148 0.979 . . . . 0.0 110.748 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -38.69 91.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.261 1.024 . . . . 0.0 111.235 178.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.0 t90 -62.67 -49.35 75.47 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.042 0.537 . . . . 0.0 112.318 172.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.6 mt -59.81 -34.35 72.94 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.403 -0.808 . . . . 0.0 112.842 175.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -53.47 -36.71 61.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.986 1.314 . . . . 0.0 113.502 177.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.63 -49.64 45.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.034 0.934 . . . . 0.0 111.49 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.61 25.97 0.02 OUTLIER Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.278 0.942 . . . . 0.0 115.25 179.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.6 -133.85 34.82 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-N 118.574 1.187 . . . . 0.0 112.413 -175.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.97 -25.57 54.16 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.082 2.521 . . . . 0.0 114.703 178.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.6 t -78.28 6.7 7.68 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -90.25 -7.62 53.02 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.494 1.918 . . . . 0.0 113.941 -176.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.6 -18.79 3.5 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 120.685 -1.26 . . . . 0.0 115.739 -176.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.6 ttt-85 -100.95 138.22 19.96 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.323 1.449 . . . . 0.0 110.963 176.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.0 159.8 47.46 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.797 2.332 . . . . 0.0 112.842 175.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.37 147.29 71.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.175 2.583 . . . . 0.0 111.432 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.3 150.35 36.77 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.652 2.235 . . . . 0.0 111.037 175.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 C--O 1.248 0.99 0 C-N-CA 127.266 2.226 . . . . 0.0 109.14 172.261 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt -77.6 2.18 17.35 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -177.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -60.85 -34.43 74.57 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.762 1.225 . . . . 0.0 112.961 -177.181 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.9 mp -58.01 -52.7 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.315 0.646 . . . . 0.0 109.947 175.518 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -40.13 87.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.88 0.872 . . . . 0.0 112.184 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -62.82 -45.93 90.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.205 0.602 . . . . 0.0 112.468 173.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.13 -37.24 84.39 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.157 -0.925 . . . . 0.0 113.127 175.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -54.34 -31.78 55.19 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.524 1.056 . . . . 0.0 113.591 175.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.66 -13.23 60.6 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 176.545 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.89 2.64 20.46 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.867 1.698 . . . . 0.0 115.29 -177.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.17 -128.69 34.03 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 118.701 1.25 . . . . 0.0 112.877 175.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.24 -24.38 67.01 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.585 2.19 . . . . 0.0 114.106 179.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.6 m -87.64 20.24 3.05 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.463 1.105 . . . . 0.0 113.467 -176.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -120.36 6.5 10.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.921 1.288 . . . . 0.0 113.698 -171.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.61 27.11 73.02 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.013 0.816 . . . . 0.0 114.136 178.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.26 132.6 10.93 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.985 1.314 . . . . 0.0 111.796 -174.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.62 157.91 57.35 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.736 2.291 . . . . 0.0 111.854 178.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.66 154.81 59.47 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.079 2.519 . . . . 0.0 112.007 178.108 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.03 139.42 24.2 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.876 2.384 . . . . 0.0 111.124 175.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.845 171.925 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.69 7.04 13.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.246 1.418 . . . . 0.0 114.13 -169.679 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.94 -29.93 69.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.577 1.551 . . . . 0.0 113.094 -176.343 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.51 -52.09 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.909 0.884 . . . . 0.0 110.195 177.291 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -57.03 -49.67 75.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.836 0.855 . . . . 0.0 111.49 174.096 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -57.52 -43.01 83.94 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 178.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.0 mt -67.01 -39.21 87.01 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.225 -0.922 . . . . 0.0 112.576 172.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.94 -35.9 62.23 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.133 1.373 . . . . 0.0 113.373 176.742 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -72.3 -19.4 61.67 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 174.721 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.91 8.74 7.88 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.731 1.157 . . . . 0.0 115.118 -175.487 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.96 -124.25 31.9 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 119.09 1.445 . . . . 0.0 113.192 175.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.04 -28.48 60.27 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.721 2.281 . . . . 0.0 113.951 179.661 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -76.44 -3.76 38.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.094 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.1 m -91.44 -3.83 56.22 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.345 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.51 -33.68 1.37 Allowed Glycine 0 CA--C 1.539 1.538 0 O-C-N 120.93 -1.106 . . . . 0.0 115.163 -179.063 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -74.18 135.5 76.44 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 118.883 1.341 . . . . 0.0 110.673 176.037 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.02 161.01 47.6 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.928 2.419 . . . . 0.0 112.842 -178.234 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.09 138.79 44.73 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.31 2.673 . . . . 0.0 111.75 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.92 138.15 16.36 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.824 2.35 . . . . 0.0 111.222 177.505 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.511 1.925 . . . . 0.0 111.604 177.389 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 117.974 -1.013 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 tp -57.76 -16.36 10.97 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.12 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.16 -36.25 40.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.434 1.494 . . . . 0.0 112.975 176.747 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.18 -44.72 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.009 0.924 . . . . 0.0 110.589 176.487 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.57 -44.8 85.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.202 0.601 . . . . 0.0 110.945 174.088 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.8 t90 -60.11 -38.13 82.1 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 176.226 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.32 -33.5 75.66 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.995 -1.065 . . . . 0.0 112.245 171.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -58.11 -35.87 72.09 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.482 1.113 . . . . 0.0 112.622 175.896 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.05 -20.72 66.63 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 173.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.64 7.75 10.5 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.344 1.449 . . . . 0.0 114.755 -171.796 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.95 -132.95 51.13 Favored Glycine 0 CA--C 1.542 1.769 0 CA-C-N 119.203 1.501 . . . . 0.0 112.446 -176.014 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -55.35 -30.81 74.41 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.512 2.808 . . . . 0.0 114.603 -178.202 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 64.5 m -79.59 14.62 1.58 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.059 1.344 . . . . 0.0 113.94 -175.553 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.82 3.5 16.45 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -168.799 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.63 21.45 78.8 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.738 1.161 . . . . 0.0 114.921 178.642 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -144.55 135.44 12.32 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.058 1.343 . . . . 0.0 111.557 -174.589 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.98 158.92 56.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.021 2.481 . . . . 0.0 111.851 -179.093 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.89 151.49 68.34 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.582 2.188 . . . . 0.0 111.556 177.523 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.89 150.32 11.06 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.437 2.758 . . . . 0.0 112.105 175.791 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.581 1.952 . . . . 0.0 113.709 -177.062 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 118.631 -0.699 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.94 -40.58 63.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.942 1.297 . . . . 0.0 113.21 177.062 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -64.82 -35.72 82.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.053 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.8 mt -62.63 -43.41 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.886 0.874 . . . . 0.0 110.173 176.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -41.69 92.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.252 1.021 . . . . 0.0 112.088 174.917 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -65.25 -43.46 91.26 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 173.522 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.4 mt -60.34 -39.49 87.28 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.506 174.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -50.69 -37.53 41.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.33 1.052 . . . . 0.0 113.028 178.019 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.5 -16.63 60.84 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.016 0.926 . . . . 0.0 113.27 -179.591 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.34 11.06 6.32 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.166 1.365 . . . . 0.0 115.095 -175.477 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.48 -119.54 7.44 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.055 1.312 . . . . 0.0 113.295 -178.418 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.9 -26.6 75.12 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.607 2.205 . . . . 0.0 114.188 177.167 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t -82.47 -0.87 48.33 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.201 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.9 m -84.5 -9.52 58.28 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.455 1.902 . . . . 0.0 114.668 -175.48 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.01 13.05 84.08 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 115.006 -174.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -137.89 136.3 19.7 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 118.875 1.338 . . . . 0.0 110.971 -178.083 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.26 160.41 42.41 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.053 2.502 . . . . 0.0 112.9 178.732 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.2 149.37 70.38 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.042 2.495 . . . . 0.0 112.022 179.049 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.34 -10.29 6.68 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.76 2.973 . . . . 0.0 114.191 -179.237 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.985 0 C-N-CA 127.315 2.246 . . . . 0.0 108.649 178.419 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.2 mt -97.05 4.1 51.54 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.222 1.374 . . . . 0.0 114.396 -176.709 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -58.25 -35.69 72.12 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.067 0.947 . . . . 0.0 112.92 -175.397 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mp -61.42 -50.38 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.324 1.05 . . . . 0.0 110.448 176.266 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -59.37 -44.58 92.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.577 1.151 . . . . 0.0 112.067 174.859 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -60.47 -46.36 90.38 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 175.924 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.14 -42.04 94.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.86 171.593 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -25.7 63.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.141 0.976 . . . . 0.0 113.557 177.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.1 -12.34 59.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 173.852 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.24 4.03 14.43 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.051 1.31 . . . . 0.0 115.248 -177.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.55 -130.58 48.58 Favored Glycine 0 CA--C 1.545 1.963 0 CA-C-N 119.567 1.684 . . . . 0.0 112.766 177.548 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -66.86 11.15 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.806 3.004 . . . . 0.0 115.935 -177.481 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.0 m -115.96 12.18 15.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.836 1.654 . . . . 0.0 113.501 -175.247 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -120.26 8.77 10.91 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.635 1.174 . . . . 0.0 113.575 -167.383 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.62 20.55 74.05 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.301 0.953 . . . . 0.0 114.963 178.881 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -136.45 133.92 19.51 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.261 1.424 . . . . 0.0 112.007 -174.085 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -70.44 159.32 53.32 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.678 2.252 . . . . 0.0 111.894 177.695 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.37 146.56 45.27 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.886 2.39 . . . . 0.0 111.987 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.65 127.63 5.73 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.634 2.89 . . . . 0.0 111.63 178.116 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.248 1.009 0 C-N-CA 126.758 2.023 . . . . 0.0 109.68 174.883 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.89 -8.41 3.1 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -178.757 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -54.66 -34.86 62.84 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.864 1.666 . . . . 0.0 113.019 -178.279 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.2 mt -60.48 -47.85 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.593 1.157 . . . . 0.0 110.378 175.514 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.42 -39.36 81.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.04 1.336 . . . . 0.0 111.471 178.432 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -62.41 -44.31 96.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.021 0.929 . . . . 0.0 112.827 173.083 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.15 -42.29 98.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.008 172.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -53.14 -32.84 49.64 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 176.493 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -76.06 -18.93 59.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.931 0.892 . . . . 0.0 113.346 177.242 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.15 9.3 5.66 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.856 1.217 . . . . 0.0 115.231 -175.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.66 -118.97 7.68 Favored Glycine 0 CA--C 1.544 1.876 0 CA-C-N 118.941 1.371 . . . . 0.0 113.379 -178.991 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.3 -26.92 72.86 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.644 2.23 . . . . 0.0 114.452 178.342 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -81.26 1.29 33.01 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -179.447 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -89.28 -1.95 58.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.89 1.676 . . . . 0.0 114.582 -176.8 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.88 -36.73 1.25 Allowed Glycine 0 CA--C 1.539 1.54 0 O-C-N 120.442 -1.411 . . . . 0.0 114.709 -177.433 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -83.23 136.79 43.05 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.706 1.253 . . . . 0.0 111.425 175.081 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.56 164.68 25.41 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.439 2.76 . . . . 0.0 113.087 174.533 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 156.18 64.62 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.713 2.275 . . . . 0.0 112.519 -179.92 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.64 -24.79 4.03 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.595 2.864 . . . . 0.0 114.285 -178.685 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 C--O 1.257 1.476 0 CA-C-O 114.592 -2.623 . . . . 0.0 109.985 -176.429 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -51.66 -40.05 59.29 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.171 1.35 . . . . 0.0 113.611 -175.742 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.28 -29.1 68.59 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.881 0.872 . . . . 0.0 113.263 177.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.6 mm -66.54 -51.12 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.577 1.151 . . . . 0.0 109.454 176.648 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -54.48 -51.85 63.77 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.19 0.996 . . . . 0.0 110.839 173.024 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.7 t90 -57.7 -44.46 85.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.829 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.2 mt -61.65 -37.06 82.64 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.225 -0.922 . . . . 0.0 111.963 172.377 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.24 -16.31 61.8 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.286 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.63 -9.74 51.09 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.488 1.515 . . . . 0.0 113.252 169.235 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.32 5.39 19.31 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.077 1.323 . . . . 0.0 114.625 -178.515 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.64 -130.25 48.04 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 119.165 1.482 . . . . 0.0 111.693 -178.498 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.97 -32.8 69.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.891 2.394 . . . . 0.0 113.814 179.638 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 m -63.67 -22.37 66.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.837 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -3.89 56.67 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 174.774 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.13 -30.5 0.95 Allowed Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.18 1.371 . . . . 0.0 115.345 177.851 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 ttt85 -65.92 133.8 94.95 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 118.886 1.343 . . . . 0.0 110.513 175.183 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.57 160.27 43.95 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.702 2.268 . . . . 0.0 112.463 178.833 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.34 153.83 70.27 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.796 2.331 . . . . 0.0 112.121 179.253 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.64 130.56 12.74 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.477 2.784 . . . . 0.0 110.666 176.032 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.253 1.256 0 C-N-CA 126.486 1.914 . . . . 0.0 113.03 171.797 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 118.78 -0.629 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.96 7.87 25.64 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -173.079 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.84 -39.86 72.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.347 1.459 . . . . 0.0 112.782 -173.881 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.14 -45.21 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.727 0.811 . . . . 0.0 110.526 177.106 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -35.23 77.96 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 176.964 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -64.93 -45.25 86.64 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.484 0.584 . . . . 0.0 112.249 171.99 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.6 mt -65.48 -32.44 74.05 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.753 -1.118 . . . . 0.0 113.514 176.315 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -52.96 -37.25 60.93 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.544 1.065 . . . . 0.0 113.617 176.791 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.17 -52.57 18.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.637 0.775 . . . . 0.0 111.341 179.329 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.43 29.35 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 N-CA-C 115.307 0.883 . . . . 0.0 115.307 177.772 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.45 -133.24 34.6 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.431 1.116 . . . . 0.0 112.236 -177.022 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.49 -24.57 62.1 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.184 2.589 . . . . 0.0 114.461 178.393 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 m -75.03 -11.24 60.06 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.994 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -69.64 -10.38 57.99 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.716 1.606 . . . . 0.0 113.46 177.779 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.94 -35.73 2.12 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.051 1.31 . . . . 0.0 114.292 -177.528 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -79.47 138.12 55.33 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 118.551 1.175 . . . . 0.0 111.328 174.665 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.01 160.68 36.61 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.615 2.877 . . . . 0.0 113.339 175.199 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.48 155.51 55.07 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.012 2.475 . . . . 0.0 112.507 179.597 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.61 -18.27 8.19 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.61 2.873 . . . . 0.0 114.177 179.142 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.417 1.487 . . . . 0.0 112.818 -178.968 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.8 p30 . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mt -75.59 5.06 6.5 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -175.861 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -59.32 -31.97 69.65 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.928 1.291 . . . . 0.0 113.053 -177.631 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mp -57.73 -49.78 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.448 0.699 . . . . 0.0 110.188 174.97 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.58 -45.16 94.99 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.917 0.887 . . . . 0.0 111.284 -179.121 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -59.65 -47.93 83.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.687 0.795 . . . . 0.0 112.283 175.461 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.56 -40.37 96.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.377 173.749 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -57.79 -38.83 76.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.521 1.128 . . . . 0.0 112.701 -179.4 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -20.05 63.64 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.918 1.287 . . . . 0.0 113.009 176.049 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.31 8.88 5.77 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.1 1.333 . . . . 0.0 114.806 -176.701 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.24 -124.95 37.54 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 119.022 1.411 . . . . 0.0 111.632 -177.205 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -56.31 -30.42 80.7 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.165 2.577 . . . . 0.0 114.178 178.379 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 m -75.34 12.05 1.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.907 1.283 . . . . 0.0 114.007 -178.11 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.99 3.32 20.33 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.916 1.686 . . . . 0.0 113.288 -172.726 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.51 20.41 75.47 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.363 -0.835 . . . . 0.0 114.222 -175.417 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.11 129.59 19.01 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.765 1.226 . . . . 0.0 110.92 -170.202 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.26 159.95 49.85 Favored 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.104 2.536 . . . . 0.0 113.221 -178.998 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.65 122.35 9.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.571 2.847 . . . . 0.0 111.461 -179.351 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.16 131.56 13.1 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.49 2.127 . . . . 0.0 110.517 178.137 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.257 1.477 0 CA-C-O 116.439 -1.744 . . . . 0.0 110.093 172.572 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -66.47 -30.9 71.34 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 mm -65.22 -45.94 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.767 1.227 . . . . 0.0 109.345 174.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.75 -30.35 71.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.46 0.704 . . . . 0.0 112.719 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.5 t90 -73.14 -43.42 61.63 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.965 0.802 . . . . 0.0 112.485 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.2 mt -64.88 -43.25 93.51 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.99 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -25.7 64.69 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.653 1.115 . . . . 0.0 113.921 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.99 -8.82 58.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.908 1.683 . . . . 0.0 113.646 174.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.78 8.08 24.77 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.373 1.463 . . . . 0.0 114.798 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.24 -124.37 32.77 Favored Glycine 0 CA--C 1.541 1.713 0 CA-C-N 118.825 1.312 . . . . 0.0 112.149 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.98 -28.77 84.35 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.794 2.33 . . . . 0.0 113.813 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.7 m -81.83 19.13 1.14 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.089 1.356 . . . . 0.0 113.737 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.06 13.4 9.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.843 1.257 . . . . 0.0 113.82 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.93 25.22 74.35 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.471 -0.768 . . . . 0.0 114.505 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -143.95 131.3 10.57 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.873 1.269 . . . . 0.0 111.893 -172.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.1 160.07 50.92 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.82 2.347 . . . . 0.0 111.692 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.48 145.67 59.48 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.472 2.115 . . . . 0.0 111.422 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 CA--C 1.539 0.759 0 C-N-CA 123.169 2.579 . . . . 0.0 110.894 176.285 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -54.78 -31.94 59.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.07 1.748 . . . . 0.0 113.742 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.6 mt -59.68 -49.11 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.45 1.1 . . . . 0.0 109.474 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -33.18 74.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.487 1.115 . . . . 0.0 111.799 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -66.8 -45.94 76.78 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.3 mt -61.18 -37.0 81.36 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.938 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -52.99 -33.48 51.65 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.025 0.93 . . . . 0.0 113.282 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -75.19 -11.09 60.0 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.336 1.454 . . . . 0.0 112.549 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.09 10.34 28.15 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.476 -1.39 . . . . 0.0 115.374 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.27 -125.2 38.76 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 118.672 1.236 . . . . 0.0 113.086 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.26 -23.17 61.05 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.446 2.098 . . . . 0.0 114.305 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.82 7.26 18.51 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.074 0.95 . . . . 0.0 113.263 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 m -103.95 1.87 31.73 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.842 1.657 . . . . 0.0 114.422 -174.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.79 -37.52 1.25 Allowed Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.831 1.205 . . . . 0.0 115.019 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.2 ttp-105 -75.92 131.69 75.73 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.934 1.293 . . . . 0.0 111.36 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.09 162.4 32.96 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.328 2.685 . . . . 0.0 113.069 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.71 142.3 57.68 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.063 2.509 . . . . 0.0 112.376 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 CA--C 1.538 0.677 0 C-N-CA 123.409 2.739 . . . . 0.0 110.752 177.53 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -57.54 -36.5 71.7 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.839 0.856 . . . . 0.0 112.917 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.3 mt -62.92 -44.92 99.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.923 1.289 . . . . 0.0 110.533 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -46.52 89.17 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.437 1.095 . . . . 0.0 110.776 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -64.05 -43.56 95.16 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.1 mt -63.07 -36.06 82.32 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.26 -0.9 . . . . 0.0 112.454 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -56.13 -33.51 65.23 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.456 1.025 . . . . 0.0 113.079 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -71.95 -5.99 38.77 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 118.958 0.799 . . . . 0.0 113.056 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.33 -2.05 32.9 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.704 1.621 . . . . 0.0 114.183 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.77 -129.12 46.32 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 118.655 1.228 . . . . 0.0 111.277 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -54.77 -29.76 63.92 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.81 2.34 . . . . 0.0 114.253 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 p -67.21 -23.68 65.76 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.85 -6.43 56.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.05 -31.49 1.1 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.801 1.191 . . . . 0.0 115.159 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -64.15 135.28 96.26 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 118.82 1.31 . . . . 0.0 110.592 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.4 159.86 45.5 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.875 2.383 . . . . 0.0 112.847 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.99 162.81 41.41 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.383 2.722 . . . . 0.0 112.74 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.537 0.652 0 C-N-CA 123.616 2.877 . . . . 0.0 114.327 179.156 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.55 -30.97 68.99 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.126 0.97 . . . . 0.0 113.418 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.2 -51.19 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.074 0.949 . . . . 0.0 109.462 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -56.53 -48.06 78.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.452 1.101 . . . . 0.0 111.567 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -57.54 -46.99 83.22 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -65.07 -39.71 93.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.272 -0.87 . . . . 0.0 112.547 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -54.72 -40.0 68.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.236 1.015 . . . . 0.0 112.389 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -76.66 -11.85 59.91 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.014 1.326 . . . . 0.0 113.388 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.81 9.28 6.35 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.165 1.364 . . . . 0.0 115.714 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.06 -108.74 0.53 Allowed Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.383 1.468 . . . . 0.0 113.446 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.01 -27.66 65.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.537 2.158 . . . . 0.0 114.499 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.3 p -89.61 7.34 36.99 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -84.14 -5.23 59.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.006 1.322 . . . . 0.0 114.427 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.28 17.5 77.55 Favored Glycine 0 CA--C 1.538 1.494 0 O-C-N 120.561 -1.337 . . . . 0.0 115.171 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -143.27 143.64 25.21 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.502 1.521 . . . . 0.0 110.401 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.28 157.93 55.1 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.635 2.223 . . . . 0.0 112.767 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.89 140.7 39.01 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.205 2.603 . . . . 0.0 111.547 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 C-N-CA 123.205 2.603 . . . . 0.0 110.902 176.482 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -39.32 66.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.364 1.466 . . . . 0.0 113.701 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.5 mp -61.26 -50.03 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.016 0.927 . . . . 0.0 110.758 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -64.82 -37.82 88.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.389 0.676 . . . . 0.0 111.658 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -61.39 -46.32 90.65 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 172.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.5 mt -59.64 -37.11 77.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.96 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -57.06 -31.95 65.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.2 -19.84 63.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.267 1.027 . . . . 0.0 112.763 175.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.08 5.66 8.75 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 126.004 1.764 . . . . 0.0 114.549 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.94 -133.7 51.03 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 119.026 1.413 . . . . 0.0 112.198 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.21 -29.12 55.17 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.643 2.895 . . . . 0.0 114.464 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -81.44 21.32 0.79 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.803 1.641 . . . . 0.0 113.78 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.28 8.43 9.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.64 1.576 . . . . 0.0 113.317 -169.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.53 24.98 73.93 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.3 1.429 . . . . 0.0 114.784 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -148.93 134.08 9.37 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.974 1.31 . . . . 0.0 112.023 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.56 161.72 44.47 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.235 2.624 . . . . 0.0 112.029 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.79 146.25 65.6 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.01 2.473 . . . . 0.0 112.611 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo . . . . . 0 CA--C 1.538 0.699 0 C-N-CA 123.786 2.99 . . . . 0.0 111.086 178.117 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -54.35 -32.06 55.92 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.572 2.749 . . . . 0.0 113.588 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.46 -46.98 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.979 0.911 . . . . 0.0 110.718 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -44.25 96.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.252 0.621 . . . . 0.0 111.142 175.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -62.92 -39.33 94.24 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.75 -38.36 90.73 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.043 -1.035 . . . . 0.0 112.16 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -54.79 -33.78 61.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.302 1.041 . . . . 0.0 113.562 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -67.38 -20.35 65.54 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.429 1.013 . . . . 0.0 113.469 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.37 8.02 9.58 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.0 1.286 . . . . 0.0 114.889 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.49 -133.77 51.8 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-N 119.139 1.469 . . . . 0.0 112.183 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.75 -31.3 60.61 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.505 2.803 . . . . 0.0 114.726 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.2 m -77.09 10.13 2.57 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.614 1.166 . . . . 0.0 113.808 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -98.96 -1.81 38.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.467 1.507 . . . . 0.0 114.272 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -38.95 0.89 Allowed Glycine 0 CA--C 1.54 1.631 0 C-N-CA 125.043 1.306 . . . . 0.0 114.643 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -73.85 136.53 76.88 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.036 1.334 . . . . 0.0 112.283 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -70.64 161.3 46.55 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.334 2.689 . . . . 0.0 112.144 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.3 147.75 66.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.792 2.328 . . . . 0.0 111.723 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 CA--C 1.536 0.616 0 C-N-CA 123.075 2.516 . . . . 0.0 113.756 -179.122 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mt . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -54.24 -39.51 66.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.412 1.085 . . . . 0.0 113.406 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.25 -45.13 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.825 0.85 . . . . 0.0 110.627 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -34.93 77.34 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.339 1.455 . . . . 0.0 112.262 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -65.01 -47.19 78.36 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.661 0.784 . . . . 0.0 111.769 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.9 mt -60.75 -30.18 69.85 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 118.022 -0.989 . . . . 0.0 113.63 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -54.04 -34.85 61.11 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -74.09 -48.02 32.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.45 0.7 . . . . 0.0 111.079 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.9 26.91 0.02 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.373 0.987 . . . . 0.0 115.252 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.68 -133.38 43.72 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 118.869 1.335 . . . . 0.0 112.332 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -55.74 -28.77 68.33 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.026 2.484 . . . . 0.0 114.525 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.2 m -75.78 3.29 10.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.439 1.095 . . . . 0.0 113.679 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 m -81.75 -7.87 59.64 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.403 1.481 . . . . 0.0 114.169 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.05 12.29 84.78 Favored Glycine 0 CA--C 1.539 1.537 0 O-C-N 120.982 -1.074 . . . . 0.0 115.009 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -143.86 138.0 14.76 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.993 1.317 . . . . 0.0 111.167 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.87 161.01 41.22 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.948 2.432 . . . . 0.0 113.016 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.73 162.59 41.49 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.489 2.793 . . . . 0.0 112.708 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 CA--C 1.539 0.772 0 C-N-CA 123.592 2.861 . . . . 0.0 114.149 177.947 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -62.66 -33.79 75.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.1 mm -64.9 -45.53 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.069 0.948 . . . . 0.0 109.737 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.64 -38.89 92.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.158 0.583 . . . . 0.0 112.254 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -63.03 -45.13 93.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.021 0.828 . . . . 0.0 112.694 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.0 mt -58.65 -37.42 75.92 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.273 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -57.08 -27.65 61.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.738 1.215 . . . . 0.0 114.22 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.92 -20.14 60.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.776 0.831 . . . . 0.0 112.575 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.35 10.07 6.85 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.776 1.655 . . . . 0.0 114.751 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.24 -134.96 52.12 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-N 118.968 1.384 . . . . 0.0 111.823 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.89 -27.22 61.95 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.608 2.872 . . . . 0.0 114.893 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m -78.31 12.18 2.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.173 0.989 . . . . 0.0 113.62 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 m -107.19 -4.08 19.17 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.822 1.649 . . . . 0.0 113.905 -170.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.64 19.44 76.51 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 119.176 -0.791 . . . . 0.0 114.817 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -135.5 134.14 20.85 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 125.395 1.478 . . . . 0.0 111.839 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.98 160.05 51.47 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.768 2.312 . . . . 0.0 111.917 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.61 149.04 60.85 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.881 2.387 . . . . 0.0 112.012 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 CA--C 1.541 0.858 0 C-N-CA 124.074 3.182 . . . . 0.0 114.387 -179.062 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.39 -38.91 85.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.995 1.718 . . . . 0.0 113.032 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 4' ' ' ILE . 4.1 mp -60.25 -47.28 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.791 0.836 . . . . 0.0 110.693 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -63.46 -38.1 89.86 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.372 0.669 . . . . 0.0 112.449 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -64.49 -45.32 87.81 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.868 0.758 . . . . 0.0 112.487 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.8 mt -60.58 -40.45 91.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.384 -0.817 . . . . 0.0 112.696 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -51.32 -34.12 32.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.136 1.374 . . . . 0.0 114.179 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -71.65 -39.97 69.99 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.572 0.749 . . . . 0.0 111.866 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.76 12.64 0.08 OUTLIER Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.45 -134.87 51.62 Favored Glycine 0 CA--C 1.543 1.836 0 CA-C-N 119.614 1.707 . . . . 0.0 112.416 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.8 -26.2 81.54 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.057 2.504 . . . . 0.0 115.565 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.1 p -82.14 8.5 10.73 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.649 1.113 . . . . 0.0 113.673 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -91.62 -4.27 55.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.807 2.043 . . . . 0.0 114.524 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.03 -38.33 1.76 Allowed Glycine 0 CA--C 1.539 1.59 0 O-C-N 120.583 -1.323 . . . . 0.0 114.886 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -74.44 135.49 75.6 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 118.847 1.324 . . . . 0.0 111.199 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -67.32 160.07 49.37 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.153 2.569 . . . . 0.0 113.192 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.03 139.53 39.53 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.099 2.533 . . . . 0.0 111.814 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo . . . . . 0 CA--C 1.538 0.723 0 C-N-CA 123.234 2.623 . . . . 0.0 110.913 175.72 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.42 -30.22 66.72 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.849 1.259 . . . . 0.0 113.952 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 mp -59.0 -48.13 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.719 0.808 . . . . 0.0 110.413 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -31.11 72.18 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.213 1.405 . . . . 0.0 112.456 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -76.39 -43.61 39.81 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.702 0.801 . . . . 0.0 112.804 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.6 mt -65.56 -43.98 88.18 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.939 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -19.41 56.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -15.86 58.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.241 1.417 . . . . 0.0 113.121 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.84 6.01 11.6 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.338 1.447 . . . . 0.0 114.671 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.93 -128.52 43.56 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 119.189 1.494 . . . . 0.0 112.04 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.62 -34.21 72.41 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.51 2.807 . . . . 0.0 114.545 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.4 m -74.98 7.04 3.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.717 1.207 . . . . 0.0 114.054 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -95.08 -11.28 28.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.7 27.89 66.29 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 118.8 0.727 . . . . 0.0 114.631 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.91 140.44 15.63 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.111 1.364 . . . . 0.0 111.684 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -70.67 160.32 49.83 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.067 2.512 . . . . 0.0 111.916 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.04 154.48 62.63 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.674 2.249 . . . . 0.0 112.141 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo . . . . . 0 CA--C 1.536 0.606 0 C-N-CA 123.62 2.88 . . . . 0.0 111.467 178.617 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -35.51 72.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.297 1.039 . . . . 0.0 112.345 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.25 -51.09 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.649 1.18 . . . . 0.0 109.621 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -55.68 -47.56 76.55 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.756 1.223 . . . . 0.0 111.836 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.0 t90 -61.59 -47.1 87.02 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.2 mt -63.42 -34.6 78.1 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.598 -0.689 . . . . 0.0 112.5 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -58.36 -36.6 73.72 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.75 1.22 . . . . 0.0 113.092 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.9 -21.1 63.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.025 0.93 . . . . 0.0 112.367 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.87 20.52 6.02 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.48 1.514 . . . . 0.0 113.708 -175.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.71 -124.69 30.29 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.061 1.43 . . . . 0.0 112.742 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -58.29 -23.88 64.92 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.488 2.125 . . . . 0.0 114.431 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.3 p -60.97 -31.22 70.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.209 0.913 . . . . 0.0 112.924 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -81.19 -5.08 57.32 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.917 1.287 . . . . 0.0 113.25 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.91 -27.63 1.95 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.616 1.579 . . . . 0.0 115.206 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -64.02 137.14 97.02 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 118.793 1.297 . . . . 0.0 111.14 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.22 161.23 46.7 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.119 2.546 . . . . 0.0 113.004 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.5 148.09 53.36 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.08 2.52 . . . . 0.0 112.105 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 123.128 2.552 . . . . 0.0 110.551 176.897 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -58.69 -39.79 81.76 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.95 1.7 . . . . 0.0 112.82 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.578 HD12 ' H ' ' A' ' 4' ' ' ILE . 3.6 mp -56.15 -45.07 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.384 1.074 . . . . 0.0 110.814 175.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -52.16 65.5 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.444 0.698 . . . . 0.0 111.062 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.7 t90 -61.22 -39.1 89.01 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.14 -37.1 85.88 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.343 -0.848 . . . . 0.0 111.876 171.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -58.81 -31.71 68.69 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -66.07 -24.0 66.64 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.938 0.79 . . . . 0.0 113.071 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.98 10.25 6.96 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 124.937 1.256 . . . . 0.0 115.286 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.39 -127.07 38.66 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 118.794 1.297 . . . . 0.0 113.554 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.46 -23.67 57.01 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.917 2.411 . . . . 0.0 114.714 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.7 m -83.39 2.54 35.92 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -93.44 -3.5 52.99 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.51 -39.72 0.75 Allowed Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.793 1.187 . . . . 0.0 114.757 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -68.6 137.51 90.73 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.789 1.235 . . . . 0.0 112.099 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.14 159.18 52.95 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.081 2.521 . . . . 0.0 112.359 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.18 156.2 46.8 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.062 2.508 . . . . 0.0 113.157 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo . . . . . 0 CA--C 1.542 0.917 0 C-N-CA 125.034 3.823 . . . . 0.0 114.168 178.131 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.04 -33.53 65.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.583 1.553 . . . . 0.0 113.513 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -63.57 -50.79 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.015 0.926 . . . . 0.0 110.767 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.89 -42.08 97.28 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.409 0.684 . . . . 0.0 111.667 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -62.03 -46.07 90.78 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.7 mt -60.87 -37.77 83.29 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.928 -1.107 . . . . 0.0 112.538 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -56.68 -28.26 60.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.95 0.796 . . . . 0.0 112.587 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -75.92 -11.01 59.89 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.269 -0.894 . . . . 0.0 113.187 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.71 11.25 27.13 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-N 120.293 1.406 . . . . 0.0 115.714 -172.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.9 -127.79 44.99 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 124.727 1.156 . . . . 0.0 113.475 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.98 -20.68 46.14 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.693 2.262 . . . . 0.0 114.657 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.5 p -88.95 4.97 46.27 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.705 1.202 . . . . 0.0 114.177 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.6 m -99.13 -1.17 40.1 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -172.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.79 -34.95 1.21 Allowed Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.733 1.159 . . . . 0.0 115.009 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -72.86 133.76 81.86 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.682 1.241 . . . . 0.0 110.967 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.38 157.74 58.73 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.816 2.344 . . . . 0.0 112.746 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.15 134.93 28.28 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.336 2.69 . . . . 0.0 111.313 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 CA--C 1.537 0.67 0 C-N-CA 122.564 2.176 . . . . 0.0 110.736 175.902 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.46 -33.62 74.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.845 1.258 . . . . 0.0 113.126 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.4 mt -58.56 -50.38 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.767 1.227 . . . . 0.0 109.955 176.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -41.89 96.27 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.845 1.258 . . . . 0.0 111.593 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -62.81 -43.57 98.44 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.22 -35.93 82.6 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.344 -0.836 . . . . 0.0 112.532 173.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -54.07 -37.95 64.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.469 1.108 . . . . 0.0 113.475 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -83.38 -8.42 59.41 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.582 1.953 . . . . 0.0 112.744 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.98 23.17 5.66 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.747 1.642 . . . . 0.0 115.067 177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 48.8 -108.99 0.47 Allowed Glycine 0 CA--C 1.54 1.595 0 C-N-CA 126.495 1.998 . . . . 0.0 113.708 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.12 -28.67 62.07 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.005 2.47 . . . . 0.0 114.3 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -82.69 -0.04 45.59 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.2 m -82.42 -3.67 56.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.459 1.504 . . . . 0.0 115.003 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.43 17.51 79.11 Favored Glycine 0 CA--C 1.539 1.573 0 O-C-N 121.178 -0.952 . . . . 0.0 115.26 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -153.85 144.82 16.18 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 125.472 1.509 . . . . 0.0 111.448 -172.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.52 164.74 34.19 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.532 2.821 . . . . 0.0 112.695 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.91 138.78 54.2 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.147 2.565 . . . . 0.0 112.651 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 CA--C 1.54 0.789 0 C-N-CA 123.633 2.889 . . . . 0.0 112.114 -179.4 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.99 -38.53 73.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.815 1.246 . . . . 0.0 112.649 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.49 -50.22 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 123.926 0.89 . . . . 0.0 110.552 176.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -62.07 -42.27 99.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.323 0.649 . . . . 0.0 111.979 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.8 t90 -60.72 -39.66 89.41 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.7 mt -66.42 -37.66 85.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 117.999 -1.001 . . . . 0.0 112.892 173.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -53.41 -39.77 64.59 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.736 1.153 . . . . 0.0 113.376 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.51 -11.96 61.26 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.22 14.42 9.88 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.326 0.965 . . . . 0.0 114.521 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.91 -120.21 8.79 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 117.998 -1.446 . . . . 0.0 112.219 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -54.7 -28.24 55.78 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.468 2.778 . . . . 0.0 114.466 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.9 p -79.6 2.97 20.4 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -88.96 -8.95 53.16 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.27 20.08 79.7 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 114.957 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.3 138.87 16.98 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 125.405 1.482 . . . . 0.0 110.681 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.58 159.36 48.43 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.882 2.388 . . . . 0.0 112.548 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.44 148.0 59.72 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.803 2.336 . . . . 0.0 111.711 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.538 0.7 0 C-N-CA 123.228 2.619 . . . . 0.0 111.418 175.883 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -62.1 -39.69 93.35 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mp -58.97 -51.5 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.771 1.229 . . . . 0.0 110.344 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -55.13 -46.54 75.63 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.175 0.99 . . . . 0.0 112.477 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -63.97 -47.29 80.98 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.69 -39.21 87.65 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.039 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -57.22 -34.45 68.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.89 1.276 . . . . 0.0 112.929 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -17.54 61.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.418 1.087 . . . . 0.0 112.722 176.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.75 5.86 8.89 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.762 1.648 . . . . 0.0 114.204 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.56 -124.07 32.27 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.026 -1.43 . . . . 0.0 111.509 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.27 -33.71 85.75 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.212 2.608 . . . . 0.0 114.299 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.4 m -60.75 -23.17 64.75 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.761 0.824 . . . . 0.0 112.932 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.67 -12.94 61.87 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.804 1.642 . . . . 0.0 113.199 175.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.89 12.09 74.57 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.051 0.834 . . . . 0.0 114.844 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -120.85 138.28 27.5 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.918 1.687 . . . . 0.0 110.09 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.38 158.67 43.78 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.844 2.363 . . . . 0.0 112.784 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.58 154.26 68.7 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.836 2.357 . . . . 0.0 112.372 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 123.635 2.89 . . . . 0.0 111.358 176.72 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.83 -35.52 73.02 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.695 0.798 . . . . 0.0 112.899 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 mm -64.69 -46.47 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.095 0.958 . . . . 0.0 109.971 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -59.45 -45.96 90.11 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.036 0.534 . . . . 0.0 111.744 175.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -60.07 -44.51 94.69 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.67 -38.65 88.57 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.456 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -56.84 -35.23 68.59 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.108 0.963 . . . . 0.0 113.573 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.36 -23.23 66.3 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.17 0.988 . . . . 0.0 112.447 175.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.54 11.18 5.65 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.721 1.629 . . . . 0.0 114.61 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.55 -134.83 52.32 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 118.857 -0.968 . . . . 0.0 111.648 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.5 -21.15 44.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.711 2.941 . . . . 0.0 114.414 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.0 p -86.47 21.1 2.22 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.952 1.301 . . . . 0.0 114.075 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 16' ' ' ARG . 0.9 OUTLIER -122.0 11.76 10.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.271 1.428 . . . . 0.0 112.969 -171.424 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.12 23.19 71.26 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.478 1.037 . . . . 0.0 114.143 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 14' ' ' SER . 14.5 ptp180 -144.51 130.56 9.81 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.032 1.333 . . . . 0.0 112.149 -175.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.95 166.67 28.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.285 2.656 . . . . 0.0 112.334 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.97 142.54 69.03 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.132 2.555 . . . . 0.0 112.172 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.458 -0.587 0 C-N-CA 123.494 2.796 . . . . 0.0 110.147 178.884 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.553 1.075 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -61.0 -35.77 77.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.022 1.729 . . . . 0.0 113.239 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.88 -41.82 94.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.132 0.973 . . . . 0.0 111.073 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -66.78 -39.72 87.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.854 0.862 . . . . 0.0 111.531 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -62.8 -46.14 89.38 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.8 mt -60.62 -37.68 82.23 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.689 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.07 -34.13 59.3 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.212 0.914 . . . . 0.0 113.0 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -80.74 -2.81 48.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.899 0.88 . . . . 0.0 113.298 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.61 9.23 31.29 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.896 -1.127 . . . . 0.0 115.555 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 52.14 -114.65 3.42 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.118 1.342 . . . . 0.0 113.218 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.12 -24.23 48.64 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.506 2.138 . . . . 0.0 114.416 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 4.03 41.48 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.165 0.986 . . . . 0.0 113.631 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 m -93.47 4.34 54.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.785 1.634 . . . . 0.0 114.711 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.47 13.01 67.53 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.019 -1.051 . . . . 0.0 114.823 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -144.96 137.63 13.6 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.497 1.519 . . . . 0.0 110.788 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.27 162.03 35.1 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.924 2.416 . . . . 0.0 112.657 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.34 146.64 69.69 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.852 2.368 . . . . 0.0 112.168 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.454 -0.817 0 C-N-CA 122.68 2.253 . . . . 0.0 110.133 173.055 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -59.23 -38.59 80.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.495 1.518 . . . . 0.0 113.632 -174.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 4' ' ' ILE . 4.0 mp -59.82 -50.95 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 110.299 175.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -40.72 92.2 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.902 0.881 . . . . 0.0 112.703 176.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -60.69 -45.41 94.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.248 0.619 . . . . 0.0 112.563 173.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.8 mt -61.96 -44.1 97.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.432 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -54.45 -35.47 63.03 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.28 0.946 . . . . 0.0 113.238 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.04 -32.71 72.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.295 0.638 . . . . 0.0 112.444 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.56 4.3 2.5 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.989 1.281 . . . . 0.0 114.843 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.23 -125.97 40.67 Favored Glycine 0 CA--C 1.54 1.625 0 CA-C-N 118.794 1.297 . . . . 0.0 112.154 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.74 -25.32 75.38 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.648 2.232 . . . . 0.0 114.147 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.2 m -80.04 7.92 8.14 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 m -108.55 7.18 26.61 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.815 1.646 . . . . 0.0 114.522 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.49 19.86 74.94 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 114.07 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -137.62 128.17 15.76 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.607 1.563 . . . . 0.0 111.44 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.96 165.13 31.08 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.006 2.471 . . . . 0.0 111.863 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.13 135.63 51.86 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.729 2.286 . . . . 0.0 111.355 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 122.454 2.103 . . . . 0.0 110.777 176.443 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -57.04 -37.15 71.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.946 1.698 . . . . 0.0 113.646 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -56.94 -50.62 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.547 0.739 . . . . 0.0 109.897 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -44.43 96.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.694 1.198 . . . . 0.0 111.224 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.5 t90 -59.92 -47.1 87.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.79 0.836 . . . . 0.0 113.031 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.7 mt -61.86 -41.31 97.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.534 -0.746 . . . . 0.0 112.156 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -55.97 -36.22 67.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.658 1.183 . . . . 0.0 112.35 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.04 -22.64 63.06 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.066 0.946 . . . . 0.0 113.44 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.2 5.31 6.21 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.543 1.544 . . . . 0.0 114.906 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.61 -123.8 29.61 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 119.054 1.427 . . . . 0.0 112.34 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -58.11 -29.5 87.38 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.553 2.169 . . . . 0.0 113.863 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 t -64.51 -18.8 65.14 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.84 -4.64 58.83 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.461 1.904 . . . . 0.0 112.707 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.39 -35.73 0.97 Allowed Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.569 1.557 . . . . 0.0 114.68 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -62.42 133.4 94.56 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.951 1.3 . . . . 0.0 111.016 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.49 163.23 33.31 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.359 2.706 . . . . 0.0 113.128 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.79 159.34 51.83 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.0 2.467 . . . . 0.0 112.662 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 CA--C 1.538 0.689 0 C-N-CA 123.42 2.747 . . . . 0.0 114.606 179.513 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.04 -34.53 68.31 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.32 1.048 . . . . 0.0 113.16 177.397 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.9 mm -62.83 -47.6 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.522 0.729 . . . . 0.0 109.665 176.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -42.63 99.21 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.799 0.84 . . . . 0.0 111.133 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -61.42 -47.51 85.45 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.41 -36.11 81.33 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.718 -0.614 . . . . 0.0 112.085 174.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.5 tttp -58.89 -35.57 73.23 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.278 1.031 . . . . 0.0 113.376 178.482 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.5 -7.16 45.77 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.098 1.759 . . . . 0.0 113.502 173.248 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.81 10.1 29.18 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.071 1.32 . . . . 0.0 114.547 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.9 -129.62 49.81 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-N 119.319 1.559 . . . . 0.0 111.752 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -57.78 -27.29 77.39 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.652 2.234 . . . . 0.0 113.941 178.474 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.1 m -62.51 -33.47 74.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.887 0.875 . . . . 0.0 112.87 -177.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -15.06 62.7 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 176.326 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.05 35.79 23.28 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 118.593 0.633 . . . . 0.0 113.828 177.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 143.21 36.84 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.016 1.326 . . . . 0.0 111.761 -178.209 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.45 160.04 47.75 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.261 2.641 . . . . 0.0 112.064 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.75 152.67 58.84 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.669 2.246 . . . . 0.0 112.034 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.456 -0.7 0 C-N-CA 124.029 3.153 . . . . 0.0 110.328 179.009 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.8 mt . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -36.11 63.66 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.912 1.285 . . . . 0.0 112.625 178.001 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.8 mt -62.51 -49.59 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.577 0.751 . . . . 0.0 109.673 177.2 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -63.83 -40.23 96.1 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.394 0.678 . . . . 0.0 111.799 178.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -61.49 -47.22 86.63 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.895 0.878 . . . . 0.0 112.309 174.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.9 mt -64.63 -36.37 84.02 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.331 174.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -57.8 -39.25 77.11 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 178.102 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.01 -15.69 62.58 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.201 1.0 . . . . 0.0 113.162 176.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.52 8.36 9.22 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.524 1.059 . . . . 0.0 115.272 -177.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.14 -118.51 13.5 Favored Glycine 0 CA--C 1.542 1.74 0 CA-C-N 118.763 1.282 . . . . 0.0 112.608 177.183 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -58.65 -23.3 64.95 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.514 2.142 . . . . 0.0 114.127 176.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.2 m -92.54 27.89 2.16 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.632 1.173 . . . . 0.0 113.056 -178.434 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 m -118.07 3.16 12.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.607 1.163 . . . . 0.0 113.462 -176.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.66 28.26 73.55 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.757 0.694 . . . . 0.0 113.612 -178.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -153.71 141.52 13.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.57 1.148 . . . . 0.0 112.566 -176.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.33 165.35 32.78 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.359 2.706 . . . . 0.0 112.132 177.514 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.72 150.63 86.02 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.886 2.391 . . . . 0.0 111.911 177.854 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.537 0.672 0 C-N-CA 123.192 2.595 . . . . 0.0 113.623 -178.934 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -55.86 -37.04 68.26 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.76 1.224 . . . . 0.0 112.504 -178.178 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 mt -58.97 -50.03 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.92 1.288 . . . . 0.0 110.611 174.329 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -61.88 -40.41 95.28 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.806 0.843 . . . . 0.0 111.979 175.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -60.22 -45.55 92.82 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.429 0.559 . . . . 0.0 112.327 172.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.47 -39.25 93.97 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.785 173.504 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -55.05 -34.34 63.47 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.599 1.091 . . . . 0.0 112.976 176.386 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.53 -20.28 63.7 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 175.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.57 6.93 14.35 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.22 1.391 . . . . 0.0 113.929 -171.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.96 -127.45 42.99 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-N 118.614 1.207 . . . . 0.0 111.673 -178.739 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -59.29 -22.57 65.87 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.856 2.37 . . . . 0.0 114.26 177.42 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 t -61.11 -29.4 69.74 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.089 0.859 . . . . 0.0 113.168 -176.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.4 m -89.37 6.33 41.07 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.685 1.194 . . . . 0.0 113.141 175.164 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.58 -28.21 0.73 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.518 1.532 . . . . 0.0 115.368 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 ptm85 -56.55 127.59 72.96 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.35 1.46 . . . . 0.0 111.726 175.192 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -70.17 162.42 42.37 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.737 2.292 . . . . 0.0 111.856 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.08 159.74 52.68 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.786 2.324 . . . . 0.0 112.25 178.454 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 CA--C 1.541 0.826 0 C-N-CA 123.438 2.759 . . . . 0.0 113.912 178.73 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -56.33 -33.94 66.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.346 1.459 . . . . 0.0 113.436 -176.247 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.56 -43.9 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.11 0.964 . . . . 0.0 110.996 176.019 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -48.12 80.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.025 0.93 . . . . 0.0 110.861 175.706 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -60.63 -38.19 83.97 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.26 -37.61 87.93 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.713 -1.137 . . . . 0.0 112.459 171.247 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -57.68 -32.38 67.27 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.29 1.405 . . . . 0.0 113.244 173.289 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -67.01 -13.45 61.92 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 174.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.91 11.6 24.13 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.27 1.414 . . . . 0.0 114.045 -174.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.33 -135.17 48.13 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 118.661 1.23 . . . . 0.0 112.037 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.16 -32.01 68.23 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.094 2.529 . . . . 0.0 113.928 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.3 p -63.52 -23.24 67.31 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.76 -3.9 57.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.832 1.253 . . . . 0.0 113.415 176.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.98 -33.99 0.75 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.603 1.573 . . . . 0.0 115.513 177.538 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -60.68 138.58 93.14 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.986 1.393 . . . . 0.0 111.758 175.081 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.91 159.3 50.79 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.047 2.498 . . . . 0.0 112.155 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.37 149.96 63.81 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.834 2.356 . . . . 0.0 112.186 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 N--CA 1.459 -0.534 0 C-N-CA 124.005 3.137 . . . . 0.0 110.275 178.697 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.9 -36.76 65.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.77 1.228 . . . . 0.0 113.215 176.167 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.04 -52.6 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.741 0.817 . . . . 0.0 109.308 177.179 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -46.15 89.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.79 1.236 . . . . 0.0 110.75 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -55.5 -50.77 69.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.818 1.247 . . . . 0.0 112.478 174.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.72 -41.11 99.0 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.614 174.25 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -55.57 -41.82 73.86 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.3 1.04 . . . . 0.0 111.277 176.608 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -6.97 26.16 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.06 10.8 31.34 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.888 1.232 . . . . 0.0 114.09 -178.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.08 -119.18 14.51 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.683 1.611 . . . . 0.0 111.922 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.04 -27.37 45.29 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.956 2.437 . . . . 0.0 113.634 176.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 m -59.54 -28.93 67.53 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.94 1.296 . . . . 0.0 113.026 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 t -77.95 -7.21 56.49 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 176.265 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.03 -9.85 44.05 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.077 1.323 . . . . 0.0 115.07 178.061 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 -88.42 139.56 30.05 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.751 1.276 . . . . 0.0 110.692 176.567 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.71 163.32 28.07 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.055 2.503 . . . . 0.0 113.213 174.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.45 136.16 42.1 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.419 2.746 . . . . 0.0 112.262 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 CA--C 1.541 0.834 0 C-N-CA 124.048 3.166 . . . . 0.0 112.43 -178.986 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 tp . . . . . 0 CA--C 1.552 1.03 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -57.32 -37.34 72.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.868 1.267 . . . . 0.0 113.107 -176.347 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.51 -41.33 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.724 0.809 . . . . 0.0 111.656 177.661 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -63.55 -41.47 98.43 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.861 0.864 . . . . 0.0 111.852 176.546 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -64.34 -42.37 96.3 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 173.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.48 -37.68 84.53 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.489 173.155 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -37.56 59.98 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.329 1.052 . . . . 0.0 113.08 176.222 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.67 -25.95 63.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.279 0.632 . . . . 0.0 112.57 178.718 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.34 2.24 5.97 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.873 1.225 . . . . 0.0 114.614 -172.2 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.21 -125.42 38.98 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 119.033 1.417 . . . . 0.0 112.246 177.346 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.83 -28.71 68.86 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.51 2.14 . . . . 0.0 114.09 178.542 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 m -74.75 -3.76 33.52 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.7 m -93.38 -4.87 50.7 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.42 -36.02 0.97 Allowed Glycine 0 CA--C 1.539 1.581 0 O-C-N 120.764 -1.21 . . . . 0.0 114.792 -176.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -72.42 134.37 82.36 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 118.914 1.357 . . . . 0.0 111.227 174.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.26 163.98 34.14 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.259 2.64 . . . . 0.0 112.951 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.03 154.22 66.9 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.078 2.519 . . . . 0.0 112.79 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 C--N 1.35 0.636 0 C-N-CA 123.869 3.046 . . . . 0.0 114.176 -177.625 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -53.3 -36.19 60.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.842 1.257 . . . . 0.0 113.08 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mt -63.15 -38.09 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.838 0.855 . . . . 0.0 112.092 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -67.96 -46.73 70.59 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.449 1.1 . . . . 0.0 110.67 175.402 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -60.63 -41.98 96.0 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 175.18 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.99 -37.48 79.78 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.274 -0.891 . . . . 0.0 111.894 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -34.56 68.85 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.192 0.997 . . . . 0.0 113.06 175.093 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -67.16 -16.75 64.51 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.674 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.07 8.71 21.55 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.322 1.439 . . . . 0.0 114.327 -172.648 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.71 -132.94 52.23 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-N 119.149 1.474 . . . . 0.0 112.298 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -56.44 -29.19 76.75 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.885 2.39 . . . . 0.0 113.785 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 m -73.83 3.41 6.65 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.806 1.242 . . . . 0.0 113.965 -177.582 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.8 13.09 17.15 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.137 1.375 . . . . 0.0 113.813 -176.406 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.07 24.48 74.58 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.597 1.094 . . . . 0.0 115.067 172.057 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -141.15 135.32 15.09 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.319 1.448 . . . . 0.0 111.564 -170.576 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.92 160.25 46.38 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.781 2.32 . . . . 0.0 111.711 178.238 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.29 157.11 60.38 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.942 2.428 . . . . 0.0 112.754 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 CA--C 1.538 0.695 0 C-N-CA 124.194 3.263 . . . . 0.0 113.733 -179.544 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -39.1 77.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.479 1.511 . . . . 0.0 113.549 -172.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.61 -42.4 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.781 0.832 . . . . 0.0 110.632 175.164 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.6 -42.43 86.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.974 0.91 . . . . 0.0 111.895 177.467 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.0 t90 -61.05 -42.99 99.53 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 172.579 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.12 -37.12 86.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.26 -0.876 . . . . 0.0 113.361 176.262 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -55.25 -38.33 68.38 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.773 1.169 . . . . 0.0 113.023 176.679 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.11 3.37 12.72 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.954 1.302 . . . . 0.0 113.828 174.536 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.7 11.44 43.93 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.273 -1.517 . . . . 0.0 115.603 178.464 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.68 -110.41 0.93 Allowed Glycine 0 CA--C 1.542 1.778 0 C-N-CA 125.83 1.681 . . . . 0.0 113.665 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -55.72 -26.8 58.16 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.392 2.062 . . . . 0.0 114.15 177.097 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.8 m -86.59 4.4 40.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.301 1.04 . . . . 0.0 113.505 -178.605 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.4 m -91.4 -4.8 55.32 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.469 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.09 -10.0 10.94 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -179.136 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -112.49 139.76 23.02 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.866 1.667 . . . . 0.0 110.269 177.084 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.38 159.94 41.59 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.911 2.407 . . . . 0.0 112.954 176.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.73 140.81 43.7 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.068 2.512 . . . . 0.0 111.852 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 N--CA 1.458 -0.616 0 C-N-CA 122.909 2.406 . . . . 0.0 110.312 172.986 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.79 -36.96 62.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.132 1.773 . . . . 0.0 113.116 179.526 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mp -60.18 -48.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.148 0.979 . . . . 0.0 110.748 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -38.69 91.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.261 1.024 . . . . 0.0 111.235 178.749 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.0 t90 -62.67 -49.35 75.47 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.042 0.537 . . . . 0.0 112.318 172.815 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.6 mt -59.81 -34.35 72.94 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.403 -0.808 . . . . 0.0 112.842 175.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -53.47 -36.71 61.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.986 1.314 . . . . 0.0 113.502 177.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.63 -49.64 45.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.034 0.934 . . . . 0.0 111.49 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.61 25.97 0.02 OUTLIER Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.278 0.942 . . . . 0.0 115.25 179.168 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.6 -133.85 34.82 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-N 118.574 1.187 . . . . 0.0 112.413 -175.929 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.97 -25.57 54.16 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.082 2.521 . . . . 0.0 114.703 178.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.6 t -78.28 6.7 7.68 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -90.25 -7.62 53.02 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.494 1.918 . . . . 0.0 113.941 -176.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.6 -18.79 3.5 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 120.685 -1.26 . . . . 0.0 115.739 -176.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.6 ttt-85 -100.95 138.22 19.96 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.323 1.449 . . . . 0.0 110.963 176.631 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.0 159.8 47.46 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.797 2.332 . . . . 0.0 112.842 175.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.37 147.29 71.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.175 2.583 . . . . 0.0 111.432 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo . . . . . 0 CA--C 1.539 0.741 0 C-N-CA 122.652 2.235 . . . . 0.0 111.037 175.333 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -60.85 -34.43 74.57 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.762 1.225 . . . . 0.0 112.961 -177.181 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.9 mp -58.01 -52.7 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.315 0.646 . . . . 0.0 109.947 175.518 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -40.13 87.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.88 0.872 . . . . 0.0 112.184 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -62.82 -45.93 90.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.205 0.602 . . . . 0.0 112.468 173.491 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.13 -37.24 84.39 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.157 -0.925 . . . . 0.0 113.127 175.744 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -54.34 -31.78 55.19 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.524 1.056 . . . . 0.0 113.591 175.524 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.66 -13.23 60.6 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 176.545 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.89 2.64 20.46 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.867 1.698 . . . . 0.0 115.29 -177.044 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.17 -128.69 34.03 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 118.701 1.25 . . . . 0.0 112.877 175.651 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.24 -24.38 67.01 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.585 2.19 . . . . 0.0 114.106 179.22 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.6 m -87.64 20.24 3.05 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.463 1.105 . . . . 0.0 113.467 -176.103 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -120.36 6.5 10.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.921 1.288 . . . . 0.0 113.698 -171.899 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.61 27.11 73.02 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.013 0.816 . . . . 0.0 114.136 178.625 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.26 132.6 10.93 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.985 1.314 . . . . 0.0 111.796 -174.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.62 157.91 57.35 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.736 2.291 . . . . 0.0 111.854 178.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.66 154.81 59.47 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.079 2.519 . . . . 0.0 112.007 178.108 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 CA--C 1.538 0.705 0 C-N-CA 122.876 2.384 . . . . 0.0 111.124 175.936 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.94 -29.93 69.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.577 1.551 . . . . 0.0 113.094 -176.343 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.51 -52.09 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.909 0.884 . . . . 0.0 110.195 177.291 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -57.03 -49.67 75.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.836 0.855 . . . . 0.0 111.49 174.096 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -57.52 -43.01 83.94 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 178.111 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.0 mt -67.01 -39.21 87.01 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.225 -0.922 . . . . 0.0 112.576 172.932 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.94 -35.9 62.23 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.133 1.373 . . . . 0.0 113.373 176.742 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -72.3 -19.4 61.67 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 174.721 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.91 8.74 7.88 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.731 1.157 . . . . 0.0 115.118 -175.487 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.96 -124.25 31.9 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 119.09 1.445 . . . . 0.0 113.192 175.968 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.04 -28.48 60.27 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.721 2.281 . . . . 0.0 113.951 179.661 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -76.44 -3.76 38.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.094 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.1 m -91.44 -3.83 56.22 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.345 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.51 -33.68 1.37 Allowed Glycine 0 CA--C 1.539 1.538 0 O-C-N 120.93 -1.106 . . . . 0.0 115.163 -179.063 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -74.18 135.5 76.44 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 118.883 1.341 . . . . 0.0 110.673 176.037 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.02 161.01 47.6 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.928 2.419 . . . . 0.0 112.842 -178.234 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.09 138.79 44.73 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.31 2.673 . . . . 0.0 111.75 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 0 CA--C 1.538 0.701 0 C-N-CA 122.824 2.35 . . . . 0.0 111.222 177.505 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 tp . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.16 -36.25 40.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.434 1.494 . . . . 0.0 112.975 176.747 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.18 -44.72 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.009 0.924 . . . . 0.0 110.589 176.487 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.57 -44.8 85.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.202 0.601 . . . . 0.0 110.945 174.088 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.8 t90 -60.11 -38.13 82.1 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 176.226 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.32 -33.5 75.66 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.995 -1.065 . . . . 0.0 112.245 171.963 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -58.11 -35.87 72.09 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.482 1.113 . . . . 0.0 112.622 175.896 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.05 -20.72 66.63 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 173.627 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.64 7.75 10.5 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.344 1.449 . . . . 0.0 114.755 -171.796 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.95 -132.95 51.13 Favored Glycine 0 CA--C 1.542 1.769 0 CA-C-N 119.203 1.501 . . . . 0.0 112.446 -176.014 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -55.35 -30.81 74.41 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.512 2.808 . . . . 0.0 114.603 -178.202 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 64.5 m -79.59 14.62 1.58 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.059 1.344 . . . . 0.0 113.94 -175.553 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.82 3.5 16.45 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -168.799 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.63 21.45 78.8 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.738 1.161 . . . . 0.0 114.921 178.642 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -144.55 135.44 12.32 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.058 1.343 . . . . 0.0 111.557 -174.589 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.98 158.92 56.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.021 2.481 . . . . 0.0 111.851 -179.093 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.89 151.49 68.34 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.582 2.188 . . . . 0.0 111.556 177.523 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 N--CA 1.457 -0.676 0 C-N-CA 123.437 2.758 . . . . 0.0 112.105 175.791 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -64.82 -35.72 82.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.053 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.8 mt -62.63 -43.41 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.886 0.874 . . . . 0.0 110.173 176.736 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -41.69 92.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.252 1.021 . . . . 0.0 112.088 174.917 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -65.25 -43.46 91.26 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 173.522 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.4 mt -60.34 -39.49 87.28 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.506 174.923 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -50.69 -37.53 41.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.33 1.052 . . . . 0.0 113.028 178.019 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.5 -16.63 60.84 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.016 0.926 . . . . 0.0 113.27 -179.591 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.34 11.06 6.32 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.166 1.365 . . . . 0.0 115.095 -175.477 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.48 -119.54 7.44 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.055 1.312 . . . . 0.0 113.295 -178.418 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.9 -26.6 75.12 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.607 2.205 . . . . 0.0 114.188 177.167 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t -82.47 -0.87 48.33 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.201 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.9 m -84.5 -9.52 58.28 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.455 1.902 . . . . 0.0 114.668 -175.48 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.01 13.05 84.08 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 115.006 -174.787 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -137.89 136.3 19.7 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 118.875 1.338 . . . . 0.0 110.971 -178.083 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.26 160.41 42.41 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.053 2.502 . . . . 0.0 112.9 178.732 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.2 149.37 70.38 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.042 2.495 . . . . 0.0 112.022 179.049 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 CA--C 1.541 0.863 0 C-N-CA 123.76 2.973 . . . . 0.0 114.191 -179.237 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -58.25 -35.69 72.12 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.067 0.947 . . . . 0.0 112.92 -175.397 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mp -61.42 -50.38 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.324 1.05 . . . . 0.0 110.448 176.266 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -59.37 -44.58 92.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.577 1.151 . . . . 0.0 112.067 174.859 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -60.47 -46.36 90.38 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 175.924 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.14 -42.04 94.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.86 171.593 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -25.7 63.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.141 0.976 . . . . 0.0 113.557 177.941 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.1 -12.34 59.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 173.852 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.24 4.03 14.43 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.051 1.31 . . . . 0.0 115.248 -177.855 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.55 -130.58 48.58 Favored Glycine 0 CA--C 1.545 1.963 0 CA-C-N 119.567 1.684 . . . . 0.0 112.766 177.548 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -66.86 11.15 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.806 3.004 . . . . 0.0 115.935 -177.481 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.0 m -115.96 12.18 15.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.836 1.654 . . . . 0.0 113.501 -175.247 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -120.26 8.77 10.91 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.635 1.174 . . . . 0.0 113.575 -167.383 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.62 20.55 74.05 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.301 0.953 . . . . 0.0 114.963 178.881 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -136.45 133.92 19.51 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.261 1.424 . . . . 0.0 112.007 -174.085 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -70.44 159.32 53.32 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.678 2.252 . . . . 0.0 111.894 177.695 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.37 146.56 45.27 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.886 2.39 . . . . 0.0 111.987 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 CA--C 1.54 0.803 0 C-N-CA 123.634 2.89 . . . . 0.0 111.63 178.116 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.551 0.987 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -54.66 -34.86 62.84 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.864 1.666 . . . . 0.0 113.019 -178.279 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.2 mt -60.48 -47.85 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.593 1.157 . . . . 0.0 110.378 175.514 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.42 -39.36 81.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.04 1.336 . . . . 0.0 111.471 178.432 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -62.41 -44.31 96.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.021 0.929 . . . . 0.0 112.827 173.083 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.15 -42.29 98.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.008 172.935 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -53.14 -32.84 49.64 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 176.493 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -76.06 -18.93 59.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.931 0.892 . . . . 0.0 113.346 177.242 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.15 9.3 5.66 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.856 1.217 . . . . 0.0 115.231 -175.791 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.66 -118.97 7.68 Favored Glycine 0 CA--C 1.544 1.876 0 CA-C-N 118.941 1.371 . . . . 0.0 113.379 -178.991 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.3 -26.92 72.86 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.644 2.23 . . . . 0.0 114.452 178.342 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -81.26 1.29 33.01 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -179.447 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -89.28 -1.95 58.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.89 1.676 . . . . 0.0 114.582 -176.8 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.88 -36.73 1.25 Allowed Glycine 0 CA--C 1.539 1.54 0 O-C-N 120.442 -1.411 . . . . 0.0 114.709 -177.433 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -83.23 136.79 43.05 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.706 1.253 . . . . 0.0 111.425 175.081 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.56 164.68 25.41 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.439 2.76 . . . . 0.0 113.087 174.533 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 156.18 64.62 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.713 2.275 . . . . 0.0 112.519 -179.92 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 CA--C 1.539 0.758 0 C-N-CA 123.595 2.864 . . . . 0.0 114.285 -178.685 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.28 -29.1 68.59 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.881 0.872 . . . . 0.0 113.263 177.348 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.6 mm -66.54 -51.12 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.577 1.151 . . . . 0.0 109.454 176.648 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -54.48 -51.85 63.77 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.19 0.996 . . . . 0.0 110.839 173.024 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.7 t90 -57.7 -44.46 85.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.829 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.2 mt -61.65 -37.06 82.64 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.225 -0.922 . . . . 0.0 111.963 172.377 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.24 -16.31 61.8 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.286 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.63 -9.74 51.09 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.488 1.515 . . . . 0.0 113.252 169.235 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.32 5.39 19.31 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.077 1.323 . . . . 0.0 114.625 -178.515 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.64 -130.25 48.04 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 119.165 1.482 . . . . 0.0 111.693 -178.498 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.97 -32.8 69.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.891 2.394 . . . . 0.0 113.814 179.638 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 m -63.67 -22.37 66.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.837 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -3.89 56.67 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 174.774 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.13 -30.5 0.95 Allowed Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.18 1.371 . . . . 0.0 115.345 177.851 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 ttt85 -65.92 133.8 94.95 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 118.886 1.343 . . . . 0.0 110.513 175.183 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.57 160.27 43.95 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.702 2.268 . . . . 0.0 112.463 178.833 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.34 153.83 70.27 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.796 2.331 . . . . 0.0 112.121 179.253 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 N--CA 1.456 -0.693 0 C-N-CA 123.477 2.784 . . . . 0.0 110.666 176.032 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.84 -39.86 72.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.347 1.459 . . . . 0.0 112.782 -173.881 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.14 -45.21 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.727 0.811 . . . . 0.0 110.526 177.106 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -35.23 77.96 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 176.964 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -64.93 -45.25 86.64 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.484 0.584 . . . . 0.0 112.249 171.99 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.6 mt -65.48 -32.44 74.05 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.753 -1.118 . . . . 0.0 113.514 176.315 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -52.96 -37.25 60.93 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.544 1.065 . . . . 0.0 113.617 176.791 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.17 -52.57 18.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.637 0.775 . . . . 0.0 111.341 179.329 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.43 29.35 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 N-CA-C 115.307 0.883 . . . . 0.0 115.307 177.772 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.45 -133.24 34.6 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.431 1.116 . . . . 0.0 112.236 -177.022 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.49 -24.57 62.1 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.184 2.589 . . . . 0.0 114.461 178.393 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 m -75.03 -11.24 60.06 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.994 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -69.64 -10.38 57.99 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.716 1.606 . . . . 0.0 113.46 177.779 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.94 -35.73 2.12 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.051 1.31 . . . . 0.0 114.292 -177.528 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -79.47 138.12 55.33 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 118.551 1.175 . . . . 0.0 111.328 174.665 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.01 160.68 36.61 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.615 2.877 . . . . 0.0 113.339 175.199 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.48 155.51 55.07 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.012 2.475 . . . . 0.0 112.507 179.597 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 CA--C 1.537 0.658 0 C-N-CA 123.61 2.873 . . . . 0.0 114.177 179.142 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 CA--C 1.545 0.768 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -59.32 -31.97 69.65 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.928 1.291 . . . . 0.0 113.053 -177.631 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mp -57.73 -49.78 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.448 0.699 . . . . 0.0 110.188 174.97 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.58 -45.16 94.99 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.917 0.887 . . . . 0.0 111.284 -179.121 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -59.65 -47.93 83.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.687 0.795 . . . . 0.0 112.283 175.461 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.56 -40.37 96.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.377 173.749 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.441 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -57.79 -38.83 76.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.521 1.128 . . . . 0.0 112.701 -179.4 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -20.05 63.64 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.918 1.287 . . . . 0.0 113.009 176.049 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.31 8.88 5.77 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.1 1.333 . . . . 0.0 114.806 -176.701 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.24 -124.95 37.54 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 119.022 1.411 . . . . 0.0 111.632 -177.205 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -56.31 -30.42 80.7 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.165 2.577 . . . . 0.0 114.178 178.379 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 m -75.34 12.05 1.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.907 1.283 . . . . 0.0 114.007 -178.11 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.99 3.32 20.33 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.916 1.686 . . . . 0.0 113.288 -172.726 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.51 20.41 75.47 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.363 -0.835 . . . . 0.0 114.222 -175.417 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.11 129.59 19.01 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.765 1.226 . . . . 0.0 110.92 -170.202 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.26 159.95 49.85 Favored 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.104 2.536 . . . . 0.0 113.221 -178.998 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.65 122.35 9.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.571 2.847 . . . . 0.0 111.461 -179.351 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 C--N 1.349 0.6 0 C-N-CA 122.49 2.127 . . . . 0.0 110.517 178.137 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 117.846 -1.074 . . . . 0.0 113.507 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 pp -43.98 -51.31 7.82 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -66.47 -30.9 71.34 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 mm -65.22 -45.94 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.767 1.227 . . . . 0.0 109.345 174.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.75 -30.35 71.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.46 0.704 . . . . 0.0 112.719 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.5 t90 -73.14 -43.42 61.63 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.965 0.802 . . . . 0.0 112.485 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.2 mt -64.88 -43.25 93.51 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.99 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -25.7 64.69 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.653 1.115 . . . . 0.0 113.921 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.99 -8.82 58.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.908 1.683 . . . . 0.0 113.646 174.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.78 8.08 24.77 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.373 1.463 . . . . 0.0 114.798 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.24 -124.37 32.77 Favored Glycine 0 CA--C 1.541 1.713 0 CA-C-N 118.825 1.312 . . . . 0.0 112.149 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.98 -28.77 84.35 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.794 2.33 . . . . 0.0 113.813 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.7 m -81.83 19.13 1.14 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.089 1.356 . . . . 0.0 113.737 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.06 13.4 9.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.843 1.257 . . . . 0.0 113.82 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.93 25.22 74.35 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.471 -0.768 . . . . 0.0 114.505 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -143.95 131.3 10.57 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.873 1.269 . . . . 0.0 111.893 -172.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.1 160.07 50.92 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.82 2.347 . . . . 0.0 111.692 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.48 145.67 59.48 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.472 2.115 . . . . 0.0 111.422 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.26 124.22 7.07 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.169 2.579 . . . . 0.0 110.894 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.25 1.119 0 C-N-CA 125.739 1.616 . . . . 0.0 111.968 171.654 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 m120 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 118.229 -0.891 . . . . 0.0 113.058 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 mp -62.0 -10.74 10.64 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -54.78 -31.94 59.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.07 1.748 . . . . 0.0 113.742 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.6 mt -59.68 -49.11 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.45 1.1 . . . . 0.0 109.474 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -33.18 74.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.487 1.115 . . . . 0.0 111.799 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -66.8 -45.94 76.78 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.3 mt -61.18 -37.0 81.36 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.938 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -52.99 -33.48 51.65 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.025 0.93 . . . . 0.0 113.282 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -75.19 -11.09 60.0 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.336 1.454 . . . . 0.0 112.549 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.09 10.34 28.15 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.476 -1.39 . . . . 0.0 115.374 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.27 -125.2 38.76 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 118.672 1.236 . . . . 0.0 113.086 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.26 -23.17 61.05 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.446 2.098 . . . . 0.0 114.305 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.82 7.26 18.51 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.074 0.95 . . . . 0.0 113.263 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 m -103.95 1.87 31.73 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.842 1.657 . . . . 0.0 114.422 -174.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.79 -37.52 1.25 Allowed Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.831 1.205 . . . . 0.0 115.019 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.2 ttp-105 -75.92 131.69 75.73 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.934 1.293 . . . . 0.0 111.36 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.09 162.4 32.96 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.328 2.685 . . . . 0.0 113.069 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.71 142.3 57.68 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.063 2.509 . . . . 0.0 112.376 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.66 117.65 4.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.409 2.739 . . . . 0.0 110.752 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.251 1.14 0 CA-C-O 115.622 -2.132 . . . . 0.0 112.502 172.685 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.03 -0.3 57.47 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.205 1.366 . . . . 0.0 114.352 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -57.54 -36.5 71.7 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.839 0.856 . . . . 0.0 112.917 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.3 mt -62.92 -44.92 99.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.923 1.289 . . . . 0.0 110.533 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -46.52 89.17 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.437 1.095 . . . . 0.0 110.776 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -64.05 -43.56 95.16 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.1 mt -63.07 -36.06 82.32 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.26 -0.9 . . . . 0.0 112.454 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -56.13 -33.51 65.23 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.456 1.025 . . . . 0.0 113.079 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -71.95 -5.99 38.77 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 118.958 0.799 . . . . 0.0 113.056 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.33 -2.05 32.9 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.704 1.621 . . . . 0.0 114.183 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.77 -129.12 46.32 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 118.655 1.228 . . . . 0.0 111.277 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -54.77 -29.76 63.92 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.81 2.34 . . . . 0.0 114.253 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 p -67.21 -23.68 65.76 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.85 -6.43 56.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.05 -31.49 1.1 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.801 1.191 . . . . 0.0 115.159 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -64.15 135.28 96.26 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 118.82 1.31 . . . . 0.0 110.592 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.4 159.86 45.5 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.875 2.383 . . . . 0.0 112.847 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.99 162.81 41.41 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.383 2.722 . . . . 0.0 112.74 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.84 -21.75 12.28 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.616 2.877 . . . . 0.0 114.327 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 C--O 1.248 1.011 0 C-N-CA 126.468 1.907 . . . . 0.0 110.883 174.877 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.2 m120 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 117.195 -1.383 . . . . 0.0 113.94 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -49.42 -38.98 31.18 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.596 1.544 . . . . 0.0 114.302 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.55 -30.97 68.99 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.126 0.97 . . . . 0.0 113.418 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.2 -51.19 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.074 0.949 . . . . 0.0 109.462 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -56.53 -48.06 78.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.452 1.101 . . . . 0.0 111.567 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -57.54 -46.99 83.22 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -65.07 -39.71 93.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.272 -0.87 . . . . 0.0 112.547 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -54.72 -40.0 68.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.236 1.015 . . . . 0.0 112.389 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -76.66 -11.85 59.91 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.014 1.326 . . . . 0.0 113.388 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.81 9.28 6.35 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.165 1.364 . . . . 0.0 115.714 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.06 -108.74 0.53 Allowed Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.383 1.468 . . . . 0.0 113.446 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.01 -27.66 65.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.537 2.158 . . . . 0.0 114.499 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.3 p -89.61 7.34 36.99 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -84.14 -5.23 59.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.006 1.322 . . . . 0.0 114.427 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.28 17.5 77.55 Favored Glycine 0 CA--C 1.538 1.494 0 O-C-N 120.561 -1.337 . . . . 0.0 115.171 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -143.27 143.64 25.21 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.502 1.521 . . . . 0.0 110.401 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.28 157.93 55.1 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.635 2.223 . . . . 0.0 112.767 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.89 140.7 39.01 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.205 2.603 . . . . 0.0 111.547 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.97 133.46 12.44 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.205 2.603 . . . . 0.0 110.902 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.245 0.817 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 173.689 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 116.716 -1.612 . . . . 0.0 115.14 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt 72.95 -34.83 0.31 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.312 1.845 . . . . 0.0 113.125 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -39.32 66.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.364 1.466 . . . . 0.0 113.701 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.5 mp -61.26 -50.03 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.016 0.927 . . . . 0.0 110.758 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -64.82 -37.82 88.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.389 0.676 . . . . 0.0 111.658 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -61.39 -46.32 90.65 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 172.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.5 mt -59.64 -37.11 77.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.96 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -57.06 -31.95 65.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.2 -19.84 63.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.267 1.027 . . . . 0.0 112.763 175.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.08 5.66 8.75 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 126.004 1.764 . . . . 0.0 114.549 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.94 -133.7 51.03 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 119.026 1.413 . . . . 0.0 112.198 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.21 -29.12 55.17 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.643 2.895 . . . . 0.0 114.464 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -81.44 21.32 0.79 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.803 1.641 . . . . 0.0 113.78 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.28 8.43 9.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.64 1.576 . . . . 0.0 113.317 -169.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.53 24.98 73.93 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.3 1.429 . . . . 0.0 114.784 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -148.93 134.08 9.37 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.974 1.31 . . . . 0.0 112.023 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.56 161.72 44.47 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.235 2.624 . . . . 0.0 112.029 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.79 146.25 65.6 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.01 2.473 . . . . 0.0 112.611 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -82.74 97.09 0.85 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.786 2.99 . . . . 0.0 111.086 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 115.677 -2.106 . . . . 0.0 114.0 -179.368 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tp 63.45 -33.93 0.13 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -54.35 -32.06 55.92 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.572 2.749 . . . . 0.0 113.588 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.46 -46.98 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.979 0.911 . . . . 0.0 110.718 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -44.25 96.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.252 0.621 . . . . 0.0 111.142 175.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -62.92 -39.33 94.24 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.75 -38.36 90.73 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.043 -1.035 . . . . 0.0 112.16 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -54.79 -33.78 61.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.302 1.041 . . . . 0.0 113.562 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -67.38 -20.35 65.54 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.429 1.013 . . . . 0.0 113.469 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.37 8.02 9.58 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.0 1.286 . . . . 0.0 114.889 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.49 -133.77 51.8 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-N 119.139 1.469 . . . . 0.0 112.183 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.75 -31.3 60.61 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.505 2.803 . . . . 0.0 114.726 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.2 m -77.09 10.13 2.57 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.614 1.166 . . . . 0.0 113.808 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -98.96 -1.81 38.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.467 1.507 . . . . 0.0 114.272 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -38.95 0.89 Allowed Glycine 0 CA--C 1.54 1.631 0 C-N-CA 125.043 1.306 . . . . 0.0 114.643 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -73.85 136.53 76.88 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.036 1.334 . . . . 0.0 112.283 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -70.64 161.3 46.55 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.334 2.689 . . . . 0.0 112.144 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.3 147.75 66.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.792 2.328 . . . . 0.0 111.723 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.62 -18.53 10.58 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.075 2.516 . . . . 0.0 113.756 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.258 1.517 0 CA-C-O 116.0 -1.952 . . . . 0.0 112.868 -171.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mt -71.45 -13.36 61.8 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.383 0.992 . . . . 0.0 113.632 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -54.24 -39.51 66.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.412 1.085 . . . . 0.0 113.406 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.25 -45.13 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.825 0.85 . . . . 0.0 110.627 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -34.93 77.34 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.339 1.455 . . . . 0.0 112.262 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -65.01 -47.19 78.36 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.661 0.784 . . . . 0.0 111.769 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.9 mt -60.75 -30.18 69.85 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 118.022 -0.989 . . . . 0.0 113.63 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -54.04 -34.85 61.11 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -74.09 -48.02 32.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.45 0.7 . . . . 0.0 111.079 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.9 26.91 0.02 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.373 0.987 . . . . 0.0 115.252 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.68 -133.38 43.72 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 118.869 1.335 . . . . 0.0 112.332 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -55.74 -28.77 68.33 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.026 2.484 . . . . 0.0 114.525 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.2 m -75.78 3.29 10.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.439 1.095 . . . . 0.0 113.679 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 m -81.75 -7.87 59.64 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.403 1.481 . . . . 0.0 114.169 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.05 12.29 84.78 Favored Glycine 0 CA--C 1.539 1.537 0 O-C-N 120.982 -1.074 . . . . 0.0 115.009 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -143.86 138.0 14.76 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.993 1.317 . . . . 0.0 111.167 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.87 161.01 41.22 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.948 2.432 . . . . 0.0 113.016 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.73 162.59 41.49 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.489 2.793 . . . . 0.0 112.708 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.18 -19.7 7.82 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.592 2.861 . . . . 0.0 114.149 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.248 1.019 0 C-N-CA 126.245 1.818 . . . . 0.0 110.4 170.413 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.427 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.3 OUTLIER -43.94 -46.94 8.4 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 120.229 1.377 . . . . 0.0 114.088 178.518 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -62.66 -33.79 75.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.1 mm -64.9 -45.53 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.069 0.948 . . . . 0.0 109.737 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.64 -38.89 92.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.158 0.583 . . . . 0.0 112.254 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -63.03 -45.13 93.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.021 0.828 . . . . 0.0 112.694 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.0 mt -58.65 -37.42 75.92 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.273 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -57.08 -27.65 61.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.738 1.215 . . . . 0.0 114.22 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.92 -20.14 60.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.776 0.831 . . . . 0.0 112.575 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.35 10.07 6.85 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.776 1.655 . . . . 0.0 114.751 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.24 -134.96 52.12 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-N 118.968 1.384 . . . . 0.0 111.823 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.89 -27.22 61.95 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.608 2.872 . . . . 0.0 114.893 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m -78.31 12.18 2.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.173 0.989 . . . . 0.0 113.62 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 m -107.19 -4.08 19.17 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.822 1.649 . . . . 0.0 113.905 -170.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.64 19.44 76.51 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 119.176 -0.791 . . . . 0.0 114.817 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -135.5 134.14 20.85 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 125.395 1.478 . . . . 0.0 111.839 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.98 160.05 51.47 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.768 2.312 . . . . 0.0 111.917 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.61 149.04 60.85 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.881 2.387 . . . . 0.0 112.012 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -85.46 -8.17 8.58 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.074 3.182 . . . . 0.0 114.387 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.254 1.298 0 CA-C-O 116.12 -1.895 . . . . 0.0 109.33 177.437 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 117.179 -1.391 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 57.13 -18.34 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 128.729 2.812 . . . . 0.0 117.039 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.39 -38.91 85.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.995 1.718 . . . . 0.0 113.032 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 4' ' ' ILE . 4.1 mp -60.25 -47.28 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.791 0.836 . . . . 0.0 110.693 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -63.46 -38.1 89.86 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.372 0.669 . . . . 0.0 112.449 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -64.49 -45.32 87.81 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.868 0.758 . . . . 0.0 112.487 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.8 mt -60.58 -40.45 91.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.384 -0.817 . . . . 0.0 112.696 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -51.32 -34.12 32.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.136 1.374 . . . . 0.0 114.179 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -71.65 -39.97 69.99 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.572 0.749 . . . . 0.0 111.866 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.76 12.64 0.08 OUTLIER Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.45 -134.87 51.62 Favored Glycine 0 CA--C 1.543 1.836 0 CA-C-N 119.614 1.707 . . . . 0.0 112.416 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.8 -26.2 81.54 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.057 2.504 . . . . 0.0 115.565 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.1 p -82.14 8.5 10.73 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.649 1.113 . . . . 0.0 113.673 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -91.62 -4.27 55.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.807 2.043 . . . . 0.0 114.524 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.03 -38.33 1.76 Allowed Glycine 0 CA--C 1.539 1.59 0 O-C-N 120.583 -1.323 . . . . 0.0 114.886 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -74.44 135.49 75.6 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 118.847 1.324 . . . . 0.0 111.199 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -67.32 160.07 49.37 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.153 2.569 . . . . 0.0 113.192 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.03 139.53 39.53 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.099 2.533 . . . . 0.0 111.814 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.82 138.73 15.09 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.234 2.623 . . . . 0.0 110.913 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.252 1.219 0 CA-C-O 116.271 -1.823 . . . . 0.0 109.342 176.581 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 117.449 -1.262 . . . . 0.0 113.747 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.31 -4.25 41.1 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 121.175 1.807 . . . . 0.0 114.332 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.42 -30.22 66.72 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.849 1.259 . . . . 0.0 113.952 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 mp -59.0 -48.13 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.719 0.808 . . . . 0.0 110.413 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -31.11 72.18 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.213 1.405 . . . . 0.0 112.456 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -76.39 -43.61 39.81 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.702 0.801 . . . . 0.0 112.804 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.6 mt -65.56 -43.98 88.18 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.939 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -19.41 56.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -15.86 58.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.241 1.417 . . . . 0.0 113.121 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.84 6.01 11.6 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.338 1.447 . . . . 0.0 114.671 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.93 -128.52 43.56 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 119.189 1.494 . . . . 0.0 112.04 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.62 -34.21 72.41 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.51 2.807 . . . . 0.0 114.545 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.4 m -74.98 7.04 3.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.717 1.207 . . . . 0.0 114.054 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -95.08 -11.28 28.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.7 27.89 66.29 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 118.8 0.727 . . . . 0.0 114.631 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.91 140.44 15.63 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.111 1.364 . . . . 0.0 111.684 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -70.67 160.32 49.83 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.067 2.512 . . . . 0.0 111.916 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.04 154.48 62.63 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.674 2.249 . . . . 0.0 112.141 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.24 110.89 3.09 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.62 2.88 . . . . 0.0 111.467 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 C--O 1.258 1.506 0 CA-C-O 114.774 -2.536 . . . . 0.0 110.659 177.504 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.2 t30 . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mt -79.8 -4.32 51.56 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.923 1.238 . . . . 0.0 114.058 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -35.51 72.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.297 1.039 . . . . 0.0 112.345 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.25 -51.09 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.649 1.18 . . . . 0.0 109.621 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -55.68 -47.56 76.55 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.756 1.223 . . . . 0.0 111.836 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.0 t90 -61.59 -47.1 87.02 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.2 mt -63.42 -34.6 78.1 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.598 -0.689 . . . . 0.0 112.5 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -58.36 -36.6 73.72 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.75 1.22 . . . . 0.0 113.092 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.9 -21.1 63.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.025 0.93 . . . . 0.0 112.367 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.87 20.52 6.02 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.48 1.514 . . . . 0.0 113.708 -175.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.71 -124.69 30.29 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.061 1.43 . . . . 0.0 112.742 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -58.29 -23.88 64.92 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.488 2.125 . . . . 0.0 114.431 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.3 p -60.97 -31.22 70.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.209 0.913 . . . . 0.0 112.924 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -81.19 -5.08 57.32 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.917 1.287 . . . . 0.0 113.25 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.91 -27.63 1.95 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.616 1.579 . . . . 0.0 115.206 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -64.02 137.14 97.02 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 118.793 1.297 . . . . 0.0 111.14 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.22 161.23 46.7 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.119 2.546 . . . . 0.0 113.004 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.5 148.09 53.36 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.08 2.52 . . . . 0.0 112.105 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.28 142.18 23.84 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.128 2.552 . . . . 0.0 110.551 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.088 1.755 . . . . 0.0 109.564 176.654 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.68 0.82 0.7 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.998 1.719 . . . . 0.0 115.241 175.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -58.69 -39.79 81.76 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.95 1.7 . . . . 0.0 112.82 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.578 HD12 ' H ' ' A' ' 4' ' ' ILE . 3.6 mp -56.15 -45.07 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.384 1.074 . . . . 0.0 110.814 175.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -52.16 65.5 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.444 0.698 . . . . 0.0 111.062 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.7 t90 -61.22 -39.1 89.01 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.14 -37.1 85.88 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.343 -0.848 . . . . 0.0 111.876 171.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -58.81 -31.71 68.69 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -66.07 -24.0 66.64 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.938 0.79 . . . . 0.0 113.071 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.98 10.25 6.96 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 124.937 1.256 . . . . 0.0 115.286 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.39 -127.07 38.66 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 118.794 1.297 . . . . 0.0 113.554 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.46 -23.67 57.01 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.917 2.411 . . . . 0.0 114.714 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.7 m -83.39 2.54 35.92 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -93.44 -3.5 52.99 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.51 -39.72 0.75 Allowed Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.793 1.187 . . . . 0.0 114.757 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -68.6 137.51 90.73 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.789 1.235 . . . . 0.0 112.099 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.14 159.18 52.95 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.081 2.521 . . . . 0.0 112.359 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.18 156.2 46.8 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.062 2.508 . . . . 0.0 113.157 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -84.77 -5.67 9.8 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 125.034 3.823 . . . . 0.0 114.168 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.4 m . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.367 1.867 . . . . 0.0 108.747 179.366 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 116.349 -1.786 . . . . 0.0 115.326 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mt 66.32 -33.72 0.19 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.449 1.9 . . . . 0.0 114.841 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.04 -33.53 65.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.583 1.553 . . . . 0.0 113.513 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -63.57 -50.79 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.015 0.926 . . . . 0.0 110.767 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.89 -42.08 97.28 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.409 0.684 . . . . 0.0 111.667 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -62.03 -46.07 90.78 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.7 mt -60.87 -37.77 83.29 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.928 -1.107 . . . . 0.0 112.538 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -56.68 -28.26 60.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.95 0.796 . . . . 0.0 112.587 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -75.92 -11.01 59.89 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.269 -0.894 . . . . 0.0 113.187 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.71 11.25 27.13 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-N 120.293 1.406 . . . . 0.0 115.714 -172.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.9 -127.79 44.99 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 124.727 1.156 . . . . 0.0 113.475 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.98 -20.68 46.14 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.693 2.262 . . . . 0.0 114.657 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.5 p -88.95 4.97 46.27 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.705 1.202 . . . . 0.0 114.177 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.6 m -99.13 -1.17 40.1 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -172.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.79 -34.95 1.21 Allowed Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.733 1.159 . . . . 0.0 115.009 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -72.86 133.76 81.86 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.682 1.241 . . . . 0.0 110.967 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.38 157.74 58.73 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.816 2.344 . . . . 0.0 112.746 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.15 134.93 28.28 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.336 2.69 . . . . 0.0 111.313 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.11 142.08 21.42 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.564 2.176 . . . . 0.0 110.736 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.253 1.271 0 CA-C-O 116.201 -1.857 . . . . 0.0 110.475 176.009 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -110.11 -3.64 16.28 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.003 -1.061 . . . . 0.0 113.65 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.46 -33.62 74.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.845 1.258 . . . . 0.0 113.126 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.4 mt -58.56 -50.38 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.767 1.227 . . . . 0.0 109.955 176.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -41.89 96.27 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.845 1.258 . . . . 0.0 111.593 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -62.81 -43.57 98.44 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.22 -35.93 82.6 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.344 -0.836 . . . . 0.0 112.532 173.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -54.07 -37.95 64.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.469 1.108 . . . . 0.0 113.475 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -83.38 -8.42 59.41 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.582 1.953 . . . . 0.0 112.744 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.98 23.17 5.66 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.747 1.642 . . . . 0.0 115.067 177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 48.8 -108.99 0.47 Allowed Glycine 0 CA--C 1.54 1.595 0 C-N-CA 126.495 1.998 . . . . 0.0 113.708 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.12 -28.67 62.07 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.005 2.47 . . . . 0.0 114.3 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -82.69 -0.04 45.59 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.2 m -82.42 -3.67 56.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.459 1.504 . . . . 0.0 115.003 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.43 17.51 79.11 Favored Glycine 0 CA--C 1.539 1.573 0 O-C-N 121.178 -0.952 . . . . 0.0 115.26 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -153.85 144.82 16.18 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 125.472 1.509 . . . . 0.0 111.448 -172.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.52 164.74 34.19 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.532 2.821 . . . . 0.0 112.695 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.91 138.78 54.2 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.147 2.565 . . . . 0.0 112.651 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.77 106.84 1.3 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.633 2.889 . . . . 0.0 112.114 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 t . . . . . 0 C--O 1.25 1.121 0 C-N-CA 127.884 2.473 . . . . 0.0 114.927 175.779 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.5 t30 . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.5 mt -105.58 1.9 27.82 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.631 -1.293 . . . . 0.0 113.143 -175.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.99 -38.53 73.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.815 1.246 . . . . 0.0 112.649 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.49 -50.22 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 123.926 0.89 . . . . 0.0 110.552 176.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -62.07 -42.27 99.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.323 0.649 . . . . 0.0 111.979 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.8 t90 -60.72 -39.66 89.41 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.7 mt -66.42 -37.66 85.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 117.999 -1.001 . . . . 0.0 112.892 173.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -53.41 -39.77 64.59 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.736 1.153 . . . . 0.0 113.376 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.51 -11.96 61.26 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.22 14.42 9.88 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.326 0.965 . . . . 0.0 114.521 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.91 -120.21 8.79 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 117.998 -1.446 . . . . 0.0 112.219 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -54.7 -28.24 55.78 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.468 2.778 . . . . 0.0 114.466 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.9 p -79.6 2.97 20.4 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -88.96 -8.95 53.16 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.27 20.08 79.7 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 114.957 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.3 138.87 16.98 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 125.405 1.482 . . . . 0.0 110.681 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.58 159.36 48.43 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.882 2.388 . . . . 0.0 112.548 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.44 148.0 59.72 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.803 2.336 . . . . 0.0 111.711 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.79 145.57 18.07 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.228 2.619 . . . . 0.0 111.418 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.6 p . . . . . 0 C--O 1.258 1.509 0 CA-C-O 114.601 -2.618 . . . . 0.0 109.565 176.435 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 117.391 -1.29 . . . . 0.0 113.124 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -41.27 -60.78 1.16 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -62.1 -39.69 93.35 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mp -58.97 -51.5 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.771 1.229 . . . . 0.0 110.344 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -55.13 -46.54 75.63 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.175 0.99 . . . . 0.0 112.477 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -63.97 -47.29 80.98 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.69 -39.21 87.65 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.039 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -57.22 -34.45 68.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.89 1.276 . . . . 0.0 112.929 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -17.54 61.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.418 1.087 . . . . 0.0 112.722 176.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.75 5.86 8.89 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.762 1.648 . . . . 0.0 114.204 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.56 -124.07 32.27 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.026 -1.43 . . . . 0.0 111.509 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.27 -33.71 85.75 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.212 2.608 . . . . 0.0 114.299 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.4 m -60.75 -23.17 64.75 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.761 0.824 . . . . 0.0 112.932 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.67 -12.94 61.87 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.804 1.642 . . . . 0.0 113.199 175.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.89 12.09 74.57 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.051 0.834 . . . . 0.0 114.844 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -120.85 138.28 27.5 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.918 1.687 . . . . 0.0 110.09 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.38 158.67 43.78 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.844 2.363 . . . . 0.0 112.784 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.58 154.26 68.7 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.836 2.357 . . . . 0.0 112.372 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.06 114.03 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.635 2.89 . . . . 0.0 111.358 176.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 C--O 1.257 1.498 0 CA-C-O 114.156 -2.83 . . . . 0.0 115.318 176.29 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 117.864 -1.065 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.1 mt -52.37 -37.27 55.84 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.084 1.311 . . . . 0.0 114.141 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.83 -35.52 73.02 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.695 0.798 . . . . 0.0 112.899 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 mm -64.69 -46.47 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.095 0.958 . . . . 0.0 109.971 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -59.45 -45.96 90.11 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.036 0.534 . . . . 0.0 111.744 175.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -60.07 -44.51 94.69 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.67 -38.65 88.57 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.456 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -56.84 -35.23 68.59 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.108 0.963 . . . . 0.0 113.573 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.36 -23.23 66.3 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.17 0.988 . . . . 0.0 112.447 175.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.54 11.18 5.65 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.721 1.629 . . . . 0.0 114.61 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.55 -134.83 52.32 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 118.857 -0.968 . . . . 0.0 111.648 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.5 -21.15 44.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.711 2.941 . . . . 0.0 114.414 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.0 p -86.47 21.1 2.22 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.952 1.301 . . . . 0.0 114.075 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 16' ' ' ARG . 0.9 OUTLIER -122.0 11.76 10.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.271 1.428 . . . . 0.0 112.969 -171.424 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.12 23.19 71.26 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.478 1.037 . . . . 0.0 114.143 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 14' ' ' SER . 14.5 ptp180 -144.51 130.56 9.81 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.032 1.333 . . . . 0.0 112.149 -175.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.95 166.67 28.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.285 2.656 . . . . 0.0 112.334 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.97 142.54 69.03 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.132 2.555 . . . . 0.0 112.172 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.59 106.69 2.32 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.494 2.796 . . . . 0.0 110.147 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.0 m . . . . . 0 C--O 1.252 1.226 0 CA-C-O 116.764 -1.589 . . . . 0.0 111.062 174.195 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.5 -3.11 0.15 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.653 2.381 . . . . 0.0 115.959 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -61.0 -35.77 77.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.022 1.729 . . . . 0.0 113.239 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.88 -41.82 94.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.132 0.973 . . . . 0.0 111.073 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -66.78 -39.72 87.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.854 0.862 . . . . 0.0 111.531 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -62.8 -46.14 89.38 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.8 mt -60.62 -37.68 82.23 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.689 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.07 -34.13 59.3 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.212 0.914 . . . . 0.0 113.0 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -80.74 -2.81 48.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.899 0.88 . . . . 0.0 113.298 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.61 9.23 31.29 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.896 -1.127 . . . . 0.0 115.555 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 52.14 -114.65 3.42 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.118 1.342 . . . . 0.0 113.218 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.12 -24.23 48.64 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.506 2.138 . . . . 0.0 114.416 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 4.03 41.48 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.165 0.986 . . . . 0.0 113.631 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 m -93.47 4.34 54.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.785 1.634 . . . . 0.0 114.711 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.47 13.01 67.53 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.019 -1.051 . . . . 0.0 114.823 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -144.96 137.63 13.6 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.497 1.519 . . . . 0.0 110.788 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.27 162.03 35.1 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.924 2.416 . . . . 0.0 112.657 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.34 146.64 69.69 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.852 2.368 . . . . 0.0 112.168 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.65 137.68 22.91 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.68 2.253 . . . . 0.0 110.133 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 116.813 -1.565 . . . . 0.0 109.883 174.899 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.1 t30 . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 58.98 -1.16 0.12 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 178.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -59.23 -38.59 80.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.495 1.518 . . . . 0.0 113.632 -174.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 4' ' ' ILE . 4.0 mp -59.82 -50.95 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 110.299 175.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -40.72 92.2 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.902 0.881 . . . . 0.0 112.703 176.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -60.69 -45.41 94.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.248 0.619 . . . . 0.0 112.563 173.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.8 mt -61.96 -44.1 97.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.432 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -54.45 -35.47 63.03 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.28 0.946 . . . . 0.0 113.238 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.04 -32.71 72.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.295 0.638 . . . . 0.0 112.444 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.56 4.3 2.5 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.989 1.281 . . . . 0.0 114.843 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.23 -125.97 40.67 Favored Glycine 0 CA--C 1.54 1.625 0 CA-C-N 118.794 1.297 . . . . 0.0 112.154 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.74 -25.32 75.38 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.648 2.232 . . . . 0.0 114.147 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.2 m -80.04 7.92 8.14 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 m -108.55 7.18 26.61 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.815 1.646 . . . . 0.0 114.522 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.49 19.86 74.94 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 114.07 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -137.62 128.17 15.76 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.607 1.563 . . . . 0.0 111.44 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.96 165.13 31.08 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.006 2.471 . . . . 0.0 111.863 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.13 135.63 51.86 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.729 2.286 . . . . 0.0 111.355 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -81.12 145.7 15.52 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.454 2.103 . . . . 0.0 110.777 176.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.068 0 C-N-CA 127.182 2.193 . . . . 0.0 116.104 167.126 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 68.39 -32.96 0.22 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.936 1.695 . . . . 0.0 114.931 -178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -57.04 -37.15 71.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.946 1.698 . . . . 0.0 113.646 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -56.94 -50.62 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.547 0.739 . . . . 0.0 109.897 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -44.43 96.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.694 1.198 . . . . 0.0 111.224 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.5 t90 -59.92 -47.1 87.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.79 0.836 . . . . 0.0 113.031 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.7 mt -61.86 -41.31 97.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.534 -0.746 . . . . 0.0 112.156 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -55.97 -36.22 67.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.658 1.183 . . . . 0.0 112.35 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.04 -22.64 63.06 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.066 0.946 . . . . 0.0 113.44 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.2 5.31 6.21 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.543 1.544 . . . . 0.0 114.906 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.61 -123.8 29.61 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 119.054 1.427 . . . . 0.0 112.34 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -58.11 -29.5 87.38 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.553 2.169 . . . . 0.0 113.863 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 t -64.51 -18.8 65.14 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.84 -4.64 58.83 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.461 1.904 . . . . 0.0 112.707 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.39 -35.73 0.97 Allowed Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.569 1.557 . . . . 0.0 114.68 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -62.42 133.4 94.56 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.951 1.3 . . . . 0.0 111.016 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.49 163.23 33.31 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.359 2.706 . . . . 0.0 113.128 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.79 159.34 51.83 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.0 2.467 . . . . 0.0 112.662 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.94 -20.91 8.57 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.42 2.747 . . . . 0.0 114.606 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--O 1.254 1.325 0 C-N-CA 126.645 1.978 . . . . 0.0 111.099 175.957 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 118.495 -0.764 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.16 -36.06 60.45 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.381 1.073 . . . . 0.0 113.656 -178.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.04 -34.53 68.31 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.32 1.048 . . . . 0.0 113.16 177.397 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.9 mm -62.83 -47.6 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.522 0.729 . . . . 0.0 109.665 176.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -42.63 99.21 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.799 0.84 . . . . 0.0 111.133 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -61.42 -47.51 85.45 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.41 -36.11 81.33 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.718 -0.614 . . . . 0.0 112.085 174.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.5 tttp -58.89 -35.57 73.23 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.278 1.031 . . . . 0.0 113.376 178.482 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.5 -7.16 45.77 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.098 1.759 . . . . 0.0 113.502 173.248 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.81 10.1 29.18 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.071 1.32 . . . . 0.0 114.547 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.9 -129.62 49.81 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-N 119.319 1.559 . . . . 0.0 111.752 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -57.78 -27.29 77.39 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.652 2.234 . . . . 0.0 113.941 178.474 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.1 m -62.51 -33.47 74.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.887 0.875 . . . . 0.0 112.87 -177.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -15.06 62.7 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 176.326 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.05 35.79 23.28 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 118.593 0.633 . . . . 0.0 113.828 177.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 143.21 36.84 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.016 1.326 . . . . 0.0 111.761 -178.209 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.45 160.04 47.75 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.261 2.641 . . . . 0.0 112.064 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.75 152.67 58.84 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.669 2.246 . . . . 0.0 112.034 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.33 105.37 2.03 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.029 3.153 . . . . 0.0 110.328 179.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.697 -1.621 . . . . 0.0 111.016 175.188 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 118.946 -0.55 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.8 mt -58.81 -24.43 61.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.104 1.362 . . . . 0.0 113.632 -178.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -36.11 63.66 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.912 1.285 . . . . 0.0 112.625 178.001 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.8 mt -62.51 -49.59 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.577 0.751 . . . . 0.0 109.673 177.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -63.83 -40.23 96.1 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.394 0.678 . . . . 0.0 111.799 178.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -61.49 -47.22 86.63 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.895 0.878 . . . . 0.0 112.309 174.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.9 mt -64.63 -36.37 84.02 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.331 174.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -57.8 -39.25 77.11 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 178.102 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.01 -15.69 62.58 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.201 1.0 . . . . 0.0 113.162 176.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.52 8.36 9.22 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.524 1.059 . . . . 0.0 115.272 -177.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.14 -118.51 13.5 Favored Glycine 0 CA--C 1.542 1.74 0 CA-C-N 118.763 1.282 . . . . 0.0 112.608 177.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -58.65 -23.3 64.95 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.514 2.142 . . . . 0.0 114.127 176.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.2 m -92.54 27.89 2.16 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.632 1.173 . . . . 0.0 113.056 -178.434 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 m -118.07 3.16 12.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.607 1.163 . . . . 0.0 113.462 -176.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.66 28.26 73.55 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.757 0.694 . . . . 0.0 113.612 -178.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -153.71 141.52 13.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.57 1.148 . . . . 0.0 112.566 -176.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.33 165.35 32.78 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.359 2.706 . . . . 0.0 112.132 177.514 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.72 150.63 86.02 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.886 2.391 . . . . 0.0 111.911 177.854 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.59 -35.99 0.7 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.192 2.595 . . . . 0.0 113.623 -178.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.733 175.839 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp 63.92 -47.12 0.27 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.648 2.379 . . . . 0.0 115.475 -177.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -55.86 -37.04 68.26 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.76 1.224 . . . . 0.0 112.504 -178.178 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 mt -58.97 -50.03 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.92 1.288 . . . . 0.0 110.611 174.329 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -61.88 -40.41 95.28 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.806 0.843 . . . . 0.0 111.979 175.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -60.22 -45.55 92.82 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.429 0.559 . . . . 0.0 112.327 172.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.47 -39.25 93.97 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.785 173.504 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -55.05 -34.34 63.47 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.599 1.091 . . . . 0.0 112.976 176.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.53 -20.28 63.7 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 175.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.57 6.93 14.35 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.22 1.391 . . . . 0.0 113.929 -171.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.96 -127.45 42.99 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-N 118.614 1.207 . . . . 0.0 111.673 -178.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -59.29 -22.57 65.87 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.856 2.37 . . . . 0.0 114.26 177.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 t -61.11 -29.4 69.74 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.089 0.859 . . . . 0.0 113.168 -176.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.4 m -89.37 6.33 41.07 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.685 1.194 . . . . 0.0 113.141 175.164 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.58 -28.21 0.73 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.518 1.532 . . . . 0.0 115.368 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 ptm85 -56.55 127.59 72.96 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.35 1.46 . . . . 0.0 111.726 175.192 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -70.17 162.42 42.37 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.737 2.292 . . . . 0.0 111.856 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.08 159.74 52.68 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.786 2.324 . . . . 0.0 112.25 178.454 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.28 -18.85 12.3 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.438 2.759 . . . . 0.0 113.912 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 C--O 1.26 1.628 0 CA-C-O 114.251 -2.785 . . . . 0.0 111.116 174.073 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.2 0.54 48.35 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.426 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -56.33 -33.94 66.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.346 1.459 . . . . 0.0 113.436 -176.247 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.56 -43.9 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.11 0.964 . . . . 0.0 110.996 176.019 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -48.12 80.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.025 0.93 . . . . 0.0 110.861 175.706 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -60.63 -38.19 83.97 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.26 -37.61 87.93 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.713 -1.137 . . . . 0.0 112.459 171.247 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -57.68 -32.38 67.27 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.29 1.405 . . . . 0.0 113.244 173.289 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -67.01 -13.45 61.92 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 174.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.91 11.6 24.13 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.27 1.414 . . . . 0.0 114.045 -174.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.33 -135.17 48.13 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 118.661 1.23 . . . . 0.0 112.037 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.16 -32.01 68.23 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.094 2.529 . . . . 0.0 113.928 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.3 p -63.52 -23.24 67.31 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.76 -3.9 57.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.832 1.253 . . . . 0.0 113.415 176.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.98 -33.99 0.75 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.603 1.573 . . . . 0.0 115.513 177.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -60.68 138.58 93.14 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.986 1.393 . . . . 0.0 111.758 175.081 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.91 159.3 50.79 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.047 2.498 . . . . 0.0 112.155 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.37 149.96 63.81 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.834 2.356 . . . . 0.0 112.186 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.02 127.37 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.005 3.137 . . . . 0.0 110.275 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 C--O 1.249 1.061 0 C-N-CA 124.323 1.049 . . . . 0.0 113.127 175.962 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 118.712 -0.661 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.19 -34.58 68.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.462 1.505 . . . . 0.0 111.739 -176.446 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.9 -36.76 65.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.77 1.228 . . . . 0.0 113.215 176.167 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.04 -52.6 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.741 0.817 . . . . 0.0 109.308 177.179 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -46.15 89.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.79 1.236 . . . . 0.0 110.75 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -55.5 -50.77 69.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.818 1.247 . . . . 0.0 112.478 174.498 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.72 -41.11 99.0 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.614 174.25 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -55.57 -41.82 73.86 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.3 1.04 . . . . 0.0 111.277 176.608 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -6.97 26.16 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.06 10.8 31.34 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.888 1.232 . . . . 0.0 114.09 -178.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.08 -119.18 14.51 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.683 1.611 . . . . 0.0 111.922 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.04 -27.37 45.29 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.956 2.437 . . . . 0.0 113.634 176.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 m -59.54 -28.93 67.53 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.94 1.296 . . . . 0.0 113.026 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 t -77.95 -7.21 56.49 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 176.265 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.03 -9.85 44.05 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.077 1.323 . . . . 0.0 115.07 178.061 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 -88.42 139.56 30.05 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.751 1.276 . . . . 0.0 110.692 176.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.71 163.32 28.07 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.055 2.503 . . . . 0.0 113.213 174.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.45 136.16 42.1 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.419 2.746 . . . . 0.0 112.262 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -88.66 108.99 0.51 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.048 3.166 . . . . 0.0 112.43 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 116.719 -1.61 . . . . 0.0 113.44 -172.902 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 22.7 t30 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 tp -72.37 4.88 3.31 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -57.32 -37.34 72.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.868 1.267 . . . . 0.0 113.107 -176.347 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.51 -41.33 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.724 0.809 . . . . 0.0 111.656 177.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -63.55 -41.47 98.43 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.861 0.864 . . . . 0.0 111.852 176.546 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -64.34 -42.37 96.3 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 173.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.48 -37.68 84.53 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.489 173.155 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -37.56 59.98 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.329 1.052 . . . . 0.0 113.08 176.222 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.67 -25.95 63.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.279 0.632 . . . . 0.0 112.57 178.718 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.34 2.24 5.97 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.873 1.225 . . . . 0.0 114.614 -172.2 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.21 -125.42 38.98 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 119.033 1.417 . . . . 0.0 112.246 177.346 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.83 -28.71 68.86 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.51 2.14 . . . . 0.0 114.09 178.542 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 m -74.75 -3.76 33.52 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.7 m -93.38 -4.87 50.7 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.42 -36.02 0.97 Allowed Glycine 0 CA--C 1.539 1.581 0 O-C-N 120.764 -1.21 . . . . 0.0 114.792 -176.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -72.42 134.37 82.36 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 118.914 1.357 . . . . 0.0 111.227 174.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.26 163.98 34.14 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.259 2.64 . . . . 0.0 112.951 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.03 154.22 66.9 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.078 2.519 . . . . 0.0 112.79 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.85 -25.41 3.56 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.869 3.046 . . . . 0.0 114.176 -177.625 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.345 1.858 . . . . 0.0 111.092 -178.418 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.442 ' O ' HD12 ' A' ' 4' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.913 . . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -10.13 2.88 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 179.326 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -53.3 -36.19 60.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.842 1.257 . . . . 0.0 113.08 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 1' ' ' ASN . 2.8 mt -63.15 -38.09 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.838 0.855 . . . . 0.0 112.092 177.766 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -67.96 -46.73 70.59 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.449 1.1 . . . . 0.0 110.67 175.402 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -60.63 -41.98 96.0 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 175.18 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.99 -37.48 79.78 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.274 -0.891 . . . . 0.0 111.894 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -34.56 68.85 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.192 0.997 . . . . 0.0 113.06 175.093 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -67.16 -16.75 64.51 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.674 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.07 8.71 21.55 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.322 1.439 . . . . 0.0 114.327 -172.648 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.71 -132.94 52.23 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-N 119.149 1.474 . . . . 0.0 112.298 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -56.44 -29.19 76.75 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.885 2.39 . . . . 0.0 113.785 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 m -73.83 3.41 6.65 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.806 1.242 . . . . 0.0 113.965 -177.582 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.8 13.09 17.15 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.137 1.375 . . . . 0.0 113.813 -176.406 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.07 24.48 74.58 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.597 1.094 . . . . 0.0 115.067 172.057 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -141.15 135.32 15.09 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.319 1.448 . . . . 0.0 111.564 -170.576 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.92 160.25 46.38 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.781 2.32 . . . . 0.0 111.711 178.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.29 157.11 60.38 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.942 2.428 . . . . 0.0 112.754 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.51 -16.98 10.31 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.194 3.263 . . . . 0.0 113.733 -179.544 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p . . . . . 0 C--O 1.245 0.852 0 C-N-CA 127.686 2.394 . . . . 0.0 109.019 -178.427 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 51.0 t30 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mp 61.26 -2.46 0.22 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.968 2.507 . . . . 0.0 115.917 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -39.1 77.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.479 1.511 . . . . 0.0 113.549 -172.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.61 -42.4 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.781 0.832 . . . . 0.0 110.632 175.164 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.6 -42.43 86.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.974 0.91 . . . . 0.0 111.895 177.467 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.0 t90 -61.05 -42.99 99.53 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 172.579 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.12 -37.12 86.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.26 -0.876 . . . . 0.0 113.361 176.262 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -55.25 -38.33 68.38 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.773 1.169 . . . . 0.0 113.023 176.679 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.11 3.37 12.72 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.954 1.302 . . . . 0.0 113.828 174.536 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.7 11.44 43.93 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.273 -1.517 . . . . 0.0 115.603 178.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.68 -110.41 0.93 Allowed Glycine 0 CA--C 1.542 1.778 0 C-N-CA 125.83 1.681 . . . . 0.0 113.665 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -55.72 -26.8 58.16 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.392 2.062 . . . . 0.0 114.15 177.097 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.8 m -86.59 4.4 40.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.301 1.04 . . . . 0.0 113.505 -178.605 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.4 m -91.4 -4.8 55.32 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.469 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.09 -10.0 10.94 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -179.136 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -112.49 139.76 23.02 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.866 1.667 . . . . 0.0 110.269 177.084 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.38 159.94 41.59 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.911 2.407 . . . . 0.0 112.954 176.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.73 140.81 43.7 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.068 2.512 . . . . 0.0 111.852 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.39 141.07 22.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.909 2.406 . . . . 0.0 110.312 172.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 C--O 1.252 1.199 0 CA-C-O 116.041 -1.933 . . . . 0.0 110.082 177.171 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 66.43 -42.02 0.39 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.237 1.815 . . . . 0.0 114.737 179.676 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.79 -36.96 62.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.132 1.773 . . . . 0.0 113.116 179.526 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mp -60.18 -48.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.148 0.979 . . . . 0.0 110.748 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -38.69 91.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.261 1.024 . . . . 0.0 111.235 178.749 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.0 t90 -62.67 -49.35 75.47 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.042 0.537 . . . . 0.0 112.318 172.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.6 mt -59.81 -34.35 72.94 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.403 -0.808 . . . . 0.0 112.842 175.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -53.47 -36.71 61.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.986 1.314 . . . . 0.0 113.502 177.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.63 -49.64 45.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.034 0.934 . . . . 0.0 111.49 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.61 25.97 0.02 OUTLIER Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.278 0.942 . . . . 0.0 115.25 179.168 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.6 -133.85 34.82 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-N 118.574 1.187 . . . . 0.0 112.413 -175.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.97 -25.57 54.16 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.082 2.521 . . . . 0.0 114.703 178.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.6 t -78.28 6.7 7.68 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -90.25 -7.62 53.02 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.494 1.918 . . . . 0.0 113.941 -176.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.6 -18.79 3.5 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 120.685 -1.26 . . . . 0.0 115.739 -176.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.6 ttt-85 -100.95 138.22 19.96 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.323 1.449 . . . . 0.0 110.963 176.631 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.0 159.8 47.46 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.797 2.332 . . . . 0.0 112.842 175.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.37 147.29 71.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.175 2.583 . . . . 0.0 111.432 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.3 150.35 36.77 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.652 2.235 . . . . 0.0 111.037 175.333 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 C--O 1.248 0.99 0 C-N-CA 127.266 2.226 . . . . 0.0 109.14 172.261 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt -77.6 2.18 17.35 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -177.714 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -60.85 -34.43 74.57 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.762 1.225 . . . . 0.0 112.961 -177.181 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.9 mp -58.01 -52.7 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.315 0.646 . . . . 0.0 109.947 175.518 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -40.13 87.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.88 0.872 . . . . 0.0 112.184 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -62.82 -45.93 90.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.205 0.602 . . . . 0.0 112.468 173.491 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.13 -37.24 84.39 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.157 -0.925 . . . . 0.0 113.127 175.744 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -54.34 -31.78 55.19 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.524 1.056 . . . . 0.0 113.591 175.524 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.66 -13.23 60.6 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 176.545 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.89 2.64 20.46 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.867 1.698 . . . . 0.0 115.29 -177.044 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.17 -128.69 34.03 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 118.701 1.25 . . . . 0.0 112.877 175.651 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.24 -24.38 67.01 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.585 2.19 . . . . 0.0 114.106 179.22 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.6 m -87.64 20.24 3.05 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.463 1.105 . . . . 0.0 113.467 -176.103 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -120.36 6.5 10.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.921 1.288 . . . . 0.0 113.698 -171.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.61 27.11 73.02 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.013 0.816 . . . . 0.0 114.136 178.625 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.26 132.6 10.93 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.985 1.314 . . . . 0.0 111.796 -174.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.62 157.91 57.35 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.736 2.291 . . . . 0.0 111.854 178.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.66 154.81 59.47 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.079 2.519 . . . . 0.0 112.007 178.108 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.03 139.42 24.2 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.876 2.384 . . . . 0.0 111.124 175.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.845 171.925 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.69 7.04 13.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.246 1.418 . . . . 0.0 114.13 -169.679 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.94 -29.93 69.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.577 1.551 . . . . 0.0 113.094 -176.343 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.51 -52.09 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.909 0.884 . . . . 0.0 110.195 177.291 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -57.03 -49.67 75.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.836 0.855 . . . . 0.0 111.49 174.096 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -57.52 -43.01 83.94 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 178.111 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.0 mt -67.01 -39.21 87.01 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.225 -0.922 . . . . 0.0 112.576 172.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.94 -35.9 62.23 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.133 1.373 . . . . 0.0 113.373 176.742 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -72.3 -19.4 61.67 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 174.721 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.91 8.74 7.88 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.731 1.157 . . . . 0.0 115.118 -175.487 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.96 -124.25 31.9 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 119.09 1.445 . . . . 0.0 113.192 175.968 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.04 -28.48 60.27 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.721 2.281 . . . . 0.0 113.951 179.661 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -76.44 -3.76 38.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.094 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.1 m -91.44 -3.83 56.22 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.345 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.51 -33.68 1.37 Allowed Glycine 0 CA--C 1.539 1.538 0 O-C-N 120.93 -1.106 . . . . 0.0 115.163 -179.063 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -74.18 135.5 76.44 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 118.883 1.341 . . . . 0.0 110.673 176.037 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.02 161.01 47.6 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.928 2.419 . . . . 0.0 112.842 -178.234 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.09 138.79 44.73 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.31 2.673 . . . . 0.0 111.75 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.92 138.15 16.36 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.824 2.35 . . . . 0.0 111.222 177.505 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.511 1.925 . . . . 0.0 111.604 177.389 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 117.974 -1.013 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 tp -57.76 -16.36 10.97 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.12 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.16 -36.25 40.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.434 1.494 . . . . 0.0 112.975 176.747 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.18 -44.72 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.009 0.924 . . . . 0.0 110.589 176.487 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.57 -44.8 85.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.202 0.601 . . . . 0.0 110.945 174.088 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.8 t90 -60.11 -38.13 82.1 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 176.226 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.32 -33.5 75.66 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.995 -1.065 . . . . 0.0 112.245 171.963 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -58.11 -35.87 72.09 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.482 1.113 . . . . 0.0 112.622 175.896 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.05 -20.72 66.63 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 173.627 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.64 7.75 10.5 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.344 1.449 . . . . 0.0 114.755 -171.796 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.95 -132.95 51.13 Favored Glycine 0 CA--C 1.542 1.769 0 CA-C-N 119.203 1.501 . . . . 0.0 112.446 -176.014 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -55.35 -30.81 74.41 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.512 2.808 . . . . 0.0 114.603 -178.202 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 64.5 m -79.59 14.62 1.58 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.059 1.344 . . . . 0.0 113.94 -175.553 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.82 3.5 16.45 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -168.799 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.63 21.45 78.8 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.738 1.161 . . . . 0.0 114.921 178.642 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -144.55 135.44 12.32 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.058 1.343 . . . . 0.0 111.557 -174.589 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.98 158.92 56.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.021 2.481 . . . . 0.0 111.851 -179.093 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.89 151.49 68.34 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.582 2.188 . . . . 0.0 111.556 177.523 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.89 150.32 11.06 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.437 2.758 . . . . 0.0 112.105 175.791 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.581 1.952 . . . . 0.0 113.709 -177.062 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 118.631 -0.699 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.449 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.3 OUTLIER -52.94 -40.58 63.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.942 1.297 . . . . 0.0 113.21 177.062 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -64.82 -35.72 82.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.053 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.8 mt -62.63 -43.41 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.886 0.874 . . . . 0.0 110.173 176.736 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -41.69 92.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.252 1.021 . . . . 0.0 112.088 174.917 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -65.25 -43.46 91.26 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 173.522 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.4 mt -60.34 -39.49 87.28 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.506 174.923 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -50.69 -37.53 41.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.33 1.052 . . . . 0.0 113.028 178.019 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.5 -16.63 60.84 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.016 0.926 . . . . 0.0 113.27 -179.591 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.34 11.06 6.32 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.166 1.365 . . . . 0.0 115.095 -175.477 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.48 -119.54 7.44 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.055 1.312 . . . . 0.0 113.295 -178.418 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.9 -26.6 75.12 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.607 2.205 . . . . 0.0 114.188 177.167 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t -82.47 -0.87 48.33 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.201 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.9 m -84.5 -9.52 58.28 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.455 1.902 . . . . 0.0 114.668 -175.48 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.01 13.05 84.08 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 115.006 -174.787 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -137.89 136.3 19.7 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 118.875 1.338 . . . . 0.0 110.971 -178.083 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.26 160.41 42.41 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.053 2.502 . . . . 0.0 112.9 178.732 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.2 149.37 70.38 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.042 2.495 . . . . 0.0 112.022 179.049 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.34 -10.29 6.68 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.76 2.973 . . . . 0.0 114.191 -179.237 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.985 0 C-N-CA 127.315 2.246 . . . . 0.0 108.649 178.419 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.2 mt -97.05 4.1 51.54 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.222 1.374 . . . . 0.0 114.396 -176.709 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -58.25 -35.69 72.12 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.067 0.947 . . . . 0.0 112.92 -175.397 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mp -61.42 -50.38 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.324 1.05 . . . . 0.0 110.448 176.266 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -59.37 -44.58 92.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.577 1.151 . . . . 0.0 112.067 174.859 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -60.47 -46.36 90.38 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 175.924 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.14 -42.04 94.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.86 171.593 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -25.7 63.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.141 0.976 . . . . 0.0 113.557 177.941 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.1 -12.34 59.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 173.852 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.24 4.03 14.43 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.051 1.31 . . . . 0.0 115.248 -177.855 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.55 -130.58 48.58 Favored Glycine 0 CA--C 1.545 1.963 0 CA-C-N 119.567 1.684 . . . . 0.0 112.766 177.548 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -66.86 11.15 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.806 3.004 . . . . 0.0 115.935 -177.481 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.0 m -115.96 12.18 15.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.836 1.654 . . . . 0.0 113.501 -175.247 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -120.26 8.77 10.91 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.635 1.174 . . . . 0.0 113.575 -167.383 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.62 20.55 74.05 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.301 0.953 . . . . 0.0 114.963 178.881 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -136.45 133.92 19.51 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.261 1.424 . . . . 0.0 112.007 -174.085 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -70.44 159.32 53.32 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.678 2.252 . . . . 0.0 111.894 177.695 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.37 146.56 45.27 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.886 2.39 . . . . 0.0 111.987 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.65 127.63 5.73 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.634 2.89 . . . . 0.0 111.63 178.116 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.248 1.009 0 C-N-CA 126.758 2.023 . . . . 0.0 109.68 174.883 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.89 -8.41 3.1 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -178.757 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -54.66 -34.86 62.84 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.864 1.666 . . . . 0.0 113.019 -178.279 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.2 mt -60.48 -47.85 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.593 1.157 . . . . 0.0 110.378 175.514 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.42 -39.36 81.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.04 1.336 . . . . 0.0 111.471 178.432 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -62.41 -44.31 96.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.021 0.929 . . . . 0.0 112.827 173.083 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.15 -42.29 98.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.008 172.935 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -53.14 -32.84 49.64 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 176.493 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -76.06 -18.93 59.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.931 0.892 . . . . 0.0 113.346 177.242 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.15 9.3 5.66 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.856 1.217 . . . . 0.0 115.231 -175.791 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.66 -118.97 7.68 Favored Glycine 0 CA--C 1.544 1.876 0 CA-C-N 118.941 1.371 . . . . 0.0 113.379 -178.991 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.3 -26.92 72.86 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.644 2.23 . . . . 0.0 114.452 178.342 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -81.26 1.29 33.01 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -179.447 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -89.28 -1.95 58.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.89 1.676 . . . . 0.0 114.582 -176.8 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.88 -36.73 1.25 Allowed Glycine 0 CA--C 1.539 1.54 0 O-C-N 120.442 -1.411 . . . . 0.0 114.709 -177.433 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -83.23 136.79 43.05 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.706 1.253 . . . . 0.0 111.425 175.081 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.56 164.68 25.41 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.439 2.76 . . . . 0.0 113.087 174.533 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 156.18 64.62 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.713 2.275 . . . . 0.0 112.519 -179.92 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.64 -24.79 4.03 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.595 2.864 . . . . 0.0 114.285 -178.685 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 C--O 1.257 1.476 0 CA-C-O 114.592 -2.623 . . . . 0.0 109.985 -176.429 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -51.66 -40.05 59.29 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.171 1.35 . . . . 0.0 113.611 -175.742 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.28 -29.1 68.59 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.881 0.872 . . . . 0.0 113.263 177.348 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.6 mm -66.54 -51.12 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.577 1.151 . . . . 0.0 109.454 176.648 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -54.48 -51.85 63.77 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.19 0.996 . . . . 0.0 110.839 173.024 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.7 t90 -57.7 -44.46 85.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.829 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.2 mt -61.65 -37.06 82.64 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.225 -0.922 . . . . 0.0 111.963 172.377 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.24 -16.31 61.8 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.286 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.63 -9.74 51.09 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.488 1.515 . . . . 0.0 113.252 169.235 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.32 5.39 19.31 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.077 1.323 . . . . 0.0 114.625 -178.515 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.64 -130.25 48.04 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 119.165 1.482 . . . . 0.0 111.693 -178.498 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.97 -32.8 69.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.891 2.394 . . . . 0.0 113.814 179.638 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 m -63.67 -22.37 66.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.837 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -3.89 56.67 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 174.774 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.13 -30.5 0.95 Allowed Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.18 1.371 . . . . 0.0 115.345 177.851 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 ttt85 -65.92 133.8 94.95 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 118.886 1.343 . . . . 0.0 110.513 175.183 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.57 160.27 43.95 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.702 2.268 . . . . 0.0 112.463 178.833 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.34 153.83 70.27 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.796 2.331 . . . . 0.0 112.121 179.253 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.64 130.56 12.74 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.477 2.784 . . . . 0.0 110.666 176.032 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.253 1.256 0 C-N-CA 126.486 1.914 . . . . 0.0 113.03 171.797 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 118.78 -0.629 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.96 7.87 25.64 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -173.079 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.84 -39.86 72.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.347 1.459 . . . . 0.0 112.782 -173.881 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.14 -45.21 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.727 0.811 . . . . 0.0 110.526 177.106 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -35.23 77.96 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 176.964 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -64.93 -45.25 86.64 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.484 0.584 . . . . 0.0 112.249 171.99 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.6 mt -65.48 -32.44 74.05 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.753 -1.118 . . . . 0.0 113.514 176.315 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -52.96 -37.25 60.93 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.544 1.065 . . . . 0.0 113.617 176.791 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.17 -52.57 18.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.637 0.775 . . . . 0.0 111.341 179.329 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.43 29.35 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 N-CA-C 115.307 0.883 . . . . 0.0 115.307 177.772 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.45 -133.24 34.6 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.431 1.116 . . . . 0.0 112.236 -177.022 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.49 -24.57 62.1 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.184 2.589 . . . . 0.0 114.461 178.393 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 m -75.03 -11.24 60.06 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.994 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -69.64 -10.38 57.99 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.716 1.606 . . . . 0.0 113.46 177.779 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.94 -35.73 2.12 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.051 1.31 . . . . 0.0 114.292 -177.528 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -79.47 138.12 55.33 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 118.551 1.175 . . . . 0.0 111.328 174.665 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.01 160.68 36.61 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.615 2.877 . . . . 0.0 113.339 175.199 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.48 155.51 55.07 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.012 2.475 . . . . 0.0 112.507 179.597 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.61 -18.27 8.19 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.61 2.873 . . . . 0.0 114.177 179.142 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.417 1.487 . . . . 0.0 112.818 -178.968 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.8 p30 . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mt -75.59 5.06 6.5 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -175.861 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -59.32 -31.97 69.65 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.928 1.291 . . . . 0.0 113.053 -177.631 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mp -57.73 -49.78 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.448 0.699 . . . . 0.0 110.188 174.97 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.58 -45.16 94.99 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.917 0.887 . . . . 0.0 111.284 -179.121 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -59.65 -47.93 83.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.687 0.795 . . . . 0.0 112.283 175.461 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.56 -40.37 96.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.377 173.749 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -57.79 -38.83 76.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.521 1.128 . . . . 0.0 112.701 -179.4 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -20.05 63.64 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.918 1.287 . . . . 0.0 113.009 176.049 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.31 8.88 5.77 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.1 1.333 . . . . 0.0 114.806 -176.701 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.24 -124.95 37.54 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 119.022 1.411 . . . . 0.0 111.632 -177.205 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -56.31 -30.42 80.7 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.165 2.577 . . . . 0.0 114.178 178.379 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 m -75.34 12.05 1.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.907 1.283 . . . . 0.0 114.007 -178.11 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.99 3.32 20.33 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.916 1.686 . . . . 0.0 113.288 -172.726 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.51 20.41 75.47 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.363 -0.835 . . . . 0.0 114.222 -175.417 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.11 129.59 19.01 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.765 1.226 . . . . 0.0 110.92 -170.202 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.26 159.95 49.85 Favored 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.104 2.536 . . . . 0.0 113.221 -178.998 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.65 122.35 9.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.571 2.847 . . . . 0.0 111.461 -179.351 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.16 131.56 13.1 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.49 2.127 . . . . 0.0 110.517 178.137 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.257 1.477 0 CA-C-O 116.439 -1.744 . . . . 0.0 110.093 172.572 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -66.47 -30.9 71.34 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 mm -65.22 -45.94 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.767 1.227 . . . . 0.0 109.345 174.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.75 -30.35 71.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.46 0.704 . . . . 0.0 112.719 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.5 t90 -73.14 -43.42 61.63 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.965 0.802 . . . . 0.0 112.485 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.2 mt -64.88 -43.25 93.51 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.99 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -25.7 64.69 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.653 1.115 . . . . 0.0 113.921 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.99 -8.82 58.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.908 1.683 . . . . 0.0 113.646 174.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.78 8.08 24.77 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.373 1.463 . . . . 0.0 114.798 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.24 -124.37 32.77 Favored Glycine 0 CA--C 1.541 1.713 0 CA-C-N 118.825 1.312 . . . . 0.0 112.149 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.98 -28.77 84.35 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.794 2.33 . . . . 0.0 113.813 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.7 m -81.83 19.13 1.14 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.089 1.356 . . . . 0.0 113.737 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.06 13.4 9.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.843 1.257 . . . . 0.0 113.82 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.93 25.22 74.35 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.471 -0.768 . . . . 0.0 114.505 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -143.95 131.3 10.57 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.873 1.269 . . . . 0.0 111.893 -172.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.1 160.07 50.92 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.82 2.347 . . . . 0.0 111.692 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.48 145.67 59.48 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.472 2.115 . . . . 0.0 111.422 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 CA--C 1.539 0.759 0 C-N-CA 123.169 2.579 . . . . 0.0 110.894 176.285 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -54.78 -31.94 59.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.07 1.748 . . . . 0.0 113.742 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.6 mt -59.68 -49.11 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.45 1.1 . . . . 0.0 109.474 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -33.18 74.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.487 1.115 . . . . 0.0 111.799 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -66.8 -45.94 76.78 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.3 mt -61.18 -37.0 81.36 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.938 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -52.99 -33.48 51.65 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.025 0.93 . . . . 0.0 113.282 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -75.19 -11.09 60.0 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.336 1.454 . . . . 0.0 112.549 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.09 10.34 28.15 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.476 -1.39 . . . . 0.0 115.374 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.27 -125.2 38.76 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 118.672 1.236 . . . . 0.0 113.086 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.26 -23.17 61.05 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.446 2.098 . . . . 0.0 114.305 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.82 7.26 18.51 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.074 0.95 . . . . 0.0 113.263 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 m -103.95 1.87 31.73 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.842 1.657 . . . . 0.0 114.422 -174.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.79 -37.52 1.25 Allowed Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.831 1.205 . . . . 0.0 115.019 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.2 ttp-105 -75.92 131.69 75.73 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.934 1.293 . . . . 0.0 111.36 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.09 162.4 32.96 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.328 2.685 . . . . 0.0 113.069 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.71 142.3 57.68 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.063 2.509 . . . . 0.0 112.376 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 CA--C 1.538 0.677 0 C-N-CA 123.409 2.739 . . . . 0.0 110.752 177.53 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -57.54 -36.5 71.7 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.839 0.856 . . . . 0.0 112.917 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.3 mt -62.92 -44.92 99.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.923 1.289 . . . . 0.0 110.533 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -46.52 89.17 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.437 1.095 . . . . 0.0 110.776 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -64.05 -43.56 95.16 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.1 mt -63.07 -36.06 82.32 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.26 -0.9 . . . . 0.0 112.454 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -56.13 -33.51 65.23 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.456 1.025 . . . . 0.0 113.079 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -71.95 -5.99 38.77 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 118.958 0.799 . . . . 0.0 113.056 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.33 -2.05 32.9 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.704 1.621 . . . . 0.0 114.183 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.77 -129.12 46.32 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 118.655 1.228 . . . . 0.0 111.277 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -54.77 -29.76 63.92 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.81 2.34 . . . . 0.0 114.253 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 p -67.21 -23.68 65.76 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.85 -6.43 56.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.05 -31.49 1.1 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.801 1.191 . . . . 0.0 115.159 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -64.15 135.28 96.26 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 118.82 1.31 . . . . 0.0 110.592 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.4 159.86 45.5 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.875 2.383 . . . . 0.0 112.847 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.99 162.81 41.41 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.383 2.722 . . . . 0.0 112.74 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.537 0.652 0 C-N-CA 123.616 2.877 . . . . 0.0 114.327 179.156 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.55 -30.97 68.99 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.126 0.97 . . . . 0.0 113.418 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.2 -51.19 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.074 0.949 . . . . 0.0 109.462 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -56.53 -48.06 78.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.452 1.101 . . . . 0.0 111.567 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -57.54 -46.99 83.22 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -65.07 -39.71 93.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.272 -0.87 . . . . 0.0 112.547 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -54.72 -40.0 68.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.236 1.015 . . . . 0.0 112.389 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -76.66 -11.85 59.91 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.014 1.326 . . . . 0.0 113.388 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.81 9.28 6.35 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.165 1.364 . . . . 0.0 115.714 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.06 -108.74 0.53 Allowed Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.383 1.468 . . . . 0.0 113.446 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.01 -27.66 65.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.537 2.158 . . . . 0.0 114.499 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.3 p -89.61 7.34 36.99 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -84.14 -5.23 59.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.006 1.322 . . . . 0.0 114.427 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.28 17.5 77.55 Favored Glycine 0 CA--C 1.538 1.494 0 O-C-N 120.561 -1.337 . . . . 0.0 115.171 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -143.27 143.64 25.21 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.502 1.521 . . . . 0.0 110.401 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.28 157.93 55.1 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.635 2.223 . . . . 0.0 112.767 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.89 140.7 39.01 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.205 2.603 . . . . 0.0 111.547 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 C-N-CA 123.205 2.603 . . . . 0.0 110.902 176.482 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -39.32 66.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.364 1.466 . . . . 0.0 113.701 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.5 mp -61.26 -50.03 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.016 0.927 . . . . 0.0 110.758 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -64.82 -37.82 88.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.389 0.676 . . . . 0.0 111.658 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -61.39 -46.32 90.65 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 172.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.5 mt -59.64 -37.11 77.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.96 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -57.06 -31.95 65.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.2 -19.84 63.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.267 1.027 . . . . 0.0 112.763 175.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.08 5.66 8.75 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 126.004 1.764 . . . . 0.0 114.549 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.94 -133.7 51.03 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 119.026 1.413 . . . . 0.0 112.198 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.21 -29.12 55.17 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.643 2.895 . . . . 0.0 114.464 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -81.44 21.32 0.79 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.803 1.641 . . . . 0.0 113.78 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.28 8.43 9.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.64 1.576 . . . . 0.0 113.317 -169.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.53 24.98 73.93 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.3 1.429 . . . . 0.0 114.784 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -148.93 134.08 9.37 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.974 1.31 . . . . 0.0 112.023 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.56 161.72 44.47 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.235 2.624 . . . . 0.0 112.029 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.79 146.25 65.6 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.01 2.473 . . . . 0.0 112.611 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo . . . . . 0 CA--C 1.538 0.699 0 C-N-CA 123.786 2.99 . . . . 0.0 111.086 178.117 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -54.35 -32.06 55.92 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.572 2.749 . . . . 0.0 113.588 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.46 -46.98 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.979 0.911 . . . . 0.0 110.718 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -44.25 96.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.252 0.621 . . . . 0.0 111.142 175.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -62.92 -39.33 94.24 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.75 -38.36 90.73 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.043 -1.035 . . . . 0.0 112.16 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -54.79 -33.78 61.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.302 1.041 . . . . 0.0 113.562 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -67.38 -20.35 65.54 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.429 1.013 . . . . 0.0 113.469 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.37 8.02 9.58 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.0 1.286 . . . . 0.0 114.889 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.49 -133.77 51.8 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-N 119.139 1.469 . . . . 0.0 112.183 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.75 -31.3 60.61 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.505 2.803 . . . . 0.0 114.726 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.2 m -77.09 10.13 2.57 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.614 1.166 . . . . 0.0 113.808 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -98.96 -1.81 38.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.467 1.507 . . . . 0.0 114.272 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -38.95 0.89 Allowed Glycine 0 CA--C 1.54 1.631 0 C-N-CA 125.043 1.306 . . . . 0.0 114.643 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -73.85 136.53 76.88 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.036 1.334 . . . . 0.0 112.283 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -70.64 161.3 46.55 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.334 2.689 . . . . 0.0 112.144 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.3 147.75 66.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.792 2.328 . . . . 0.0 111.723 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 CA--C 1.536 0.616 0 C-N-CA 123.075 2.516 . . . . 0.0 113.756 -179.122 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mt . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -54.24 -39.51 66.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.412 1.085 . . . . 0.0 113.406 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.25 -45.13 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.825 0.85 . . . . 0.0 110.627 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -34.93 77.34 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.339 1.455 . . . . 0.0 112.262 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -65.01 -47.19 78.36 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.661 0.784 . . . . 0.0 111.769 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.9 mt -60.75 -30.18 69.85 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 118.022 -0.989 . . . . 0.0 113.63 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -54.04 -34.85 61.11 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -74.09 -48.02 32.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.45 0.7 . . . . 0.0 111.079 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.9 26.91 0.02 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.373 0.987 . . . . 0.0 115.252 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.68 -133.38 43.72 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 118.869 1.335 . . . . 0.0 112.332 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -55.74 -28.77 68.33 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.026 2.484 . . . . 0.0 114.525 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.2 m -75.78 3.29 10.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.439 1.095 . . . . 0.0 113.679 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 m -81.75 -7.87 59.64 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.403 1.481 . . . . 0.0 114.169 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.05 12.29 84.78 Favored Glycine 0 CA--C 1.539 1.537 0 O-C-N 120.982 -1.074 . . . . 0.0 115.009 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -143.86 138.0 14.76 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.993 1.317 . . . . 0.0 111.167 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.87 161.01 41.22 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.948 2.432 . . . . 0.0 113.016 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.73 162.59 41.49 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.489 2.793 . . . . 0.0 112.708 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 CA--C 1.539 0.772 0 C-N-CA 123.592 2.861 . . . . 0.0 114.149 177.947 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -62.66 -33.79 75.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.1 mm -64.9 -45.53 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.069 0.948 . . . . 0.0 109.737 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.64 -38.89 92.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.158 0.583 . . . . 0.0 112.254 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -63.03 -45.13 93.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.021 0.828 . . . . 0.0 112.694 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.0 mt -58.65 -37.42 75.92 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.273 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -57.08 -27.65 61.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.738 1.215 . . . . 0.0 114.22 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.92 -20.14 60.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.776 0.831 . . . . 0.0 112.575 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.35 10.07 6.85 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.776 1.655 . . . . 0.0 114.751 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.24 -134.96 52.12 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-N 118.968 1.384 . . . . 0.0 111.823 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.89 -27.22 61.95 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.608 2.872 . . . . 0.0 114.893 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m -78.31 12.18 2.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.173 0.989 . . . . 0.0 113.62 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 m -107.19 -4.08 19.17 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.822 1.649 . . . . 0.0 113.905 -170.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.64 19.44 76.51 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 119.176 -0.791 . . . . 0.0 114.817 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -135.5 134.14 20.85 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 125.395 1.478 . . . . 0.0 111.839 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.98 160.05 51.47 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.768 2.312 . . . . 0.0 111.917 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.61 149.04 60.85 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.881 2.387 . . . . 0.0 112.012 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 CA--C 1.541 0.858 0 C-N-CA 124.074 3.182 . . . . 0.0 114.387 -179.062 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.39 -38.91 85.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.995 1.718 . . . . 0.0 113.032 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.1 mp -60.25 -47.28 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.791 0.836 . . . . 0.0 110.693 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -63.46 -38.1 89.86 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.372 0.669 . . . . 0.0 112.449 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -64.49 -45.32 87.81 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.868 0.758 . . . . 0.0 112.487 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.8 mt -60.58 -40.45 91.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.384 -0.817 . . . . 0.0 112.696 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -51.32 -34.12 32.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.136 1.374 . . . . 0.0 114.179 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -71.65 -39.97 69.99 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.572 0.749 . . . . 0.0 111.866 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.76 12.64 0.08 OUTLIER Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.45 -134.87 51.62 Favored Glycine 0 CA--C 1.543 1.836 0 CA-C-N 119.614 1.707 . . . . 0.0 112.416 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.8 -26.2 81.54 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.057 2.504 . . . . 0.0 115.565 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.1 p -82.14 8.5 10.73 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.649 1.113 . . . . 0.0 113.673 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -91.62 -4.27 55.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.807 2.043 . . . . 0.0 114.524 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.03 -38.33 1.76 Allowed Glycine 0 CA--C 1.539 1.59 0 O-C-N 120.583 -1.323 . . . . 0.0 114.886 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -74.44 135.49 75.6 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 118.847 1.324 . . . . 0.0 111.199 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -67.32 160.07 49.37 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.153 2.569 . . . . 0.0 113.192 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.03 139.53 39.53 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.099 2.533 . . . . 0.0 111.814 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo . . . . . 0 CA--C 1.538 0.723 0 C-N-CA 123.234 2.623 . . . . 0.0 110.913 175.72 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.42 -30.22 66.72 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.849 1.259 . . . . 0.0 113.952 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 mp -59.0 -48.13 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.719 0.808 . . . . 0.0 110.413 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -31.11 72.18 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.213 1.405 . . . . 0.0 112.456 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -76.39 -43.61 39.81 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.702 0.801 . . . . 0.0 112.804 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.6 mt -65.56 -43.98 88.18 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.939 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -19.41 56.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -15.86 58.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.241 1.417 . . . . 0.0 113.121 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.84 6.01 11.6 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.338 1.447 . . . . 0.0 114.671 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.93 -128.52 43.56 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 119.189 1.494 . . . . 0.0 112.04 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.62 -34.21 72.41 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.51 2.807 . . . . 0.0 114.545 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.4 m -74.98 7.04 3.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.717 1.207 . . . . 0.0 114.054 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -95.08 -11.28 28.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.7 27.89 66.29 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 118.8 0.727 . . . . 0.0 114.631 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.91 140.44 15.63 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.111 1.364 . . . . 0.0 111.684 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -70.67 160.32 49.83 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.067 2.512 . . . . 0.0 111.916 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.04 154.48 62.63 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.674 2.249 . . . . 0.0 112.141 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo . . . . . 0 CA--C 1.536 0.606 0 C-N-CA 123.62 2.88 . . . . 0.0 111.467 178.617 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -35.51 72.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.297 1.039 . . . . 0.0 112.345 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.25 -51.09 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.649 1.18 . . . . 0.0 109.621 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -55.68 -47.56 76.55 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.756 1.223 . . . . 0.0 111.836 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.0 t90 -61.59 -47.1 87.02 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.2 mt -63.42 -34.6 78.1 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.598 -0.689 . . . . 0.0 112.5 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -58.36 -36.6 73.72 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.75 1.22 . . . . 0.0 113.092 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.9 -21.1 63.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.025 0.93 . . . . 0.0 112.367 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.87 20.52 6.02 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.48 1.514 . . . . 0.0 113.708 -175.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.71 -124.69 30.29 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.061 1.43 . . . . 0.0 112.742 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -58.29 -23.88 64.92 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.488 2.125 . . . . 0.0 114.431 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.3 p -60.97 -31.22 70.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.209 0.913 . . . . 0.0 112.924 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -81.19 -5.08 57.32 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.917 1.287 . . . . 0.0 113.25 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.91 -27.63 1.95 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.616 1.579 . . . . 0.0 115.206 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -64.02 137.14 97.02 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 118.793 1.297 . . . . 0.0 111.14 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.22 161.23 46.7 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.119 2.546 . . . . 0.0 113.004 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.5 148.09 53.36 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.08 2.52 . . . . 0.0 112.105 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 123.128 2.552 . . . . 0.0 110.551 176.897 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -58.69 -39.79 81.76 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.95 1.7 . . . . 0.0 112.82 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.578 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.6 mp -56.15 -45.07 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.384 1.074 . . . . 0.0 110.814 175.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -52.16 65.5 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.444 0.698 . . . . 0.0 111.062 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.7 t90 -61.22 -39.1 89.01 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.14 -37.1 85.88 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.343 -0.848 . . . . 0.0 111.876 171.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -58.81 -31.71 68.69 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -66.07 -24.0 66.64 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.938 0.79 . . . . 0.0 113.071 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.98 10.25 6.96 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 124.937 1.256 . . . . 0.0 115.286 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.39 -127.07 38.66 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 118.794 1.297 . . . . 0.0 113.554 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.46 -23.67 57.01 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.917 2.411 . . . . 0.0 114.714 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.7 m -83.39 2.54 35.92 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -93.44 -3.5 52.99 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.51 -39.72 0.75 Allowed Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.793 1.187 . . . . 0.0 114.757 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -68.6 137.51 90.73 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.789 1.235 . . . . 0.0 112.099 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.14 159.18 52.95 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.081 2.521 . . . . 0.0 112.359 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.18 156.2 46.8 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.062 2.508 . . . . 0.0 113.157 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo . . . . . 0 CA--C 1.542 0.917 0 C-N-CA 125.034 3.823 . . . . 0.0 114.168 178.131 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.04 -33.53 65.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.583 1.553 . . . . 0.0 113.513 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -63.57 -50.79 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.015 0.926 . . . . 0.0 110.767 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.89 -42.08 97.28 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.409 0.684 . . . . 0.0 111.667 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -62.03 -46.07 90.78 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.7 mt -60.87 -37.77 83.29 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.928 -1.107 . . . . 0.0 112.538 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -56.68 -28.26 60.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.95 0.796 . . . . 0.0 112.587 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -75.92 -11.01 59.89 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.269 -0.894 . . . . 0.0 113.187 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.71 11.25 27.13 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-N 120.293 1.406 . . . . 0.0 115.714 -172.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.9 -127.79 44.99 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 124.727 1.156 . . . . 0.0 113.475 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.98 -20.68 46.14 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.693 2.262 . . . . 0.0 114.657 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.5 p -88.95 4.97 46.27 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.705 1.202 . . . . 0.0 114.177 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.6 m -99.13 -1.17 40.1 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -172.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.79 -34.95 1.21 Allowed Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.733 1.159 . . . . 0.0 115.009 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -72.86 133.76 81.86 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.682 1.241 . . . . 0.0 110.967 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.38 157.74 58.73 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.816 2.344 . . . . 0.0 112.746 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.15 134.93 28.28 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.336 2.69 . . . . 0.0 111.313 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 CA--C 1.537 0.67 0 C-N-CA 122.564 2.176 . . . . 0.0 110.736 175.902 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.46 -33.62 74.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.845 1.258 . . . . 0.0 113.126 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.4 mt -58.56 -50.38 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.767 1.227 . . . . 0.0 109.955 176.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -41.89 96.27 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.845 1.258 . . . . 0.0 111.593 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -62.81 -43.57 98.44 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.22 -35.93 82.6 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.344 -0.836 . . . . 0.0 112.532 173.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -54.07 -37.95 64.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.469 1.108 . . . . 0.0 113.475 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -83.38 -8.42 59.41 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.582 1.953 . . . . 0.0 112.744 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.98 23.17 5.66 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.747 1.642 . . . . 0.0 115.067 177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 48.8 -108.99 0.47 Allowed Glycine 0 CA--C 1.54 1.595 0 C-N-CA 126.495 1.998 . . . . 0.0 113.708 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.12 -28.67 62.07 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.005 2.47 . . . . 0.0 114.3 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -82.69 -0.04 45.59 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.2 m -82.42 -3.67 56.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.459 1.504 . . . . 0.0 115.003 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.43 17.51 79.11 Favored Glycine 0 CA--C 1.539 1.573 0 O-C-N 121.178 -0.952 . . . . 0.0 115.26 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -153.85 144.82 16.18 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 125.472 1.509 . . . . 0.0 111.448 -172.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.52 164.74 34.19 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.532 2.821 . . . . 0.0 112.695 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.91 138.78 54.2 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.147 2.565 . . . . 0.0 112.651 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 CA--C 1.54 0.789 0 C-N-CA 123.633 2.889 . . . . 0.0 112.114 -179.4 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.99 -38.53 73.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.815 1.246 . . . . 0.0 112.649 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.49 -50.22 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 123.926 0.89 . . . . 0.0 110.552 176.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -62.07 -42.27 99.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.323 0.649 . . . . 0.0 111.979 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.8 t90 -60.72 -39.66 89.41 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.7 mt -66.42 -37.66 85.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 117.999 -1.001 . . . . 0.0 112.892 173.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -53.41 -39.77 64.59 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.736 1.153 . . . . 0.0 113.376 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.51 -11.96 61.26 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.22 14.42 9.88 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.326 0.965 . . . . 0.0 114.521 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.91 -120.21 8.79 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 117.998 -1.446 . . . . 0.0 112.219 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -54.7 -28.24 55.78 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.468 2.778 . . . . 0.0 114.466 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.9 p -79.6 2.97 20.4 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -88.96 -8.95 53.16 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.27 20.08 79.7 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 114.957 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.3 138.87 16.98 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 125.405 1.482 . . . . 0.0 110.681 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.58 159.36 48.43 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.882 2.388 . . . . 0.0 112.548 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.44 148.0 59.72 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.803 2.336 . . . . 0.0 111.711 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.538 0.7 0 C-N-CA 123.228 2.619 . . . . 0.0 111.418 175.883 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -62.1 -39.69 93.35 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mp -58.97 -51.5 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.771 1.229 . . . . 0.0 110.344 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -55.13 -46.54 75.63 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.175 0.99 . . . . 0.0 112.477 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -63.97 -47.29 80.98 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.69 -39.21 87.65 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.039 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -57.22 -34.45 68.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.89 1.276 . . . . 0.0 112.929 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -17.54 61.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.418 1.087 . . . . 0.0 112.722 176.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.75 5.86 8.89 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.762 1.648 . . . . 0.0 114.204 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.56 -124.07 32.27 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.026 -1.43 . . . . 0.0 111.509 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.27 -33.71 85.75 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.212 2.608 . . . . 0.0 114.299 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.4 m -60.75 -23.17 64.75 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.761 0.824 . . . . 0.0 112.932 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.67 -12.94 61.87 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.804 1.642 . . . . 0.0 113.199 175.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.89 12.09 74.57 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.051 0.834 . . . . 0.0 114.844 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -120.85 138.28 27.5 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.918 1.687 . . . . 0.0 110.09 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.38 158.67 43.78 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.844 2.363 . . . . 0.0 112.784 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.58 154.26 68.7 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.836 2.357 . . . . 0.0 112.372 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 123.635 2.89 . . . . 0.0 111.358 176.72 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.83 -35.52 73.02 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.695 0.798 . . . . 0.0 112.899 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 mm -64.69 -46.47 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.095 0.958 . . . . 0.0 109.971 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -59.45 -45.96 90.11 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.036 0.534 . . . . 0.0 111.744 175.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -60.07 -44.51 94.69 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.67 -38.65 88.57 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.456 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -56.84 -35.23 68.59 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.108 0.963 . . . . 0.0 113.573 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.36 -23.23 66.3 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.17 0.988 . . . . 0.0 112.447 175.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.54 11.18 5.65 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.721 1.629 . . . . 0.0 114.61 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.55 -134.83 52.32 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 118.857 -0.968 . . . . 0.0 111.648 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.5 -21.15 44.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.711 2.941 . . . . 0.0 114.414 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.0 p -86.47 21.1 2.22 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.952 1.301 . . . . 0.0 114.075 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 16' ' ' ARG . 0.9 OUTLIER -122.0 11.76 10.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.271 1.428 . . . . 0.0 112.969 -171.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.12 23.19 71.26 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.478 1.037 . . . . 0.0 114.143 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 14' ' ' SER . 14.5 ptp180 -144.51 130.56 9.81 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.032 1.333 . . . . 0.0 112.149 -175.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.95 166.67 28.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.285 2.656 . . . . 0.0 112.334 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.97 142.54 69.03 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.132 2.555 . . . . 0.0 112.172 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.458 -0.587 0 C-N-CA 123.494 2.796 . . . . 0.0 110.147 178.884 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.553 1.075 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -61.0 -35.77 77.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.022 1.729 . . . . 0.0 113.239 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.88 -41.82 94.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.132 0.973 . . . . 0.0 111.073 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -66.78 -39.72 87.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.854 0.862 . . . . 0.0 111.531 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -62.8 -46.14 89.38 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.8 mt -60.62 -37.68 82.23 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.689 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.07 -34.13 59.3 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.212 0.914 . . . . 0.0 113.0 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -80.74 -2.81 48.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.899 0.88 . . . . 0.0 113.298 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.61 9.23 31.29 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.896 -1.127 . . . . 0.0 115.555 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 52.14 -114.65 3.42 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.118 1.342 . . . . 0.0 113.218 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.12 -24.23 48.64 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.506 2.138 . . . . 0.0 114.416 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 4.03 41.48 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.165 0.986 . . . . 0.0 113.631 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 m -93.47 4.34 54.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.785 1.634 . . . . 0.0 114.711 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.47 13.01 67.53 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.019 -1.051 . . . . 0.0 114.823 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -144.96 137.63 13.6 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.497 1.519 . . . . 0.0 110.788 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.27 162.03 35.1 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.924 2.416 . . . . 0.0 112.657 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.34 146.64 69.69 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.852 2.368 . . . . 0.0 112.168 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.454 -0.817 0 C-N-CA 122.68 2.253 . . . . 0.0 110.133 173.055 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -59.23 -38.59 80.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.495 1.518 . . . . 0.0 113.632 -174.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.0 mp -59.82 -50.95 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 110.299 175.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -40.72 92.2 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.902 0.881 . . . . 0.0 112.703 176.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -60.69 -45.41 94.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.248 0.619 . . . . 0.0 112.563 173.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.8 mt -61.96 -44.1 97.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.432 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -54.45 -35.47 63.03 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.28 0.946 . . . . 0.0 113.238 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.04 -32.71 72.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.295 0.638 . . . . 0.0 112.444 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.56 4.3 2.5 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.989 1.281 . . . . 0.0 114.843 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.23 -125.97 40.67 Favored Glycine 0 CA--C 1.54 1.625 0 CA-C-N 118.794 1.297 . . . . 0.0 112.154 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.74 -25.32 75.38 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.648 2.232 . . . . 0.0 114.147 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.2 m -80.04 7.92 8.14 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 m -108.55 7.18 26.61 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.815 1.646 . . . . 0.0 114.522 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.49 19.86 74.94 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 114.07 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -137.62 128.17 15.76 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.607 1.563 . . . . 0.0 111.44 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.96 165.13 31.08 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.006 2.471 . . . . 0.0 111.863 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.13 135.63 51.86 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.729 2.286 . . . . 0.0 111.355 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 122.454 2.103 . . . . 0.0 110.777 176.443 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -57.04 -37.15 71.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.946 1.698 . . . . 0.0 113.646 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -56.94 -50.62 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.547 0.739 . . . . 0.0 109.897 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -44.43 96.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.694 1.198 . . . . 0.0 111.224 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.5 t90 -59.92 -47.1 87.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.79 0.836 . . . . 0.0 113.031 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.7 mt -61.86 -41.31 97.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.534 -0.746 . . . . 0.0 112.156 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -55.97 -36.22 67.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.658 1.183 . . . . 0.0 112.35 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.04 -22.64 63.06 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.066 0.946 . . . . 0.0 113.44 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.2 5.31 6.21 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.543 1.544 . . . . 0.0 114.906 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.61 -123.8 29.61 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 119.054 1.427 . . . . 0.0 112.34 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -58.11 -29.5 87.38 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.553 2.169 . . . . 0.0 113.863 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 t -64.51 -18.8 65.14 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.84 -4.64 58.83 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.461 1.904 . . . . 0.0 112.707 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.39 -35.73 0.97 Allowed Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.569 1.557 . . . . 0.0 114.68 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -62.42 133.4 94.56 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.951 1.3 . . . . 0.0 111.016 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.49 163.23 33.31 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.359 2.706 . . . . 0.0 113.128 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.79 159.34 51.83 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.0 2.467 . . . . 0.0 112.662 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 CA--C 1.538 0.689 0 C-N-CA 123.42 2.747 . . . . 0.0 114.606 179.513 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.04 -34.53 68.31 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.32 1.048 . . . . 0.0 113.16 177.397 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.9 mm -62.83 -47.6 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.522 0.729 . . . . 0.0 109.665 176.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -42.63 99.21 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.799 0.84 . . . . 0.0 111.133 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -61.42 -47.51 85.45 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.41 -36.11 81.33 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.718 -0.614 . . . . 0.0 112.085 174.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.5 tttp -58.89 -35.57 73.23 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.278 1.031 . . . . 0.0 113.376 178.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.5 -7.16 45.77 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.098 1.759 . . . . 0.0 113.502 173.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.81 10.1 29.18 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.071 1.32 . . . . 0.0 114.547 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.9 -129.62 49.81 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-N 119.319 1.559 . . . . 0.0 111.752 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -57.78 -27.29 77.39 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.652 2.234 . . . . 0.0 113.941 178.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.1 m -62.51 -33.47 74.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.887 0.875 . . . . 0.0 112.87 -177.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -15.06 62.7 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 176.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.05 35.79 23.28 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 118.593 0.633 . . . . 0.0 113.828 177.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 143.21 36.84 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.016 1.326 . . . . 0.0 111.761 -178.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.45 160.04 47.75 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.261 2.641 . . . . 0.0 112.064 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.75 152.67 58.84 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.669 2.246 . . . . 0.0 112.034 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.456 -0.7 0 C-N-CA 124.029 3.153 . . . . 0.0 110.328 179.009 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.8 mt . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -36.11 63.66 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.912 1.285 . . . . 0.0 112.625 178.001 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.8 mt -62.51 -49.59 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.577 0.751 . . . . 0.0 109.673 177.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -63.83 -40.23 96.1 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.394 0.678 . . . . 0.0 111.799 178.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -61.49 -47.22 86.63 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.895 0.878 . . . . 0.0 112.309 174.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.9 mt -64.63 -36.37 84.02 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.331 174.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -57.8 -39.25 77.11 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 178.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.01 -15.69 62.58 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.201 1.0 . . . . 0.0 113.162 176.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.52 8.36 9.22 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.524 1.059 . . . . 0.0 115.272 -177.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.14 -118.51 13.5 Favored Glycine 0 CA--C 1.542 1.74 0 CA-C-N 118.763 1.282 . . . . 0.0 112.608 177.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -58.65 -23.3 64.95 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.514 2.142 . . . . 0.0 114.127 176.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.2 m -92.54 27.89 2.16 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.632 1.173 . . . . 0.0 113.056 -178.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 m -118.07 3.16 12.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.607 1.163 . . . . 0.0 113.462 -176.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.66 28.26 73.55 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.757 0.694 . . . . 0.0 113.612 -178.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -153.71 141.52 13.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.57 1.148 . . . . 0.0 112.566 -176.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.33 165.35 32.78 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.359 2.706 . . . . 0.0 112.132 177.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.72 150.63 86.02 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.886 2.391 . . . . 0.0 111.911 177.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.537 0.672 0 C-N-CA 123.192 2.595 . . . . 0.0 113.623 -178.934 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -55.86 -37.04 68.26 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.76 1.224 . . . . 0.0 112.504 -178.178 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 mt -58.97 -50.03 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.92 1.288 . . . . 0.0 110.611 174.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -61.88 -40.41 95.28 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.806 0.843 . . . . 0.0 111.979 175.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -60.22 -45.55 92.82 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.429 0.559 . . . . 0.0 112.327 172.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.47 -39.25 93.97 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.785 173.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -55.05 -34.34 63.47 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.599 1.091 . . . . 0.0 112.976 176.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.53 -20.28 63.7 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 175.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.57 6.93 14.35 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.22 1.391 . . . . 0.0 113.929 -171.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.96 -127.45 42.99 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-N 118.614 1.207 . . . . 0.0 111.673 -178.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -59.29 -22.57 65.87 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.856 2.37 . . . . 0.0 114.26 177.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 t -61.11 -29.4 69.74 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.089 0.859 . . . . 0.0 113.168 -176.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.4 m -89.37 6.33 41.07 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.685 1.194 . . . . 0.0 113.141 175.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.58 -28.21 0.73 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.518 1.532 . . . . 0.0 115.368 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 ptm85 -56.55 127.59 72.96 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.35 1.46 . . . . 0.0 111.726 175.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -70.17 162.42 42.37 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.737 2.292 . . . . 0.0 111.856 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.08 159.74 52.68 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.786 2.324 . . . . 0.0 112.25 178.454 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 CA--C 1.541 0.826 0 C-N-CA 123.438 2.759 . . . . 0.0 113.912 178.73 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -56.33 -33.94 66.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.346 1.459 . . . . 0.0 113.436 -176.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.56 -43.9 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.11 0.964 . . . . 0.0 110.996 176.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -48.12 80.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.025 0.93 . . . . 0.0 110.861 175.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -60.63 -38.19 83.97 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.26 -37.61 87.93 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.713 -1.137 . . . . 0.0 112.459 171.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -57.68 -32.38 67.27 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.29 1.405 . . . . 0.0 113.244 173.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -67.01 -13.45 61.92 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 174.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.91 11.6 24.13 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.27 1.414 . . . . 0.0 114.045 -174.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.33 -135.17 48.13 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 118.661 1.23 . . . . 0.0 112.037 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.16 -32.01 68.23 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.094 2.529 . . . . 0.0 113.928 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.3 p -63.52 -23.24 67.31 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.76 -3.9 57.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.832 1.253 . . . . 0.0 113.415 176.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.98 -33.99 0.75 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.603 1.573 . . . . 0.0 115.513 177.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -60.68 138.58 93.14 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.986 1.393 . . . . 0.0 111.758 175.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.91 159.3 50.79 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.047 2.498 . . . . 0.0 112.155 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.37 149.96 63.81 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.834 2.356 . . . . 0.0 112.186 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 N--CA 1.459 -0.534 0 C-N-CA 124.005 3.137 . . . . 0.0 110.275 178.697 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.9 -36.76 65.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.77 1.228 . . . . 0.0 113.215 176.167 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.04 -52.6 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.741 0.817 . . . . 0.0 109.308 177.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -46.15 89.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.79 1.236 . . . . 0.0 110.75 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -55.5 -50.77 69.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.818 1.247 . . . . 0.0 112.478 174.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.72 -41.11 99.0 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.614 174.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -55.57 -41.82 73.86 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.3 1.04 . . . . 0.0 111.277 176.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -6.97 26.16 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.06 10.8 31.34 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.888 1.232 . . . . 0.0 114.09 -178.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.08 -119.18 14.51 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.683 1.611 . . . . 0.0 111.922 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.04 -27.37 45.29 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.956 2.437 . . . . 0.0 113.634 176.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 m -59.54 -28.93 67.53 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.94 1.296 . . . . 0.0 113.026 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 t -77.95 -7.21 56.49 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 176.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.03 -9.85 44.05 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.077 1.323 . . . . 0.0 115.07 178.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 -88.42 139.56 30.05 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.751 1.276 . . . . 0.0 110.692 176.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.71 163.32 28.07 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.055 2.503 . . . . 0.0 113.213 174.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.45 136.16 42.1 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.419 2.746 . . . . 0.0 112.262 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 CA--C 1.541 0.834 0 C-N-CA 124.048 3.166 . . . . 0.0 112.43 -178.986 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 tp . . . . . 0 CA--C 1.552 1.03 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -57.32 -37.34 72.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.868 1.267 . . . . 0.0 113.107 -176.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.51 -41.33 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.724 0.809 . . . . 0.0 111.656 177.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -63.55 -41.47 98.43 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.861 0.864 . . . . 0.0 111.852 176.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -64.34 -42.37 96.3 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 173.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.48 -37.68 84.53 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.489 173.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -37.56 59.98 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.329 1.052 . . . . 0.0 113.08 176.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.67 -25.95 63.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.279 0.632 . . . . 0.0 112.57 178.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.34 2.24 5.97 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.873 1.225 . . . . 0.0 114.614 -172.2 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.21 -125.42 38.98 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 119.033 1.417 . . . . 0.0 112.246 177.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.83 -28.71 68.86 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.51 2.14 . . . . 0.0 114.09 178.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 m -74.75 -3.76 33.52 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.7 m -93.38 -4.87 50.7 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.42 -36.02 0.97 Allowed Glycine 0 CA--C 1.539 1.581 0 O-C-N 120.764 -1.21 . . . . 0.0 114.792 -176.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -72.42 134.37 82.36 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 118.914 1.357 . . . . 0.0 111.227 174.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.26 163.98 34.14 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.259 2.64 . . . . 0.0 112.951 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.03 154.22 66.9 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.078 2.519 . . . . 0.0 112.79 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 C--N 1.35 0.636 0 C-N-CA 123.869 3.046 . . . . 0.0 114.176 -177.625 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -53.3 -36.19 60.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.842 1.257 . . . . 0.0 113.08 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mt -63.15 -38.09 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.838 0.855 . . . . 0.0 112.092 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -67.96 -46.73 70.59 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.449 1.1 . . . . 0.0 110.67 175.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -60.63 -41.98 96.0 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 175.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.99 -37.48 79.78 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.274 -0.891 . . . . 0.0 111.894 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -34.56 68.85 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.192 0.997 . . . . 0.0 113.06 175.093 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -67.16 -16.75 64.51 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.07 8.71 21.55 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.322 1.439 . . . . 0.0 114.327 -172.648 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.71 -132.94 52.23 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-N 119.149 1.474 . . . . 0.0 112.298 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -56.44 -29.19 76.75 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.885 2.39 . . . . 0.0 113.785 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 m -73.83 3.41 6.65 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.806 1.242 . . . . 0.0 113.965 -177.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.8 13.09 17.15 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.137 1.375 . . . . 0.0 113.813 -176.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.07 24.48 74.58 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.597 1.094 . . . . 0.0 115.067 172.057 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -141.15 135.32 15.09 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.319 1.448 . . . . 0.0 111.564 -170.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.92 160.25 46.38 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.781 2.32 . . . . 0.0 111.711 178.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.29 157.11 60.38 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.942 2.428 . . . . 0.0 112.754 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 CA--C 1.538 0.695 0 C-N-CA 124.194 3.263 . . . . 0.0 113.733 -179.544 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -39.1 77.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.479 1.511 . . . . 0.0 113.549 -172.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.61 -42.4 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.781 0.832 . . . . 0.0 110.632 175.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.6 -42.43 86.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.974 0.91 . . . . 0.0 111.895 177.467 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.0 t90 -61.05 -42.99 99.53 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 172.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.12 -37.12 86.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.26 -0.876 . . . . 0.0 113.361 176.262 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -55.25 -38.33 68.38 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.773 1.169 . . . . 0.0 113.023 176.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.11 3.37 12.72 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.954 1.302 . . . . 0.0 113.828 174.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.7 11.44 43.93 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.273 -1.517 . . . . 0.0 115.603 178.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.68 -110.41 0.93 Allowed Glycine 0 CA--C 1.542 1.778 0 C-N-CA 125.83 1.681 . . . . 0.0 113.665 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -55.72 -26.8 58.16 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.392 2.062 . . . . 0.0 114.15 177.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.8 m -86.59 4.4 40.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.301 1.04 . . . . 0.0 113.505 -178.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.4 m -91.4 -4.8 55.32 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.469 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.09 -10.0 10.94 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -179.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -112.49 139.76 23.02 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.866 1.667 . . . . 0.0 110.269 177.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.38 159.94 41.59 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.911 2.407 . . . . 0.0 112.954 176.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.73 140.81 43.7 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.068 2.512 . . . . 0.0 111.852 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 N--CA 1.458 -0.616 0 C-N-CA 122.909 2.406 . . . . 0.0 110.312 172.986 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.79 -36.96 62.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.132 1.773 . . . . 0.0 113.116 179.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mp -60.18 -48.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.148 0.979 . . . . 0.0 110.748 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -38.69 91.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.261 1.024 . . . . 0.0 111.235 178.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.0 t90 -62.67 -49.35 75.47 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.042 0.537 . . . . 0.0 112.318 172.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.6 mt -59.81 -34.35 72.94 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.403 -0.808 . . . . 0.0 112.842 175.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -53.47 -36.71 61.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.986 1.314 . . . . 0.0 113.502 177.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.63 -49.64 45.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.034 0.934 . . . . 0.0 111.49 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.61 25.97 0.02 OUTLIER Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.278 0.942 . . . . 0.0 115.25 179.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.6 -133.85 34.82 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-N 118.574 1.187 . . . . 0.0 112.413 -175.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.97 -25.57 54.16 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.082 2.521 . . . . 0.0 114.703 178.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.6 t -78.28 6.7 7.68 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -90.25 -7.62 53.02 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.494 1.918 . . . . 0.0 113.941 -176.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.6 -18.79 3.5 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 120.685 -1.26 . . . . 0.0 115.739 -176.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.6 ttt-85 -100.95 138.22 19.96 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.323 1.449 . . . . 0.0 110.963 176.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.0 159.8 47.46 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.797 2.332 . . . . 0.0 112.842 175.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.37 147.29 71.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.175 2.583 . . . . 0.0 111.432 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo . . . . . 0 CA--C 1.539 0.741 0 C-N-CA 122.652 2.235 . . . . 0.0 111.037 175.333 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -60.85 -34.43 74.57 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.762 1.225 . . . . 0.0 112.961 -177.181 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.9 mp -58.01 -52.7 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.315 0.646 . . . . 0.0 109.947 175.518 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -40.13 87.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.88 0.872 . . . . 0.0 112.184 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -62.82 -45.93 90.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.205 0.602 . . . . 0.0 112.468 173.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.13 -37.24 84.39 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.157 -0.925 . . . . 0.0 113.127 175.744 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -54.34 -31.78 55.19 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.524 1.056 . . . . 0.0 113.591 175.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.66 -13.23 60.6 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 176.545 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.89 2.64 20.46 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.867 1.698 . . . . 0.0 115.29 -177.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.17 -128.69 34.03 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 118.701 1.25 . . . . 0.0 112.877 175.651 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.24 -24.38 67.01 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.585 2.19 . . . . 0.0 114.106 179.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.6 m -87.64 20.24 3.05 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.463 1.105 . . . . 0.0 113.467 -176.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -120.36 6.5 10.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.921 1.288 . . . . 0.0 113.698 -171.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.61 27.11 73.02 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.013 0.816 . . . . 0.0 114.136 178.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.26 132.6 10.93 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.985 1.314 . . . . 0.0 111.796 -174.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.62 157.91 57.35 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.736 2.291 . . . . 0.0 111.854 178.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.66 154.81 59.47 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.079 2.519 . . . . 0.0 112.007 178.108 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 CA--C 1.538 0.705 0 C-N-CA 122.876 2.384 . . . . 0.0 111.124 175.936 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.94 -29.93 69.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.577 1.551 . . . . 0.0 113.094 -176.343 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.51 -52.09 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.909 0.884 . . . . 0.0 110.195 177.291 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -57.03 -49.67 75.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.836 0.855 . . . . 0.0 111.49 174.096 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -57.52 -43.01 83.94 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 178.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.0 mt -67.01 -39.21 87.01 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.225 -0.922 . . . . 0.0 112.576 172.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.94 -35.9 62.23 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.133 1.373 . . . . 0.0 113.373 176.742 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -72.3 -19.4 61.67 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 174.721 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.91 8.74 7.88 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.731 1.157 . . . . 0.0 115.118 -175.487 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.96 -124.25 31.9 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 119.09 1.445 . . . . 0.0 113.192 175.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.04 -28.48 60.27 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.721 2.281 . . . . 0.0 113.951 179.661 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -76.44 -3.76 38.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.094 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.1 m -91.44 -3.83 56.22 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.345 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.51 -33.68 1.37 Allowed Glycine 0 CA--C 1.539 1.538 0 O-C-N 120.93 -1.106 . . . . 0.0 115.163 -179.063 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -74.18 135.5 76.44 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 118.883 1.341 . . . . 0.0 110.673 176.037 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.02 161.01 47.6 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.928 2.419 . . . . 0.0 112.842 -178.234 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.09 138.79 44.73 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.31 2.673 . . . . 0.0 111.75 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 0 CA--C 1.538 0.701 0 C-N-CA 122.824 2.35 . . . . 0.0 111.222 177.505 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 tp . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.16 -36.25 40.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.434 1.494 . . . . 0.0 112.975 176.747 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.18 -44.72 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.009 0.924 . . . . 0.0 110.589 176.487 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.57 -44.8 85.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.202 0.601 . . . . 0.0 110.945 174.088 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.8 t90 -60.11 -38.13 82.1 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 176.226 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.32 -33.5 75.66 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.995 -1.065 . . . . 0.0 112.245 171.963 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -58.11 -35.87 72.09 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.482 1.113 . . . . 0.0 112.622 175.896 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.05 -20.72 66.63 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 173.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.64 7.75 10.5 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.344 1.449 . . . . 0.0 114.755 -171.796 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.95 -132.95 51.13 Favored Glycine 0 CA--C 1.542 1.769 0 CA-C-N 119.203 1.501 . . . . 0.0 112.446 -176.014 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -55.35 -30.81 74.41 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.512 2.808 . . . . 0.0 114.603 -178.202 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 64.5 m -79.59 14.62 1.58 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.059 1.344 . . . . 0.0 113.94 -175.553 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.82 3.5 16.45 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -168.799 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.63 21.45 78.8 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.738 1.161 . . . . 0.0 114.921 178.642 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -144.55 135.44 12.32 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.058 1.343 . . . . 0.0 111.557 -174.589 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.98 158.92 56.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.021 2.481 . . . . 0.0 111.851 -179.093 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.89 151.49 68.34 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.582 2.188 . . . . 0.0 111.556 177.523 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 N--CA 1.457 -0.676 0 C-N-CA 123.437 2.758 . . . . 0.0 112.105 175.791 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -64.82 -35.72 82.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.053 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.8 mt -62.63 -43.41 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.886 0.874 . . . . 0.0 110.173 176.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -41.69 92.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.252 1.021 . . . . 0.0 112.088 174.917 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -65.25 -43.46 91.26 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 173.522 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.4 mt -60.34 -39.49 87.28 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.506 174.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -50.69 -37.53 41.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.33 1.052 . . . . 0.0 113.028 178.019 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.5 -16.63 60.84 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.016 0.926 . . . . 0.0 113.27 -179.591 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.34 11.06 6.32 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.166 1.365 . . . . 0.0 115.095 -175.477 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.48 -119.54 7.44 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.055 1.312 . . . . 0.0 113.295 -178.418 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.9 -26.6 75.12 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.607 2.205 . . . . 0.0 114.188 177.167 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t -82.47 -0.87 48.33 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.201 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.9 m -84.5 -9.52 58.28 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.455 1.902 . . . . 0.0 114.668 -175.48 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.01 13.05 84.08 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 115.006 -174.787 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -137.89 136.3 19.7 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 118.875 1.338 . . . . 0.0 110.971 -178.083 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.26 160.41 42.41 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.053 2.502 . . . . 0.0 112.9 178.732 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.2 149.37 70.38 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.042 2.495 . . . . 0.0 112.022 179.049 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 CA--C 1.541 0.863 0 C-N-CA 123.76 2.973 . . . . 0.0 114.191 -179.237 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -58.25 -35.69 72.12 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.067 0.947 . . . . 0.0 112.92 -175.397 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mp -61.42 -50.38 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.324 1.05 . . . . 0.0 110.448 176.266 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -59.37 -44.58 92.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.577 1.151 . . . . 0.0 112.067 174.859 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -60.47 -46.36 90.38 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 175.924 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.14 -42.04 94.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.86 171.593 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -25.7 63.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.141 0.976 . . . . 0.0 113.557 177.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.1 -12.34 59.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 173.852 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.24 4.03 14.43 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.051 1.31 . . . . 0.0 115.248 -177.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.55 -130.58 48.58 Favored Glycine 0 CA--C 1.545 1.963 0 CA-C-N 119.567 1.684 . . . . 0.0 112.766 177.548 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -66.86 11.15 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.806 3.004 . . . . 0.0 115.935 -177.481 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.0 m -115.96 12.18 15.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.836 1.654 . . . . 0.0 113.501 -175.247 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -120.26 8.77 10.91 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.635 1.174 . . . . 0.0 113.575 -167.383 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.62 20.55 74.05 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.301 0.953 . . . . 0.0 114.963 178.881 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -136.45 133.92 19.51 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.261 1.424 . . . . 0.0 112.007 -174.085 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -70.44 159.32 53.32 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.678 2.252 . . . . 0.0 111.894 177.695 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.37 146.56 45.27 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.886 2.39 . . . . 0.0 111.987 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 CA--C 1.54 0.803 0 C-N-CA 123.634 2.89 . . . . 0.0 111.63 178.116 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.551 0.987 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -54.66 -34.86 62.84 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.864 1.666 . . . . 0.0 113.019 -178.279 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.2 mt -60.48 -47.85 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.593 1.157 . . . . 0.0 110.378 175.514 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.42 -39.36 81.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.04 1.336 . . . . 0.0 111.471 178.432 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -62.41 -44.31 96.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.021 0.929 . . . . 0.0 112.827 173.083 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.15 -42.29 98.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.008 172.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -53.14 -32.84 49.64 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 176.493 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -76.06 -18.93 59.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.931 0.892 . . . . 0.0 113.346 177.242 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.15 9.3 5.66 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.856 1.217 . . . . 0.0 115.231 -175.791 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.66 -118.97 7.68 Favored Glycine 0 CA--C 1.544 1.876 0 CA-C-N 118.941 1.371 . . . . 0.0 113.379 -178.991 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.3 -26.92 72.86 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.644 2.23 . . . . 0.0 114.452 178.342 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -81.26 1.29 33.01 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -179.447 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -89.28 -1.95 58.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.89 1.676 . . . . 0.0 114.582 -176.8 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.88 -36.73 1.25 Allowed Glycine 0 CA--C 1.539 1.54 0 O-C-N 120.442 -1.411 . . . . 0.0 114.709 -177.433 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -83.23 136.79 43.05 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.706 1.253 . . . . 0.0 111.425 175.081 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.56 164.68 25.41 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.439 2.76 . . . . 0.0 113.087 174.533 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 156.18 64.62 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.713 2.275 . . . . 0.0 112.519 -179.92 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 CA--C 1.539 0.758 0 C-N-CA 123.595 2.864 . . . . 0.0 114.285 -178.685 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.28 -29.1 68.59 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.881 0.872 . . . . 0.0 113.263 177.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.6 mm -66.54 -51.12 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.577 1.151 . . . . 0.0 109.454 176.648 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -54.48 -51.85 63.77 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.19 0.996 . . . . 0.0 110.839 173.024 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.7 t90 -57.7 -44.46 85.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.829 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.2 mt -61.65 -37.06 82.64 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.225 -0.922 . . . . 0.0 111.963 172.377 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.24 -16.31 61.8 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.286 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.63 -9.74 51.09 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.488 1.515 . . . . 0.0 113.252 169.235 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.32 5.39 19.31 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.077 1.323 . . . . 0.0 114.625 -178.515 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.64 -130.25 48.04 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 119.165 1.482 . . . . 0.0 111.693 -178.498 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.97 -32.8 69.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.891 2.394 . . . . 0.0 113.814 179.638 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 m -63.67 -22.37 66.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.837 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -3.89 56.67 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 174.774 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.13 -30.5 0.95 Allowed Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.18 1.371 . . . . 0.0 115.345 177.851 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 ttt85 -65.92 133.8 94.95 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 118.886 1.343 . . . . 0.0 110.513 175.183 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.57 160.27 43.95 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.702 2.268 . . . . 0.0 112.463 178.833 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.34 153.83 70.27 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.796 2.331 . . . . 0.0 112.121 179.253 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 N--CA 1.456 -0.693 0 C-N-CA 123.477 2.784 . . . . 0.0 110.666 176.032 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.84 -39.86 72.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.347 1.459 . . . . 0.0 112.782 -173.881 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.14 -45.21 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.727 0.811 . . . . 0.0 110.526 177.106 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -35.23 77.96 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 176.964 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -64.93 -45.25 86.64 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.484 0.584 . . . . 0.0 112.249 171.99 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.6 mt -65.48 -32.44 74.05 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.753 -1.118 . . . . 0.0 113.514 176.315 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -52.96 -37.25 60.93 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.544 1.065 . . . . 0.0 113.617 176.791 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.17 -52.57 18.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.637 0.775 . . . . 0.0 111.341 179.329 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.43 29.35 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 N-CA-C 115.307 0.883 . . . . 0.0 115.307 177.772 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.45 -133.24 34.6 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.431 1.116 . . . . 0.0 112.236 -177.022 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.49 -24.57 62.1 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.184 2.589 . . . . 0.0 114.461 178.393 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 m -75.03 -11.24 60.06 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.994 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -69.64 -10.38 57.99 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.716 1.606 . . . . 0.0 113.46 177.779 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.94 -35.73 2.12 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.051 1.31 . . . . 0.0 114.292 -177.528 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -79.47 138.12 55.33 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 118.551 1.175 . . . . 0.0 111.328 174.665 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.01 160.68 36.61 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.615 2.877 . . . . 0.0 113.339 175.199 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.48 155.51 55.07 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.012 2.475 . . . . 0.0 112.507 179.597 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 CA--C 1.537 0.658 0 C-N-CA 123.61 2.873 . . . . 0.0 114.177 179.142 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 CA--C 1.545 0.768 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -59.32 -31.97 69.65 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.928 1.291 . . . . 0.0 113.053 -177.631 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mp -57.73 -49.78 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.448 0.699 . . . . 0.0 110.188 174.97 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.58 -45.16 94.99 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.917 0.887 . . . . 0.0 111.284 -179.121 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -59.65 -47.93 83.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.687 0.795 . . . . 0.0 112.283 175.461 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.56 -40.37 96.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.377 173.749 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -57.79 -38.83 76.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.521 1.128 . . . . 0.0 112.701 -179.4 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -20.05 63.64 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.918 1.287 . . . . 0.0 113.009 176.049 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.31 8.88 5.77 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.1 1.333 . . . . 0.0 114.806 -176.701 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.24 -124.95 37.54 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 119.022 1.411 . . . . 0.0 111.632 -177.205 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -56.31 -30.42 80.7 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.165 2.577 . . . . 0.0 114.178 178.379 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 m -75.34 12.05 1.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.907 1.283 . . . . 0.0 114.007 -178.11 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.99 3.32 20.33 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.916 1.686 . . . . 0.0 113.288 -172.726 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.51 20.41 75.47 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.363 -0.835 . . . . 0.0 114.222 -175.417 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.11 129.59 19.01 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.765 1.226 . . . . 0.0 110.92 -170.202 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.26 159.95 49.85 Favored 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.104 2.536 . . . . 0.0 113.221 -178.998 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.65 122.35 9.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.571 2.847 . . . . 0.0 111.461 -179.351 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 C--N 1.349 0.6 0 C-N-CA 122.49 2.127 . . . . 0.0 110.517 178.137 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 117.846 -1.074 . . . . 0.0 113.507 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 pp -43.98 -51.31 7.82 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -66.47 -30.9 71.34 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 mm -65.22 -45.94 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.767 1.227 . . . . 0.0 109.345 174.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.75 -30.35 71.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.46 0.704 . . . . 0.0 112.719 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.5 t90 -73.14 -43.42 61.63 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.965 0.802 . . . . 0.0 112.485 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.2 mt -64.88 -43.25 93.51 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.291 -0.861 . . . . 0.0 112.99 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -25.7 64.69 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.653 1.115 . . . . 0.0 113.921 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.99 -8.82 58.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.908 1.683 . . . . 0.0 113.646 174.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.78 8.08 24.77 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.373 1.463 . . . . 0.0 114.798 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.24 -124.37 32.77 Favored Glycine 0 CA--C 1.541 1.713 0 CA-C-N 118.825 1.312 . . . . 0.0 112.149 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.98 -28.77 84.35 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.794 2.33 . . . . 0.0 113.813 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.7 m -81.83 19.13 1.14 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.089 1.356 . . . . 0.0 113.737 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.06 13.4 9.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.843 1.257 . . . . 0.0 113.82 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.93 25.22 74.35 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.471 -0.768 . . . . 0.0 114.505 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -143.95 131.3 10.57 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.873 1.269 . . . . 0.0 111.893 -172.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.1 160.07 50.92 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.82 2.347 . . . . 0.0 111.692 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.48 145.67 59.48 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.472 2.115 . . . . 0.0 111.422 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.26 124.22 7.07 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.169 2.579 . . . . 0.0 110.894 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.25 1.119 0 C-N-CA 125.739 1.616 . . . . 0.0 111.968 171.654 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 m120 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 118.229 -0.891 . . . . 0.0 113.058 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 mp -62.0 -10.74 10.64 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -54.78 -31.94 59.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.07 1.748 . . . . 0.0 113.742 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.6 mt -59.68 -49.11 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.45 1.1 . . . . 0.0 109.474 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -33.18 74.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.487 1.115 . . . . 0.0 111.799 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -66.8 -45.94 76.78 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.3 mt -61.18 -37.0 81.36 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.938 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -52.99 -33.48 51.65 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.025 0.93 . . . . 0.0 113.282 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -75.19 -11.09 60.0 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.336 1.454 . . . . 0.0 112.549 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.09 10.34 28.15 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.476 -1.39 . . . . 0.0 115.374 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.27 -125.2 38.76 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 118.672 1.236 . . . . 0.0 113.086 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.26 -23.17 61.05 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.446 2.098 . . . . 0.0 114.305 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.82 7.26 18.51 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.074 0.95 . . . . 0.0 113.263 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 m -103.95 1.87 31.73 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.842 1.657 . . . . 0.0 114.422 -174.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.79 -37.52 1.25 Allowed Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.831 1.205 . . . . 0.0 115.019 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.2 ttp-105 -75.92 131.69 75.73 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.934 1.293 . . . . 0.0 111.36 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.09 162.4 32.96 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.328 2.685 . . . . 0.0 113.069 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.71 142.3 57.68 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.063 2.509 . . . . 0.0 112.376 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.66 117.65 4.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.409 2.739 . . . . 0.0 110.752 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.251 1.14 0 CA-C-O 115.622 -2.132 . . . . 0.0 112.502 172.685 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.03 -0.3 57.47 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.205 1.366 . . . . 0.0 114.352 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -57.54 -36.5 71.7 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.839 0.856 . . . . 0.0 112.917 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.3 mt -62.92 -44.92 99.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.923 1.289 . . . . 0.0 110.533 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -46.52 89.17 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.437 1.095 . . . . 0.0 110.776 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -64.05 -43.56 95.16 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.1 mt -63.07 -36.06 82.32 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.26 -0.9 . . . . 0.0 112.454 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -56.13 -33.51 65.23 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.456 1.025 . . . . 0.0 113.079 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -71.95 -5.99 38.77 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 118.958 0.799 . . . . 0.0 113.056 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.33 -2.05 32.9 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.704 1.621 . . . . 0.0 114.183 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.77 -129.12 46.32 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 118.655 1.228 . . . . 0.0 111.277 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -54.77 -29.76 63.92 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.81 2.34 . . . . 0.0 114.253 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 p -67.21 -23.68 65.76 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.85 -6.43 56.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.05 -31.49 1.1 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.801 1.191 . . . . 0.0 115.159 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -64.15 135.28 96.26 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 118.82 1.31 . . . . 0.0 110.592 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.4 159.86 45.5 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.875 2.383 . . . . 0.0 112.847 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.99 162.81 41.41 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.383 2.722 . . . . 0.0 112.74 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.84 -21.75 12.28 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.616 2.877 . . . . 0.0 114.327 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 C--O 1.248 1.011 0 C-N-CA 126.468 1.907 . . . . 0.0 110.883 174.877 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.2 m120 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 117.195 -1.383 . . . . 0.0 113.94 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -49.42 -38.98 31.18 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.596 1.544 . . . . 0.0 114.302 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.55 -30.97 68.99 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.126 0.97 . . . . 0.0 113.418 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.2 -51.19 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.074 0.949 . . . . 0.0 109.462 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -56.53 -48.06 78.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.452 1.101 . . . . 0.0 111.567 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -57.54 -46.99 83.22 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -65.07 -39.71 93.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.272 -0.87 . . . . 0.0 112.547 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -54.72 -40.0 68.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.236 1.015 . . . . 0.0 112.389 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -76.66 -11.85 59.91 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.014 1.326 . . . . 0.0 113.388 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.81 9.28 6.35 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.165 1.364 . . . . 0.0 115.714 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.06 -108.74 0.53 Allowed Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.383 1.468 . . . . 0.0 113.446 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.01 -27.66 65.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.537 2.158 . . . . 0.0 114.499 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.3 p -89.61 7.34 36.99 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -84.14 -5.23 59.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.006 1.322 . . . . 0.0 114.427 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.28 17.5 77.55 Favored Glycine 0 CA--C 1.538 1.494 0 O-C-N 120.561 -1.337 . . . . 0.0 115.171 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -143.27 143.64 25.21 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.502 1.521 . . . . 0.0 110.401 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.28 157.93 55.1 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.635 2.223 . . . . 0.0 112.767 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.89 140.7 39.01 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.205 2.603 . . . . 0.0 111.547 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.97 133.46 12.44 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.205 2.603 . . . . 0.0 110.902 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.245 0.817 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 173.689 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 116.716 -1.612 . . . . 0.0 115.14 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt 72.95 -34.83 0.31 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.312 1.845 . . . . 0.0 113.125 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -39.32 66.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.364 1.466 . . . . 0.0 113.701 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.5 mp -61.26 -50.03 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.016 0.927 . . . . 0.0 110.758 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -64.82 -37.82 88.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.389 0.676 . . . . 0.0 111.658 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -61.39 -46.32 90.65 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 172.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.5 mt -59.64 -37.11 77.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.96 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -57.06 -31.95 65.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.2 -19.84 63.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.267 1.027 . . . . 0.0 112.763 175.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.08 5.66 8.75 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 126.004 1.764 . . . . 0.0 114.549 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.94 -133.7 51.03 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 119.026 1.413 . . . . 0.0 112.198 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.21 -29.12 55.17 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.643 2.895 . . . . 0.0 114.464 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -81.44 21.32 0.79 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.803 1.641 . . . . 0.0 113.78 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.28 8.43 9.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.64 1.576 . . . . 0.0 113.317 -169.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.53 24.98 73.93 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.3 1.429 . . . . 0.0 114.784 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -148.93 134.08 9.37 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.974 1.31 . . . . 0.0 112.023 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.56 161.72 44.47 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.235 2.624 . . . . 0.0 112.029 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.79 146.25 65.6 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.01 2.473 . . . . 0.0 112.611 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -82.74 97.09 0.85 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.786 2.99 . . . . 0.0 111.086 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 115.677 -2.106 . . . . 0.0 114.0 -179.368 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tp 63.45 -33.93 0.13 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -54.35 -32.06 55.92 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.572 2.749 . . . . 0.0 113.588 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.46 -46.98 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.979 0.911 . . . . 0.0 110.718 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -44.25 96.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.252 0.621 . . . . 0.0 111.142 175.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -62.92 -39.33 94.24 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.75 -38.36 90.73 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.043 -1.035 . . . . 0.0 112.16 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -54.79 -33.78 61.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.302 1.041 . . . . 0.0 113.562 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -67.38 -20.35 65.54 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.429 1.013 . . . . 0.0 113.469 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.37 8.02 9.58 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.0 1.286 . . . . 0.0 114.889 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.49 -133.77 51.8 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-N 119.139 1.469 . . . . 0.0 112.183 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.75 -31.3 60.61 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.505 2.803 . . . . 0.0 114.726 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.2 m -77.09 10.13 2.57 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.614 1.166 . . . . 0.0 113.808 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -98.96 -1.81 38.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.467 1.507 . . . . 0.0 114.272 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -38.95 0.89 Allowed Glycine 0 CA--C 1.54 1.631 0 C-N-CA 125.043 1.306 . . . . 0.0 114.643 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -73.85 136.53 76.88 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.036 1.334 . . . . 0.0 112.283 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -70.64 161.3 46.55 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.334 2.689 . . . . 0.0 112.144 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.3 147.75 66.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.792 2.328 . . . . 0.0 111.723 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.62 -18.53 10.58 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.075 2.516 . . . . 0.0 113.756 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.258 1.517 0 CA-C-O 116.0 -1.952 . . . . 0.0 112.868 -171.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mt -71.45 -13.36 61.8 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.383 0.992 . . . . 0.0 113.632 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -54.24 -39.51 66.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.412 1.085 . . . . 0.0 113.406 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.25 -45.13 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.825 0.85 . . . . 0.0 110.627 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -34.93 77.34 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.339 1.455 . . . . 0.0 112.262 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -65.01 -47.19 78.36 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.661 0.784 . . . . 0.0 111.769 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.9 mt -60.75 -30.18 69.85 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 118.022 -0.989 . . . . 0.0 113.63 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -54.04 -34.85 61.11 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -74.09 -48.02 32.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.45 0.7 . . . . 0.0 111.079 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.9 26.91 0.02 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.373 0.987 . . . . 0.0 115.252 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.68 -133.38 43.72 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 118.869 1.335 . . . . 0.0 112.332 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -55.74 -28.77 68.33 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.026 2.484 . . . . 0.0 114.525 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.2 m -75.78 3.29 10.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.439 1.095 . . . . 0.0 113.679 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 m -81.75 -7.87 59.64 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.403 1.481 . . . . 0.0 114.169 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.05 12.29 84.78 Favored Glycine 0 CA--C 1.539 1.537 0 O-C-N 120.982 -1.074 . . . . 0.0 115.009 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -143.86 138.0 14.76 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.993 1.317 . . . . 0.0 111.167 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.87 161.01 41.22 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.948 2.432 . . . . 0.0 113.016 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.73 162.59 41.49 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.489 2.793 . . . . 0.0 112.708 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.18 -19.7 7.82 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.592 2.861 . . . . 0.0 114.149 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.248 1.019 0 C-N-CA 126.245 1.818 . . . . 0.0 110.4 170.413 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 2' ' ' LEU . 0.3 OUTLIER -43.94 -46.94 8.4 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 120.229 1.377 . . . . 0.0 114.088 178.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -62.66 -33.79 75.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.1 mm -64.9 -45.53 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.069 0.948 . . . . 0.0 109.737 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.64 -38.89 92.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.158 0.583 . . . . 0.0 112.254 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -63.03 -45.13 93.72 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.021 0.828 . . . . 0.0 112.694 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.0 mt -58.65 -37.42 75.92 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.273 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -57.08 -27.65 61.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.738 1.215 . . . . 0.0 114.22 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.92 -20.14 60.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.776 0.831 . . . . 0.0 112.575 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.35 10.07 6.85 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.776 1.655 . . . . 0.0 114.751 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.24 -134.96 52.12 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-N 118.968 1.384 . . . . 0.0 111.823 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.89 -27.22 61.95 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.608 2.872 . . . . 0.0 114.893 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m -78.31 12.18 2.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.173 0.989 . . . . 0.0 113.62 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 m -107.19 -4.08 19.17 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.822 1.649 . . . . 0.0 113.905 -170.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.64 19.44 76.51 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 119.176 -0.791 . . . . 0.0 114.817 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -135.5 134.14 20.85 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 125.395 1.478 . . . . 0.0 111.839 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.98 160.05 51.47 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.768 2.312 . . . . 0.0 111.917 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.61 149.04 60.85 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.881 2.387 . . . . 0.0 112.012 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -85.46 -8.17 8.58 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.074 3.182 . . . . 0.0 114.387 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.254 1.298 0 CA-C-O 116.12 -1.895 . . . . 0.0 109.33 177.437 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 117.179 -1.391 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 57.13 -18.34 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 128.729 2.812 . . . . 0.0 117.039 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.39 -38.91 85.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.995 1.718 . . . . 0.0 113.032 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.1 mp -60.25 -47.28 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.791 0.836 . . . . 0.0 110.693 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -63.46 -38.1 89.86 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.372 0.669 . . . . 0.0 112.449 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -64.49 -45.32 87.81 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.868 0.758 . . . . 0.0 112.487 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.8 mt -60.58 -40.45 91.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.384 -0.817 . . . . 0.0 112.696 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -51.32 -34.12 32.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.136 1.374 . . . . 0.0 114.179 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -71.65 -39.97 69.99 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.572 0.749 . . . . 0.0 111.866 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.76 12.64 0.08 OUTLIER Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.45 -134.87 51.62 Favored Glycine 0 CA--C 1.543 1.836 0 CA-C-N 119.614 1.707 . . . . 0.0 112.416 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.8 -26.2 81.54 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.057 2.504 . . . . 0.0 115.565 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.1 p -82.14 8.5 10.73 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.649 1.113 . . . . 0.0 113.673 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -91.62 -4.27 55.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.807 2.043 . . . . 0.0 114.524 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.03 -38.33 1.76 Allowed Glycine 0 CA--C 1.539 1.59 0 O-C-N 120.583 -1.323 . . . . 0.0 114.886 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -74.44 135.49 75.6 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 118.847 1.324 . . . . 0.0 111.199 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -67.32 160.07 49.37 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.153 2.569 . . . . 0.0 113.192 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.03 139.53 39.53 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.099 2.533 . . . . 0.0 111.814 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.82 138.73 15.09 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.234 2.623 . . . . 0.0 110.913 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.252 1.219 0 CA-C-O 116.271 -1.823 . . . . 0.0 109.342 176.581 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 117.449 -1.262 . . . . 0.0 113.747 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.31 -4.25 41.1 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 121.175 1.807 . . . . 0.0 114.332 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.42 -30.22 66.72 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.849 1.259 . . . . 0.0 113.952 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 mp -59.0 -48.13 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.719 0.808 . . . . 0.0 110.413 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -31.11 72.18 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.213 1.405 . . . . 0.0 112.456 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -76.39 -43.61 39.81 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.702 0.801 . . . . 0.0 112.804 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.6 mt -65.56 -43.98 88.18 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.939 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -19.41 56.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -15.86 58.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.241 1.417 . . . . 0.0 113.121 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.84 6.01 11.6 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.338 1.447 . . . . 0.0 114.671 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.93 -128.52 43.56 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 119.189 1.494 . . . . 0.0 112.04 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.62 -34.21 72.41 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.51 2.807 . . . . 0.0 114.545 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.4 m -74.98 7.04 3.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.717 1.207 . . . . 0.0 114.054 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -95.08 -11.28 28.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.7 27.89 66.29 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 118.8 0.727 . . . . 0.0 114.631 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.91 140.44 15.63 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.111 1.364 . . . . 0.0 111.684 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -70.67 160.32 49.83 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.067 2.512 . . . . 0.0 111.916 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.04 154.48 62.63 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.674 2.249 . . . . 0.0 112.141 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.24 110.89 3.09 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.62 2.88 . . . . 0.0 111.467 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 C--O 1.258 1.506 0 CA-C-O 114.774 -2.536 . . . . 0.0 110.659 177.504 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.2 t30 . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mt -79.8 -4.32 51.56 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.923 1.238 . . . . 0.0 114.058 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -35.51 72.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.297 1.039 . . . . 0.0 112.345 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.25 -51.09 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.649 1.18 . . . . 0.0 109.621 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -55.68 -47.56 76.55 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.756 1.223 . . . . 0.0 111.836 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.0 t90 -61.59 -47.1 87.02 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.2 mt -63.42 -34.6 78.1 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.598 -0.689 . . . . 0.0 112.5 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -58.36 -36.6 73.72 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.75 1.22 . . . . 0.0 113.092 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.9 -21.1 63.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.025 0.93 . . . . 0.0 112.367 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.87 20.52 6.02 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.48 1.514 . . . . 0.0 113.708 -175.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.71 -124.69 30.29 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.061 1.43 . . . . 0.0 112.742 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -58.29 -23.88 64.92 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.488 2.125 . . . . 0.0 114.431 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.3 p -60.97 -31.22 70.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.209 0.913 . . . . 0.0 112.924 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -81.19 -5.08 57.32 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.917 1.287 . . . . 0.0 113.25 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.91 -27.63 1.95 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.616 1.579 . . . . 0.0 115.206 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -64.02 137.14 97.02 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 118.793 1.297 . . . . 0.0 111.14 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.22 161.23 46.7 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.119 2.546 . . . . 0.0 113.004 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.5 148.09 53.36 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.08 2.52 . . . . 0.0 112.105 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.28 142.18 23.84 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.128 2.552 . . . . 0.0 110.551 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.088 1.755 . . . . 0.0 109.564 176.654 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.68 0.82 0.7 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.998 1.719 . . . . 0.0 115.241 175.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -58.69 -39.79 81.76 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.95 1.7 . . . . 0.0 112.82 -173.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.578 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.6 mp -56.15 -45.07 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.384 1.074 . . . . 0.0 110.814 175.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -52.16 65.5 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.444 0.698 . . . . 0.0 111.062 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.7 t90 -61.22 -39.1 89.01 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.14 -37.1 85.88 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.343 -0.848 . . . . 0.0 111.876 171.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -58.81 -31.71 68.69 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -66.07 -24.0 66.64 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.938 0.79 . . . . 0.0 113.071 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.98 10.25 6.96 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 124.937 1.256 . . . . 0.0 115.286 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.39 -127.07 38.66 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 118.794 1.297 . . . . 0.0 113.554 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.46 -23.67 57.01 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.917 2.411 . . . . 0.0 114.714 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.7 m -83.39 2.54 35.92 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -93.44 -3.5 52.99 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.51 -39.72 0.75 Allowed Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.793 1.187 . . . . 0.0 114.757 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -68.6 137.51 90.73 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.789 1.235 . . . . 0.0 112.099 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.14 159.18 52.95 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.081 2.521 . . . . 0.0 112.359 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.18 156.2 46.8 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.062 2.508 . . . . 0.0 113.157 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -84.77 -5.67 9.8 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 125.034 3.823 . . . . 0.0 114.168 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.4 m . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.367 1.867 . . . . 0.0 108.747 179.366 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 116.349 -1.786 . . . . 0.0 115.326 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mt 66.32 -33.72 0.19 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.449 1.9 . . . . 0.0 114.841 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.04 -33.53 65.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.583 1.553 . . . . 0.0 113.513 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -63.57 -50.79 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.015 0.926 . . . . 0.0 110.767 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.89 -42.08 97.28 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.409 0.684 . . . . 0.0 111.667 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -62.03 -46.07 90.78 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.7 mt -60.87 -37.77 83.29 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.928 -1.107 . . . . 0.0 112.538 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -56.68 -28.26 60.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.95 0.796 . . . . 0.0 112.587 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -75.92 -11.01 59.89 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.269 -0.894 . . . . 0.0 113.187 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.71 11.25 27.13 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-N 120.293 1.406 . . . . 0.0 115.714 -172.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.9 -127.79 44.99 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 124.727 1.156 . . . . 0.0 113.475 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.98 -20.68 46.14 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.693 2.262 . . . . 0.0 114.657 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.5 p -88.95 4.97 46.27 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.705 1.202 . . . . 0.0 114.177 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.6 m -99.13 -1.17 40.1 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -172.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.79 -34.95 1.21 Allowed Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.733 1.159 . . . . 0.0 115.009 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -72.86 133.76 81.86 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.682 1.241 . . . . 0.0 110.967 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.38 157.74 58.73 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.816 2.344 . . . . 0.0 112.746 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.15 134.93 28.28 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.336 2.69 . . . . 0.0 111.313 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.11 142.08 21.42 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.564 2.176 . . . . 0.0 110.736 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.253 1.271 0 CA-C-O 116.201 -1.857 . . . . 0.0 110.475 176.009 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -110.11 -3.64 16.28 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.003 -1.061 . . . . 0.0 113.65 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.46 -33.62 74.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.845 1.258 . . . . 0.0 113.126 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.4 mt -58.56 -50.38 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.767 1.227 . . . . 0.0 109.955 176.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -41.89 96.27 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.845 1.258 . . . . 0.0 111.593 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -62.81 -43.57 98.44 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.22 -35.93 82.6 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.344 -0.836 . . . . 0.0 112.532 173.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -54.07 -37.95 64.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.469 1.108 . . . . 0.0 113.475 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -83.38 -8.42 59.41 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.582 1.953 . . . . 0.0 112.744 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.98 23.17 5.66 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.747 1.642 . . . . 0.0 115.067 177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 48.8 -108.99 0.47 Allowed Glycine 0 CA--C 1.54 1.595 0 C-N-CA 126.495 1.998 . . . . 0.0 113.708 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.12 -28.67 62.07 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.005 2.47 . . . . 0.0 114.3 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -82.69 -0.04 45.59 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.2 m -82.42 -3.67 56.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.459 1.504 . . . . 0.0 115.003 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.43 17.51 79.11 Favored Glycine 0 CA--C 1.539 1.573 0 O-C-N 121.178 -0.952 . . . . 0.0 115.26 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -153.85 144.82 16.18 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 125.472 1.509 . . . . 0.0 111.448 -172.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.52 164.74 34.19 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.532 2.821 . . . . 0.0 112.695 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.91 138.78 54.2 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.147 2.565 . . . . 0.0 112.651 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.77 106.84 1.3 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.633 2.889 . . . . 0.0 112.114 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 t . . . . . 0 C--O 1.25 1.121 0 C-N-CA 127.884 2.473 . . . . 0.0 114.927 175.779 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.5 t30 . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.5 mt -105.58 1.9 27.82 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.631 -1.293 . . . . 0.0 113.143 -175.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.99 -38.53 73.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.815 1.246 . . . . 0.0 112.649 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.49 -50.22 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 123.926 0.89 . . . . 0.0 110.552 176.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -62.07 -42.27 99.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.323 0.649 . . . . 0.0 111.979 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.8 t90 -60.72 -39.66 89.41 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.7 mt -66.42 -37.66 85.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 117.999 -1.001 . . . . 0.0 112.892 173.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -53.41 -39.77 64.59 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.736 1.153 . . . . 0.0 113.376 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.51 -11.96 61.26 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.22 14.42 9.88 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.326 0.965 . . . . 0.0 114.521 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.91 -120.21 8.79 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 117.998 -1.446 . . . . 0.0 112.219 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -54.7 -28.24 55.78 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.468 2.778 . . . . 0.0 114.466 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.9 p -79.6 2.97 20.4 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -88.96 -8.95 53.16 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.27 20.08 79.7 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 114.957 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.3 138.87 16.98 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 125.405 1.482 . . . . 0.0 110.681 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.58 159.36 48.43 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.882 2.388 . . . . 0.0 112.548 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.44 148.0 59.72 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.803 2.336 . . . . 0.0 111.711 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.79 145.57 18.07 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.228 2.619 . . . . 0.0 111.418 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.6 p . . . . . 0 C--O 1.258 1.509 0 CA-C-O 114.601 -2.618 . . . . 0.0 109.565 176.435 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 117.391 -1.29 . . . . 0.0 113.124 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -41.27 -60.78 1.16 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -62.1 -39.69 93.35 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mp -58.97 -51.5 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.771 1.229 . . . . 0.0 110.344 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -55.13 -46.54 75.63 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.175 0.99 . . . . 0.0 112.477 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -63.97 -47.29 80.98 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.69 -39.21 87.65 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.039 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -57.22 -34.45 68.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.89 1.276 . . . . 0.0 112.929 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -17.54 61.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.418 1.087 . . . . 0.0 112.722 176.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.75 5.86 8.89 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.762 1.648 . . . . 0.0 114.204 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.56 -124.07 32.27 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.026 -1.43 . . . . 0.0 111.509 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.27 -33.71 85.75 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.212 2.608 . . . . 0.0 114.299 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.4 m -60.75 -23.17 64.75 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.761 0.824 . . . . 0.0 112.932 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.67 -12.94 61.87 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.804 1.642 . . . . 0.0 113.199 175.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.89 12.09 74.57 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.051 0.834 . . . . 0.0 114.844 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -120.85 138.28 27.5 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 125.918 1.687 . . . . 0.0 110.09 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.38 158.67 43.78 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.844 2.363 . . . . 0.0 112.784 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.58 154.26 68.7 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.836 2.357 . . . . 0.0 112.372 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.06 114.03 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.635 2.89 . . . . 0.0 111.358 176.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 C--O 1.257 1.498 0 CA-C-O 114.156 -2.83 . . . . 0.0 115.318 176.29 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 117.864 -1.065 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.1 mt -52.37 -37.27 55.84 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.084 1.311 . . . . 0.0 114.141 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.83 -35.52 73.02 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.695 0.798 . . . . 0.0 112.899 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 mm -64.69 -46.47 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.095 0.958 . . . . 0.0 109.971 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -59.45 -45.96 90.11 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.036 0.534 . . . . 0.0 111.744 175.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -60.07 -44.51 94.69 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.67 -38.65 88.57 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.456 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -56.84 -35.23 68.59 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.108 0.963 . . . . 0.0 113.573 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.36 -23.23 66.3 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.17 0.988 . . . . 0.0 112.447 175.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.54 11.18 5.65 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.721 1.629 . . . . 0.0 114.61 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.55 -134.83 52.32 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 118.857 -0.968 . . . . 0.0 111.648 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.5 -21.15 44.4 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.711 2.941 . . . . 0.0 114.414 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.0 p -86.47 21.1 2.22 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.952 1.301 . . . . 0.0 114.075 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 16' ' ' ARG . 0.9 OUTLIER -122.0 11.76 10.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.271 1.428 . . . . 0.0 112.969 -171.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.12 23.19 71.26 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.478 1.037 . . . . 0.0 114.143 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 14' ' ' SER . 14.5 ptp180 -144.51 130.56 9.81 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.032 1.333 . . . . 0.0 112.149 -175.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.95 166.67 28.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.285 2.656 . . . . 0.0 112.334 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.97 142.54 69.03 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.132 2.555 . . . . 0.0 112.172 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.59 106.69 2.32 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.494 2.796 . . . . 0.0 110.147 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.0 m . . . . . 0 C--O 1.252 1.226 0 CA-C-O 116.764 -1.589 . . . . 0.0 111.062 174.195 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.5 -3.11 0.15 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.653 2.381 . . . . 0.0 115.959 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -61.0 -35.77 77.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.022 1.729 . . . . 0.0 113.239 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.88 -41.82 94.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.132 0.973 . . . . 0.0 111.073 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -66.78 -39.72 87.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.854 0.862 . . . . 0.0 111.531 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -62.8 -46.14 89.38 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.8 mt -60.62 -37.68 82.23 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.689 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.07 -34.13 59.3 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 119.212 0.914 . . . . 0.0 113.0 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -80.74 -2.81 48.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.899 0.88 . . . . 0.0 113.298 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.61 9.23 31.29 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.896 -1.127 . . . . 0.0 115.555 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 52.14 -114.65 3.42 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 125.118 1.342 . . . . 0.0 113.218 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.12 -24.23 48.64 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.506 2.138 . . . . 0.0 114.416 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 4.03 41.48 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.165 0.986 . . . . 0.0 113.631 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 m -93.47 4.34 54.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.785 1.634 . . . . 0.0 114.711 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.47 13.01 67.53 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.019 -1.051 . . . . 0.0 114.823 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -144.96 137.63 13.6 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.497 1.519 . . . . 0.0 110.788 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.27 162.03 35.1 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.924 2.416 . . . . 0.0 112.657 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.34 146.64 69.69 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.852 2.368 . . . . 0.0 112.168 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.65 137.68 22.91 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.68 2.253 . . . . 0.0 110.133 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 116.813 -1.565 . . . . 0.0 109.883 174.899 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.1 t30 . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 58.98 -1.16 0.12 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 178.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -59.23 -38.59 80.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.495 1.518 . . . . 0.0 113.632 -174.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.0 mp -59.82 -50.95 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 110.299 175.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -40.72 92.2 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.902 0.881 . . . . 0.0 112.703 176.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -60.69 -45.41 94.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.248 0.619 . . . . 0.0 112.563 173.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.8 mt -61.96 -44.1 97.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.432 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -54.45 -35.47 63.03 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.28 0.946 . . . . 0.0 113.238 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -69.04 -32.71 72.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.295 0.638 . . . . 0.0 112.444 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.56 4.3 2.5 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.989 1.281 . . . . 0.0 114.843 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.23 -125.97 40.67 Favored Glycine 0 CA--C 1.54 1.625 0 CA-C-N 118.794 1.297 . . . . 0.0 112.154 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.74 -25.32 75.38 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.648 2.232 . . . . 0.0 114.147 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.2 m -80.04 7.92 8.14 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 m -108.55 7.18 26.61 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.815 1.646 . . . . 0.0 114.522 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.49 19.86 74.94 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 114.07 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -137.62 128.17 15.76 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.607 1.563 . . . . 0.0 111.44 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.96 165.13 31.08 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.006 2.471 . . . . 0.0 111.863 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.13 135.63 51.86 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.729 2.286 . . . . 0.0 111.355 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -81.12 145.7 15.52 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.454 2.103 . . . . 0.0 110.777 176.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.068 0 C-N-CA 127.182 2.193 . . . . 0.0 116.104 167.126 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 68.39 -32.96 0.22 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.936 1.695 . . . . 0.0 114.931 -178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -57.04 -37.15 71.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.946 1.698 . . . . 0.0 113.646 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -56.94 -50.62 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.547 0.739 . . . . 0.0 109.897 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -44.43 96.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.694 1.198 . . . . 0.0 111.224 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.5 t90 -59.92 -47.1 87.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.79 0.836 . . . . 0.0 113.031 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.7 mt -61.86 -41.31 97.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.534 -0.746 . . . . 0.0 112.156 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -55.97 -36.22 67.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.658 1.183 . . . . 0.0 112.35 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.04 -22.64 63.06 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.066 0.946 . . . . 0.0 113.44 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.2 5.31 6.21 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.543 1.544 . . . . 0.0 114.906 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.61 -123.8 29.61 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 119.054 1.427 . . . . 0.0 112.34 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -58.11 -29.5 87.38 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.553 2.169 . . . . 0.0 113.863 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.4 t -64.51 -18.8 65.14 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.84 -4.64 58.83 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.461 1.904 . . . . 0.0 112.707 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.39 -35.73 0.97 Allowed Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.569 1.557 . . . . 0.0 114.68 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -62.42 133.4 94.56 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.951 1.3 . . . . 0.0 111.016 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.49 163.23 33.31 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.359 2.706 . . . . 0.0 113.128 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.79 159.34 51.83 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.0 2.467 . . . . 0.0 112.662 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.94 -20.91 8.57 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.42 2.747 . . . . 0.0 114.606 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--O 1.254 1.325 0 C-N-CA 126.645 1.978 . . . . 0.0 111.099 175.957 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 118.495 -0.764 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.16 -36.06 60.45 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.381 1.073 . . . . 0.0 113.656 -178.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.04 -34.53 68.31 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.32 1.048 . . . . 0.0 113.16 177.397 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.9 mm -62.83 -47.6 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.522 0.729 . . . . 0.0 109.665 176.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -42.63 99.21 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.799 0.84 . . . . 0.0 111.133 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -61.42 -47.51 85.45 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.41 -36.11 81.33 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.718 -0.614 . . . . 0.0 112.085 174.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.5 tttp -58.89 -35.57 73.23 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.278 1.031 . . . . 0.0 113.376 178.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.5 -7.16 45.77 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.098 1.759 . . . . 0.0 113.502 173.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.81 10.1 29.18 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.071 1.32 . . . . 0.0 114.547 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.9 -129.62 49.81 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-N 119.319 1.559 . . . . 0.0 111.752 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -57.78 -27.29 77.39 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.652 2.234 . . . . 0.0 113.941 178.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.1 m -62.51 -33.47 74.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.887 0.875 . . . . 0.0 112.87 -177.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -15.06 62.7 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 176.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.05 35.79 23.28 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 118.593 0.633 . . . . 0.0 113.828 177.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 143.21 36.84 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.016 1.326 . . . . 0.0 111.761 -178.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.45 160.04 47.75 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.261 2.641 . . . . 0.0 112.064 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.75 152.67 58.84 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.669 2.246 . . . . 0.0 112.034 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.33 105.37 2.03 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.029 3.153 . . . . 0.0 110.328 179.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.697 -1.621 . . . . 0.0 111.016 175.188 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 118.946 -0.55 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.8 mt -58.81 -24.43 61.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.104 1.362 . . . . 0.0 113.632 -178.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -36.11 63.66 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.912 1.285 . . . . 0.0 112.625 178.001 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.8 mt -62.51 -49.59 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.577 0.751 . . . . 0.0 109.673 177.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -63.83 -40.23 96.1 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.394 0.678 . . . . 0.0 111.799 178.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -61.49 -47.22 86.63 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.895 0.878 . . . . 0.0 112.309 174.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.9 mt -64.63 -36.37 84.02 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.331 174.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -57.8 -39.25 77.11 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 178.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.01 -15.69 62.58 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.201 1.0 . . . . 0.0 113.162 176.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.52 8.36 9.22 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.524 1.059 . . . . 0.0 115.272 -177.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.14 -118.51 13.5 Favored Glycine 0 CA--C 1.542 1.74 0 CA-C-N 118.763 1.282 . . . . 0.0 112.608 177.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -58.65 -23.3 64.95 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.514 2.142 . . . . 0.0 114.127 176.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.2 m -92.54 27.89 2.16 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.632 1.173 . . . . 0.0 113.056 -178.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 m -118.07 3.16 12.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.607 1.163 . . . . 0.0 113.462 -176.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.66 28.26 73.55 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.757 0.694 . . . . 0.0 113.612 -178.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -153.71 141.52 13.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.57 1.148 . . . . 0.0 112.566 -176.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.33 165.35 32.78 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.359 2.706 . . . . 0.0 112.132 177.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.72 150.63 86.02 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.886 2.391 . . . . 0.0 111.911 177.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.59 -35.99 0.7 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.192 2.595 . . . . 0.0 113.623 -178.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.733 175.839 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp 63.92 -47.12 0.27 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.648 2.379 . . . . 0.0 115.475 -177.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -55.86 -37.04 68.26 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.76 1.224 . . . . 0.0 112.504 -178.178 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 mt -58.97 -50.03 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.92 1.288 . . . . 0.0 110.611 174.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -61.88 -40.41 95.28 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.806 0.843 . . . . 0.0 111.979 175.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -60.22 -45.55 92.82 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.429 0.559 . . . . 0.0 112.327 172.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.47 -39.25 93.97 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.785 173.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -55.05 -34.34 63.47 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.599 1.091 . . . . 0.0 112.976 176.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.53 -20.28 63.7 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 175.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.57 6.93 14.35 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.22 1.391 . . . . 0.0 113.929 -171.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.96 -127.45 42.99 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-N 118.614 1.207 . . . . 0.0 111.673 -178.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -59.29 -22.57 65.87 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.856 2.37 . . . . 0.0 114.26 177.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 t -61.11 -29.4 69.74 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.089 0.859 . . . . 0.0 113.168 -176.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.4 m -89.37 6.33 41.07 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.685 1.194 . . . . 0.0 113.141 175.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.58 -28.21 0.73 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.518 1.532 . . . . 0.0 115.368 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 ptm85 -56.55 127.59 72.96 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.35 1.46 . . . . 0.0 111.726 175.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -70.17 162.42 42.37 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.737 2.292 . . . . 0.0 111.856 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.08 159.74 52.68 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.786 2.324 . . . . 0.0 112.25 178.454 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -78.28 -18.85 12.3 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.438 2.759 . . . . 0.0 113.912 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 C--O 1.26 1.628 0 CA-C-O 114.251 -2.785 . . . . 0.0 111.116 174.073 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.2 0.54 48.35 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -56.33 -33.94 66.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.346 1.459 . . . . 0.0 113.436 -176.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.56 -43.9 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.11 0.964 . . . . 0.0 110.996 176.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -48.12 80.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.025 0.93 . . . . 0.0 110.861 175.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -60.63 -38.19 83.97 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.26 -37.61 87.93 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.713 -1.137 . . . . 0.0 112.459 171.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -57.68 -32.38 67.27 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.29 1.405 . . . . 0.0 113.244 173.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -67.01 -13.45 61.92 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 174.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.91 11.6 24.13 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.27 1.414 . . . . 0.0 114.045 -174.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.33 -135.17 48.13 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 118.661 1.23 . . . . 0.0 112.037 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.16 -32.01 68.23 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.094 2.529 . . . . 0.0 113.928 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.3 p -63.52 -23.24 67.31 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.76 -3.9 57.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.832 1.253 . . . . 0.0 113.415 176.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.98 -33.99 0.75 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.603 1.573 . . . . 0.0 115.513 177.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -60.68 138.58 93.14 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.986 1.393 . . . . 0.0 111.758 175.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.91 159.3 50.79 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.047 2.498 . . . . 0.0 112.155 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.37 149.96 63.81 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.834 2.356 . . . . 0.0 112.186 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.02 127.37 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.005 3.137 . . . . 0.0 110.275 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 C--O 1.249 1.061 0 C-N-CA 124.323 1.049 . . . . 0.0 113.127 175.962 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 118.712 -0.661 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.19 -34.58 68.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.462 1.505 . . . . 0.0 111.739 -176.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.9 -36.76 65.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.77 1.228 . . . . 0.0 113.215 176.167 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.04 -52.6 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.741 0.817 . . . . 0.0 109.308 177.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -46.15 89.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.79 1.236 . . . . 0.0 110.75 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -55.5 -50.77 69.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.818 1.247 . . . . 0.0 112.478 174.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 mt -62.72 -41.11 99.0 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.614 174.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -55.57 -41.82 73.86 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.3 1.04 . . . . 0.0 111.277 176.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -6.97 26.16 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.06 10.8 31.34 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.888 1.232 . . . . 0.0 114.09 -178.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.08 -119.18 14.51 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.683 1.611 . . . . 0.0 111.922 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.04 -27.37 45.29 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.956 2.437 . . . . 0.0 113.634 176.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 m -59.54 -28.93 67.53 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.94 1.296 . . . . 0.0 113.026 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 t -77.95 -7.21 56.49 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 176.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.03 -9.85 44.05 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.077 1.323 . . . . 0.0 115.07 178.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 -88.42 139.56 30.05 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.751 1.276 . . . . 0.0 110.692 176.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.71 163.32 28.07 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.055 2.503 . . . . 0.0 113.213 174.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.45 136.16 42.1 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.419 2.746 . . . . 0.0 112.262 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -88.66 108.99 0.51 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.048 3.166 . . . . 0.0 112.43 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 116.719 -1.61 . . . . 0.0 113.44 -172.902 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 22.7 t30 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 tp -72.37 4.88 3.31 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -57.32 -37.34 72.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.868 1.267 . . . . 0.0 113.107 -176.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.51 -41.33 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.724 0.809 . . . . 0.0 111.656 177.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -63.55 -41.47 98.43 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.861 0.864 . . . . 0.0 111.852 176.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -64.34 -42.37 96.3 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 173.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.48 -37.68 84.53 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.489 173.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -37.56 59.98 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.329 1.052 . . . . 0.0 113.08 176.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.67 -25.95 63.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.279 0.632 . . . . 0.0 112.57 178.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.34 2.24 5.97 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.873 1.225 . . . . 0.0 114.614 -172.2 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.21 -125.42 38.98 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 119.033 1.417 . . . . 0.0 112.246 177.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.83 -28.71 68.86 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.51 2.14 . . . . 0.0 114.09 178.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 m -74.75 -3.76 33.52 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.7 m -93.38 -4.87 50.7 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.42 -36.02 0.97 Allowed Glycine 0 CA--C 1.539 1.581 0 O-C-N 120.764 -1.21 . . . . 0.0 114.792 -176.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -72.42 134.37 82.36 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 118.914 1.357 . . . . 0.0 111.227 174.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.26 163.98 34.14 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.259 2.64 . . . . 0.0 112.951 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.03 154.22 66.9 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.078 2.519 . . . . 0.0 112.79 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.85 -25.41 3.56 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.869 3.046 . . . . 0.0 114.176 -177.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.345 1.858 . . . . 0.0 111.092 -178.418 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.442 ' O ' HD12 ' A' ' 4' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.913 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -10.13 2.88 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 179.326 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -53.3 -36.19 60.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.842 1.257 . . . . 0.0 113.08 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 1' ' ' ASN . 2.8 mt -63.15 -38.09 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.838 0.855 . . . . 0.0 112.092 177.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -67.96 -46.73 70.59 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.449 1.1 . . . . 0.0 110.67 175.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -60.63 -41.98 96.0 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 175.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.99 -37.48 79.78 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.274 -0.891 . . . . 0.0 111.894 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -34.56 68.85 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.192 0.997 . . . . 0.0 113.06 175.093 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -67.16 -16.75 64.51 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.07 8.71 21.55 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.322 1.439 . . . . 0.0 114.327 -172.648 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.71 -132.94 52.23 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-N 119.149 1.474 . . . . 0.0 112.298 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -56.44 -29.19 76.75 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.885 2.39 . . . . 0.0 113.785 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 m -73.83 3.41 6.65 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.806 1.242 . . . . 0.0 113.965 -177.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.8 13.09 17.15 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.137 1.375 . . . . 0.0 113.813 -176.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.07 24.48 74.58 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.597 1.094 . . . . 0.0 115.067 172.057 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -141.15 135.32 15.09 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.319 1.448 . . . . 0.0 111.564 -170.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.92 160.25 46.38 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.781 2.32 . . . . 0.0 111.711 178.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.29 157.11 60.38 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.942 2.428 . . . . 0.0 112.754 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.51 -16.98 10.31 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.194 3.263 . . . . 0.0 113.733 -179.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p . . . . . 0 C--O 1.245 0.852 0 C-N-CA 127.686 2.394 . . . . 0.0 109.019 -178.427 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 51.0 t30 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mp 61.26 -2.46 0.22 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.968 2.507 . . . . 0.0 115.917 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -39.1 77.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.479 1.511 . . . . 0.0 113.549 -172.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.61 -42.4 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.781 0.832 . . . . 0.0 110.632 175.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.6 -42.43 86.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.974 0.91 . . . . 0.0 111.895 177.467 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 73.0 t90 -61.05 -42.99 99.53 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 172.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.12 -37.12 86.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.26 -0.876 . . . . 0.0 113.361 176.262 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -55.25 -38.33 68.38 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.773 1.169 . . . . 0.0 113.023 176.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.11 3.37 12.72 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.954 1.302 . . . . 0.0 113.828 174.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.7 11.44 43.93 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.273 -1.517 . . . . 0.0 115.603 178.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.68 -110.41 0.93 Allowed Glycine 0 CA--C 1.542 1.778 0 C-N-CA 125.83 1.681 . . . . 0.0 113.665 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -55.72 -26.8 58.16 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.392 2.062 . . . . 0.0 114.15 177.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.8 m -86.59 4.4 40.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.301 1.04 . . . . 0.0 113.505 -178.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.4 m -91.4 -4.8 55.32 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.469 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.09 -10.0 10.94 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -179.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -112.49 139.76 23.02 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.866 1.667 . . . . 0.0 110.269 177.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.38 159.94 41.59 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.911 2.407 . . . . 0.0 112.954 176.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.73 140.81 43.7 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.068 2.512 . . . . 0.0 111.852 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.39 141.07 22.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.909 2.406 . . . . 0.0 110.312 172.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 C--O 1.252 1.199 0 CA-C-O 116.041 -1.933 . . . . 0.0 110.082 177.171 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 66.43 -42.02 0.39 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.237 1.815 . . . . 0.0 114.737 179.676 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.79 -36.96 62.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.132 1.773 . . . . 0.0 113.116 179.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mp -60.18 -48.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.148 0.979 . . . . 0.0 110.748 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -38.69 91.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.261 1.024 . . . . 0.0 111.235 178.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 67.0 t90 -62.67 -49.35 75.47 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.042 0.537 . . . . 0.0 112.318 172.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.6 mt -59.81 -34.35 72.94 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.403 -0.808 . . . . 0.0 112.842 175.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -53.47 -36.71 61.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.986 1.314 . . . . 0.0 113.502 177.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.63 -49.64 45.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.034 0.934 . . . . 0.0 111.49 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.61 25.97 0.02 OUTLIER Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.278 0.942 . . . . 0.0 115.25 179.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.6 -133.85 34.82 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-N 118.574 1.187 . . . . 0.0 112.413 -175.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.97 -25.57 54.16 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.082 2.521 . . . . 0.0 114.703 178.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.6 t -78.28 6.7 7.68 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -90.25 -7.62 53.02 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.494 1.918 . . . . 0.0 113.941 -176.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.6 -18.79 3.5 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 120.685 -1.26 . . . . 0.0 115.739 -176.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.6 ttt-85 -100.95 138.22 19.96 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.323 1.449 . . . . 0.0 110.963 176.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.0 159.8 47.46 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.797 2.332 . . . . 0.0 112.842 175.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.37 147.29 71.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.175 2.583 . . . . 0.0 111.432 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.3 150.35 36.77 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.652 2.235 . . . . 0.0 111.037 175.333 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 C--O 1.248 0.99 0 C-N-CA 127.266 2.226 . . . . 0.0 109.14 172.261 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt -77.6 2.18 17.35 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -177.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -60.85 -34.43 74.57 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.762 1.225 . . . . 0.0 112.961 -177.181 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.9 mp -58.01 -52.7 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.315 0.646 . . . . 0.0 109.947 175.518 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -40.13 87.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.88 0.872 . . . . 0.0 112.184 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -62.82 -45.93 90.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.205 0.602 . . . . 0.0 112.468 173.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.13 -37.24 84.39 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.157 -0.925 . . . . 0.0 113.127 175.744 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -54.34 -31.78 55.19 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.524 1.056 . . . . 0.0 113.591 175.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.66 -13.23 60.6 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 176.545 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.89 2.64 20.46 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.867 1.698 . . . . 0.0 115.29 -177.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.17 -128.69 34.03 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 118.701 1.25 . . . . 0.0 112.877 175.651 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.24 -24.38 67.01 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.585 2.19 . . . . 0.0 114.106 179.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.6 m -87.64 20.24 3.05 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.463 1.105 . . . . 0.0 113.467 -176.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -120.36 6.5 10.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.921 1.288 . . . . 0.0 113.698 -171.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.61 27.11 73.02 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.013 0.816 . . . . 0.0 114.136 178.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.26 132.6 10.93 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.985 1.314 . . . . 0.0 111.796 -174.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.62 157.91 57.35 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.736 2.291 . . . . 0.0 111.854 178.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.66 154.81 59.47 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.079 2.519 . . . . 0.0 112.007 178.108 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.03 139.42 24.2 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.876 2.384 . . . . 0.0 111.124 175.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.845 171.925 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.69 7.04 13.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.246 1.418 . . . . 0.0 114.13 -169.679 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.94 -29.93 69.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.577 1.551 . . . . 0.0 113.094 -176.343 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.51 -52.09 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.909 0.884 . . . . 0.0 110.195 177.291 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -57.03 -49.67 75.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.836 0.855 . . . . 0.0 111.49 174.096 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -57.52 -43.01 83.94 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 178.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.0 mt -67.01 -39.21 87.01 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.225 -0.922 . . . . 0.0 112.576 172.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.94 -35.9 62.23 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.133 1.373 . . . . 0.0 113.373 176.742 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -72.3 -19.4 61.67 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 174.721 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.91 8.74 7.88 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.731 1.157 . . . . 0.0 115.118 -175.487 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.96 -124.25 31.9 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 119.09 1.445 . . . . 0.0 113.192 175.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.04 -28.48 60.27 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.721 2.281 . . . . 0.0 113.951 179.661 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -76.44 -3.76 38.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.094 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.1 m -91.44 -3.83 56.22 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.345 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.51 -33.68 1.37 Allowed Glycine 0 CA--C 1.539 1.538 0 O-C-N 120.93 -1.106 . . . . 0.0 115.163 -179.063 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -74.18 135.5 76.44 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 118.883 1.341 . . . . 0.0 110.673 176.037 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.02 161.01 47.6 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.928 2.419 . . . . 0.0 112.842 -178.234 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.09 138.79 44.73 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.31 2.673 . . . . 0.0 111.75 -179.656 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.92 138.15 16.36 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.824 2.35 . . . . 0.0 111.222 177.505 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.511 1.925 . . . . 0.0 111.604 177.389 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 117.974 -1.013 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 tp -57.76 -16.36 10.97 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.12 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.16 -36.25 40.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.434 1.494 . . . . 0.0 112.975 176.747 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.18 -44.72 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.009 0.924 . . . . 0.0 110.589 176.487 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.57 -44.8 85.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.202 0.601 . . . . 0.0 110.945 174.088 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.8 t90 -60.11 -38.13 82.1 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 176.226 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.2 mt -63.32 -33.5 75.66 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.995 -1.065 . . . . 0.0 112.245 171.963 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -58.11 -35.87 72.09 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.482 1.113 . . . . 0.0 112.622 175.896 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.05 -20.72 66.63 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 173.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.64 7.75 10.5 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.344 1.449 . . . . 0.0 114.755 -171.796 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.95 -132.95 51.13 Favored Glycine 0 CA--C 1.542 1.769 0 CA-C-N 119.203 1.501 . . . . 0.0 112.446 -176.014 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -55.35 -30.81 74.41 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.512 2.808 . . . . 0.0 114.603 -178.202 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 64.5 m -79.59 14.62 1.58 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.059 1.344 . . . . 0.0 113.94 -175.553 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -112.82 3.5 16.45 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -168.799 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.63 21.45 78.8 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.738 1.161 . . . . 0.0 114.921 178.642 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -144.55 135.44 12.32 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.058 1.343 . . . . 0.0 111.557 -174.589 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.98 158.92 56.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.021 2.481 . . . . 0.0 111.851 -179.093 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.89 151.49 68.34 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.582 2.188 . . . . 0.0 111.556 177.523 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.89 150.32 11.06 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.437 2.758 . . . . 0.0 112.105 175.791 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.581 1.952 . . . . 0.0 113.709 -177.062 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 118.631 -0.699 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 2' ' ' LEU . 0.3 OUTLIER -52.94 -40.58 63.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.942 1.297 . . . . 0.0 113.21 177.062 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -64.82 -35.72 82.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.053 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.8 mt -62.63 -43.41 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.886 0.874 . . . . 0.0 110.173 176.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -41.69 92.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.252 1.021 . . . . 0.0 112.088 174.917 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -65.25 -43.46 91.26 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 173.522 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.4 mt -60.34 -39.49 87.28 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.506 174.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -50.69 -37.53 41.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.33 1.052 . . . . 0.0 113.028 178.019 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.5 -16.63 60.84 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.016 0.926 . . . . 0.0 113.27 -179.591 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.34 11.06 6.32 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.166 1.365 . . . . 0.0 115.095 -175.477 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.48 -119.54 7.44 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.055 1.312 . . . . 0.0 113.295 -178.418 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.9 -26.6 75.12 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.607 2.205 . . . . 0.0 114.188 177.167 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t -82.47 -0.87 48.33 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.201 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.9 m -84.5 -9.52 58.28 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.455 1.902 . . . . 0.0 114.668 -175.48 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.01 13.05 84.08 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 115.006 -174.787 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -137.89 136.3 19.7 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 118.875 1.338 . . . . 0.0 110.971 -178.083 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.26 160.41 42.41 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.053 2.502 . . . . 0.0 112.9 178.732 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.2 149.37 70.38 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.042 2.495 . . . . 0.0 112.022 179.049 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.34 -10.29 6.68 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.76 2.973 . . . . 0.0 114.191 -179.237 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.985 0 C-N-CA 127.315 2.246 . . . . 0.0 108.649 178.419 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.2 mt -97.05 4.1 51.54 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.222 1.374 . . . . 0.0 114.396 -176.709 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -58.25 -35.69 72.12 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.067 0.947 . . . . 0.0 112.92 -175.397 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mp -61.42 -50.38 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.324 1.05 . . . . 0.0 110.448 176.266 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -59.37 -44.58 92.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.577 1.151 . . . . 0.0 112.067 174.859 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -60.47 -46.36 90.38 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 175.924 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.14 -42.04 94.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.86 171.593 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -25.7 63.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.141 0.976 . . . . 0.0 113.557 177.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.1 -12.34 59.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 173.852 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.24 4.03 14.43 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.051 1.31 . . . . 0.0 115.248 -177.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.55 -130.58 48.58 Favored Glycine 0 CA--C 1.545 1.963 0 CA-C-N 119.567 1.684 . . . . 0.0 112.766 177.548 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -66.86 11.15 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.806 3.004 . . . . 0.0 115.935 -177.481 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.0 m -115.96 12.18 15.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.836 1.654 . . . . 0.0 113.501 -175.247 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -120.26 8.77 10.91 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.635 1.174 . . . . 0.0 113.575 -167.383 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.62 20.55 74.05 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.301 0.953 . . . . 0.0 114.963 178.881 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -136.45 133.92 19.51 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.261 1.424 . . . . 0.0 112.007 -174.085 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -70.44 159.32 53.32 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.678 2.252 . . . . 0.0 111.894 177.695 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.37 146.56 45.27 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.886 2.39 . . . . 0.0 111.987 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.65 127.63 5.73 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.634 2.89 . . . . 0.0 111.63 178.116 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.248 1.009 0 C-N-CA 126.758 2.023 . . . . 0.0 109.68 174.883 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.89 -8.41 3.1 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -178.757 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -54.66 -34.86 62.84 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.864 1.666 . . . . 0.0 113.019 -178.279 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.2 mt -60.48 -47.85 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.593 1.157 . . . . 0.0 110.378 175.514 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.42 -39.36 81.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.04 1.336 . . . . 0.0 111.471 178.432 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -62.41 -44.31 96.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.021 0.929 . . . . 0.0 112.827 173.083 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.15 -42.29 98.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.008 172.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -53.14 -32.84 49.64 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 176.493 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -76.06 -18.93 59.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.931 0.892 . . . . 0.0 113.346 177.242 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.15 9.3 5.66 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.856 1.217 . . . . 0.0 115.231 -175.791 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.66 -118.97 7.68 Favored Glycine 0 CA--C 1.544 1.876 0 CA-C-N 118.941 1.371 . . . . 0.0 113.379 -178.991 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.3 -26.92 72.86 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.644 2.23 . . . . 0.0 114.452 178.342 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -81.26 1.29 33.01 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -179.447 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -89.28 -1.95 58.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.89 1.676 . . . . 0.0 114.582 -176.8 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.88 -36.73 1.25 Allowed Glycine 0 CA--C 1.539 1.54 0 O-C-N 120.442 -1.411 . . . . 0.0 114.709 -177.433 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -83.23 136.79 43.05 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.706 1.253 . . . . 0.0 111.425 175.081 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.56 164.68 25.41 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.439 2.76 . . . . 0.0 113.087 174.533 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 156.18 64.62 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.713 2.275 . . . . 0.0 112.519 -179.92 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.64 -24.79 4.03 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.595 2.864 . . . . 0.0 114.285 -178.685 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 C--O 1.257 1.476 0 CA-C-O 114.592 -2.623 . . . . 0.0 109.985 -176.429 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -51.66 -40.05 59.29 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.171 1.35 . . . . 0.0 113.611 -175.742 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.28 -29.1 68.59 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.881 0.872 . . . . 0.0 113.263 177.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.6 mm -66.54 -51.12 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.577 1.151 . . . . 0.0 109.454 176.648 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -54.48 -51.85 63.77 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.19 0.996 . . . . 0.0 110.839 173.024 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.7 t90 -57.7 -44.46 85.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.829 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.2 mt -61.65 -37.06 82.64 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.225 -0.922 . . . . 0.0 111.963 172.377 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.24 -16.31 61.8 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.286 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.63 -9.74 51.09 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.488 1.515 . . . . 0.0 113.252 169.235 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.32 5.39 19.31 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.077 1.323 . . . . 0.0 114.625 -178.515 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.64 -130.25 48.04 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 119.165 1.482 . . . . 0.0 111.693 -178.498 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.97 -32.8 69.81 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.891 2.394 . . . . 0.0 113.814 179.638 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 m -63.67 -22.37 66.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.837 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -3.89 56.67 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 174.774 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.13 -30.5 0.95 Allowed Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.18 1.371 . . . . 0.0 115.345 177.851 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 ttt85 -65.92 133.8 94.95 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 118.886 1.343 . . . . 0.0 110.513 175.183 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.57 160.27 43.95 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.702 2.268 . . . . 0.0 112.463 178.833 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.34 153.83 70.27 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.796 2.331 . . . . 0.0 112.121 179.253 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.64 130.56 12.74 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.477 2.784 . . . . 0.0 110.666 176.032 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.253 1.256 0 C-N-CA 126.486 1.914 . . . . 0.0 113.03 171.797 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 118.78 -0.629 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.96 7.87 25.64 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -173.079 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.84 -39.86 72.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.347 1.459 . . . . 0.0 112.782 -173.881 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.14 -45.21 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.727 0.811 . . . . 0.0 110.526 177.106 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -35.23 77.96 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 176.964 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -64.93 -45.25 86.64 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.484 0.584 . . . . 0.0 112.249 171.99 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.6 mt -65.48 -32.44 74.05 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.753 -1.118 . . . . 0.0 113.514 176.315 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -52.96 -37.25 60.93 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.544 1.065 . . . . 0.0 113.617 176.791 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.17 -52.57 18.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.637 0.775 . . . . 0.0 111.341 179.329 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.43 29.35 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 N-CA-C 115.307 0.883 . . . . 0.0 115.307 177.772 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.45 -133.24 34.6 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.431 1.116 . . . . 0.0 112.236 -177.022 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.49 -24.57 62.1 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.184 2.589 . . . . 0.0 114.461 178.393 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 m -75.03 -11.24 60.06 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.994 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -69.64 -10.38 57.99 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.716 1.606 . . . . 0.0 113.46 177.779 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.94 -35.73 2.12 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.051 1.31 . . . . 0.0 114.292 -177.528 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -79.47 138.12 55.33 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 118.551 1.175 . . . . 0.0 111.328 174.665 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.01 160.68 36.61 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.615 2.877 . . . . 0.0 113.339 175.199 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.48 155.51 55.07 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.012 2.475 . . . . 0.0 112.507 179.597 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.61 -18.27 8.19 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.61 2.873 . . . . 0.0 114.177 179.142 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.417 1.487 . . . . 0.0 112.818 -178.968 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.8 p30 . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mt -75.59 5.06 6.5 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -175.861 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -59.32 -31.97 69.65 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.928 1.291 . . . . 0.0 113.053 -177.631 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mp -57.73 -49.78 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.448 0.699 . . . . 0.0 110.188 174.97 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.58 -45.16 94.99 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.917 0.887 . . . . 0.0 111.284 -179.121 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -59.65 -47.93 83.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.687 0.795 . . . . 0.0 112.283 175.461 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.56 -40.37 96.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.377 173.749 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -57.79 -38.83 76.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.521 1.128 . . . . 0.0 112.701 -179.4 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -20.05 63.64 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.918 1.287 . . . . 0.0 113.009 176.049 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.31 8.88 5.77 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.1 1.333 . . . . 0.0 114.806 -176.701 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.24 -124.95 37.54 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 119.022 1.411 . . . . 0.0 111.632 -177.205 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -56.31 -30.42 80.7 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.165 2.577 . . . . 0.0 114.178 178.379 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 m -75.34 12.05 1.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.907 1.283 . . . . 0.0 114.007 -178.11 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.99 3.32 20.33 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.916 1.686 . . . . 0.0 113.288 -172.726 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.51 20.41 75.47 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.363 -0.835 . . . . 0.0 114.222 -175.417 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.11 129.59 19.01 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.765 1.226 . . . . 0.0 110.92 -170.202 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.26 159.95 49.85 Favored 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.104 2.536 . . . . 0.0 113.221 -178.998 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.65 122.35 9.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.571 2.847 . . . . 0.0 111.461 -179.351 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.16 131.56 13.1 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.49 2.127 . . . . 0.0 110.517 178.137 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.257 1.477 0 CA-C-O 116.439 -1.744 . . . . 0.0 110.093 172.572 . . . . . . . . 0 0 . 1 stop_ save_